Introduction - Marsland Press



Updates in management of Parathyroid Gland TumorsRafik Ramsis Morcos, Abdallah Hamed Ibrahim and Mohammad Refaat Nor-EldinGeneral Surgery Department, Faculty of Medicine, Ain Shams University, Egypt.m.refat1987@Abstract: Background: Primary hyperparathyroidism emerged from relative obscurity before the 1970s to become the third most common endocrine disorder in more recent times. Pathological correlates in primary hyperparathyroidism include parathyroid adenoma (80-85%) and hyperplasia (10-15%) and malignancy, which can occur in <1-5% of patients. In the past, both benign and malignant parathyroid disease would present symptomatically in affected patients. However, with the advance of routine serum calcium testing, the majority of patients with benign hyperparathyroidism are now diagnosed incidentally and asymptomatically. In addition to clinical and biochemical information, certain radiological features can help to distinguish benign from malignant parathyroid disease in the preoperative setting in all patients with primary hyperparathyroidism, radiological investigations is warranted to assess the extent of disease for treatment planning. Patients with primary hyperparathyroidism and symptoms or signs should undergo surgical removal of their parathyroid gland (s). Aim of the Work: The aim of this essay is to review the management of parathyroid glands tumours and the most recent updates in the parathyroid glands surgeries. Conclusion: Parathyroid surgery has evolved from conventional open parathyroidectomy, with exploration of all four parathyroid glands, to minimal access open or endoscopic parathyroidectomy. This evolution was made possible by the development of high resolution radiological techniques and the development of the rapid IOPTH assay. Sonography and technetium-99m-sestamibi (99mTc-sestamibi) scintigraphy are the most commonly used imaging techniques for the demonstration of parathyroid lesions. Neck ultrasonography is a non-invasive and relatively inexpensive tool that should be considered in all patients with overt hyperparathyroidism. The recent development and adoption of 99technetium-labelled sestamibi (99mTc-sestamibi) scintigraphy has enhanced our ability to distinguish between single-gland and multigland parathyroid disease. Although not routine, CT scan of the neck and chest may also be indicated in some cases to assess for disseminated disease. Recently, some investigators described a promising method by which a 3rd-generation to 2nd-generation PTH ratio >1 can help predict whether a parathyroid tumor is more likely to be malignant in the preoperative setting (sensitivity: ~75-82%; specificity: ~97-98%).. Rapid intraoperative assay is extremely helpful in confirming the complete removal of abnormal “hyperfunctioning” parathyroid tissue (demonstrated by >50% decrease in circulating PTH level 10-15 min after surgical excision), and can help distinguish between single-gland and multi-gland disease. Patients with primary hyperparathyroidism and symptoms or signs should undergo surgical removal of their parathyroid gland (s). However. In some patients, with medical comorbidities may preclude surgery, controlling hypercalcemia alone may be the goal.[Rafik Ramsis Morcos, Abdallah Hamed Ibrahim and Mohammad Refaat Nor-Eldin. Updates in management of Parathyroid Gland Tumors. Researcher 2019;11(8):30-41]. ISSN 1553-9865 (print); ISSN 2163-8950 (online). . 5. doi:10.7537/marsrsj110819.05.Keywords: Primary hyperparathyroidism, parathyroid adenoma, (99mTc-sestamibi) scintigraphy, Minimal invasive parathyroidectomy, endoscopicparathyroidectomy.IntroductionThe parathyroid glands are small glands located in the neck near the thyroid gland. Usually, 4 parathyroid glands develop, and are responsible for maintaining normal serum calcium levels. This is essential for normal bone metabolism, muscle and nerve physiology, in the nonpathologic state. The parathyroid glands respond to low serum calcium levels by releasing parathyroid hormone (PTH), PTH increases serum calcium levels through direct action on bone and the kidneys (1).The term primary hyperparathyroidism (P-HPT) refers to the inappropriate overproduction of parathyroid hormone (PTH), resulting in abnormal calcium homeostasis. High levels of PTH lead to increased renal resorption of calcium, phosphaturia, increased synthesis of 1,24 (OH)2D3 and increased bone resorption. Primary hyperparathyroidism emerged from relative obscurity before the 1970s to become the third most common endocrine disorder in more recent times (2).Pathological correlates in primary hyperparathyroidism include parathyroid adenoma (80-85%) and hyperplasia (10-15%) and malignancy, which can occur in <1-5% of patients (3).In addition to clinical and biochemical information, certain radiological features can help distinguish benign from malignant parathyroid disease in the preoperative setting (4).Nonetheless, in all patients with primary hyperparathyroidism, radiological investigations is warranted to assess the extent of disease for treatment planning (5).Parathyroid surgery has evolved from conventional open parathyroidectomy, with exploration of all four parathyroid glands, to minimal access open or endoscopic parathyroidectomy (6).Aim of the WorkThe aim of this essay is to review the management of parathyroid glands tumours and the most recent updates in the parathyroid glands surgeries.Anatomy of Parathyroid GlandsEmbryological backgroundThe parathyroid glands develop from the endoderm epithelial cells of third and fourth pharyngeal pouches in weeks 5-6 of gestation ADDIN EN.CITE <EndNote><Cite><Author>Scharpf</Author><Year>2016</Year><RecNum>5502</RecNum><DisplayText>(Scharpf et al. 2016)</DisplayText><record><rec-number>5502</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5502</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Scharpf, Joseph</author><author>Kyriazidis, Natalia</author><author>Kamani, Dipti</author><author>Randolph, Gregory</author></authors></contributors><titles><title>Anatomy and embryology of the parathyroid gland</title><secondary-title>Operative Techniques in Otolaryngology-Head and Neck Surgery</secondary-title></titles><periodical><full-title>Operative Techniques in Otolaryngology-Head and Neck Surgery</full-title></periodical><pages>117-121</pages><volume>27</volume><number>3</number><keywords><keyword>Parathyroid glands anatomy</keyword><keyword>Recurrent laryngeal nerve</keyword><keyword>failed surgical explorations</keyword><keyword>Parathyroid gland embryology</keyword><keyword>ectopic locations</keyword><keyword>supernumerary glands</keyword></keywords><dates><year>2016</year><pub-dates><date>9//</date></pub-dates></dates><isbn>1043-1810</isbn><urls><related-urls><url>;(7). The inferior parathyroid glands arise from a more superior pharyngeal location (third pouch) than the superior thyroids (fourth pouch). The developing glands detach from the pouches at the fifth week of development, and descend to join the thyroid gland during the seventh week. In normal development the attachment is lost and the inferior parathyroid glands take up their normal position posterior to the thyroid, deviation of the normal will result in ectopic parathyroid glands ADDIN EN.CITE <EndNote><Cite><Author>Stewart</Author><Year>2012</Year><RecNum>5489</RecNum><DisplayText>(Stewart et al. 2012)</DisplayText><record><rec-number>5489</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5489</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Stewart, William B.</author><author>Rizzolo, Lawrence J.</author></authors><secondary-authors><author>Oertli, Daniel</author><author>Udelsman, Robert</author></secondary-authors></contributors><titles><title>Embryology and Surgical Anatomy of the Thyroid and Parathyroid Glands</title><secondary-title>Surgery of the Thyroid and Parathyroid Glands</secondary-title></titles><pages>15-23</pages><dates><year>2012</year></dates><pub-location>Berlin, Heidelberg</pub-location><publisher>Springer Berlin Heidelberg</publisher><isbn>978-3-642-23459-0</isbn><label>Stewart2012</label><urls><related-urls><url>;(8).Figure (1): Embryology of the thyroid and parathyroid and their development from the pharyngeal pouches. TD = thyroglossal diverticulum, PT = parathyroid ADDIN EN.CITE <EndNote><Cite><Author>Stewart</Author><Year>2012</Year><RecNum>5489</RecNum><DisplayText>(Stewart et al. 2012)</DisplayText><record><rec-number>5489</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5489</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Stewart, William B.</author><author>Rizzolo, Lawrence J.</author></authors><secondary-authors><author>Oertli, Daniel</author><author>Udelsman, Robert</author></secondary-authors></contributors><titles><title>Embryology and Surgical Anatomy of the Thyroid and Parathyroid Glands</title><secondary-title>Surgery of the Thyroid and Parathyroid Glands</secondary-title></titles><pages>15-23</pages><dates><year>2012</year></dates><pub-location>Berlin, Heidelberg</pub-location><publisher>Springer Berlin Heidelberg</publisher><isbn>978-3-642-23459-0</isbn><label>Stewart2012</label><urls><related-urls><url>;(8).AnatomyNormally, the two pairs of parathyroid glands are located along the posterior aspect of the thyroid gland. However, there can be 5 or more glands present, but it is rare to find less than 4 glands. In a Large autopsy series by Akerstrom and his colleagues, 4 glands were seen in 84% of patients and 3% of the patients had only 3 glands. There was 13% incidence of supernumerary glands. The supernumerary parathyroid glands were quite small, less than 5 mg, and were located in close proximity to normal glands, another common locations are in the thymus and in the mediastinum ADDIN EN.CITE <EndNote><Cite><Author>Akerstrom</Author><Year>1984</Year><RecNum>5449</RecNum><DisplayText>(Akerstrom et al. 1984)</DisplayText><record><rec-number>5449</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5449</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Akerstrom, G.</author><author>Malmaeus, J.</author><author>Bergstrom, R.</author></authors></contributors><titles><title>Surgical anatomy of human parathyroid glands</title><secondary-title>Surgery</secondary-title><alt-title>Surgery</alt-title></titles><periodical><full-title>Surgery</full-title><abbr-1>Surgery</abbr-1></periodical><alt-periodical><full-title>Surgery</full-title><abbr-1>Surgery</abbr-1></alt-periodical><pages>14-21</pages><volume>95</volume><number>1</number><edition>1984/01/01</edition><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Autopsy</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/surgery</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Glands/*anatomy &amp; histology/pathology</keyword></keywords><dates><year>1984</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0039-6060 (Print)&#xD;0039-6060</isbn><accession-num>6691181</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(9).It is important to consider this numeric variation by surgeons performing parathyroid explorations.The glands are ovoid glands weighing roughly 35-40 mg and measuring 3-8 mm in all dimensions. They have been described as flat-bean or leaf-like shaped, yellow tan or caramel in color and thus may be distinguished from the closely associated fat which is brighter, less distinct yellow ADDIN EN.CITE <EndNote><Cite><Author>Kalinin</Author><Year>2013</Year><RecNum>5491</RecNum><DisplayText>(Kalinin et al. 2013)</DisplayText><record><rec-number>5491</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5491</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Kalinin, Arian P.</author><author>Pavlov, Alexey V.</author><author>Alexandrov, Yury K.</author><author>Kotova, Irina V.</author><author>Patrunov, Yury N.</author><author>Pamputis, Sergey N.</author></authors></contributors><titles><title>Embryonic Development and Anatomic and Histological Structure of the Parathyroid Glands</title><secondary-title>The Parathyroid Glands: Imaging and Surgery</secondary-title></titles><pages>1-12</pages><dates><year>2013</year></dates><pub-location>Berlin, Heidelberg</pub-location><publisher>Springer Berlin Heidelberg</publisher><isbn>978-3-642-30873-4</isbn><label>Kalinin2013</label><urls><related-urls><url>;(10).The glands are primarily subserved by the inferior thyroid artery, which is the primary vascular supply to both upper and lower parathyroid glands in 76%-86% of cases and only in 15 % of cases, the superior parathyroid glands receive blood from the superior thyroid artery, and in 5 % of cases, from anastomoses of two thyroid arterial systems ADDIN EN.CITE <EndNote><Cite><Author>Pavlov</Author><Year>2004</Year><RecNum>5460</RecNum><DisplayText>(Pavlov 2004)</DisplayText><record><rec-number>5460</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5460</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pavlov, A. V.</author></authors></contributors><titles><title>[Adrenergic regulation of the structure and function of the parathyroid glands]</title><secondary-title>Morfologiia</secondary-title><alt-title>Morfologiia (Saint Petersburg, Russia)</alt-title></titles><periodical><full-title>Morfologiia</full-title><abbr-1>Morfologiia (Saint Petersburg, Russia)</abbr-1></periodical><alt-periodical><full-title>Morfologiia</full-title><abbr-1>Morfologiia (Saint Petersburg, Russia)</abbr-1></alt-periodical><pages>103-8</pages><volume>125</volume><number>3</number><edition>2004/09/14</edition><keywords><keyword>Animals</keyword><keyword>Catecholamines/metabolism</keyword><keyword>Cell Division/physiology</keyword><keyword>Humans</keyword><keyword>Parathyroid Glands/cytology/*innervation/metabolism/physiology</keyword><keyword>Receptors, Adrenergic/*physiology</keyword><keyword>Sympathetic Nervous System/*physiology</keyword></keywords><dates><year>2004</year></dates><orig-pub>Adrenergicheskaia reguliatsiia struktury i funktsii okoloshchitovidnykh zhelez.</orig-pub><isbn>1026-3543 (Print)&#xD;1026-3543</isbn><accession-num>15359709</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>rus</language></record></Cite></EndNote>(11).The venous blood of the parathyroid glands flows through the veins of the thyroid, trachea, and esophagus. The superior, median and inferior neck sympathetic nodes and stellate ganglia are sources of sympathetic innervations while parasympathetic sources are the vagus and descending branches of the hypoglossal and glossopharyngeal nerves, spinal nodes of CV–DII segments and vagal nodulous ganglia are the source of the sensitive fibers to parathyroid glands ( ADDIN EN.CITE <EndNote><Cite><Author>Pavlov</Author><Year>2004</Year><RecNum>5460</RecNum><DisplayText>(Pavlov 2004)</DisplayText><record><rec-number>5460</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5460</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pavlov, A. V.</author></authors></contributors><titles><title>[Adrenergic regulation of the structure and function of the parathyroid glands]</title><secondary-title>Morfologiia</secondary-title><alt-title>Morfologiia (Saint Petersburg, Russia)</alt-title></titles><periodical><full-title>Morfologiia</full-title><abbr-1>Morfologiia (Saint Petersburg, Russia)</abbr-1></periodical><alt-periodical><full-title>Morfologiia</full-title><abbr-1>Morfologiia (Saint Petersburg, Russia)</abbr-1></alt-periodical><pages>103-8</pages><volume>125</volume><number>3</number><edition>2004/09/14</edition><keywords><keyword>Animals</keyword><keyword>Catecholamines/metabolism</keyword><keyword>Cell Division/physiology</keyword><keyword>Humans</keyword><keyword>Parathyroid Glands/cytology/*innervation/metabolism/physiology</keyword><keyword>Receptors, Adrenergic/*physiology</keyword><keyword>Sympathetic Nervous System/*physiology</keyword></keywords><dates><year>2004</year></dates><orig-pub>Adrenergicheskaia reguliatsiia struktury i funktsii okoloshchitovidnykh zhelez.</orig-pub><isbn>1026-3543 (Print)&#xD;1026-3543</isbn><accession-num>15359709</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>rus</language></record></Cite></EndNote>11).Etiology and Pathophysiology of Primary HyperparathyroidismPrimary hyperparathyroidism (PHPT) is characterized by excessive secretion of parathyroid hormone (PTH) leading to hypercalcemia and a tendency toward hypophosphatemia ADDIN EN.CITE <EndNote><Cite><Author>Limone</Author><Year>2016</Year><RecNum>5501</RecNum><DisplayText>(Limone et al. 2016)</DisplayText><record><rec-number>5501</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5501</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Limone, Paolo P.</author><author>Deandrea, Maurilio</author><author>Gamarra, Elena</author><author>Garino, Francesca</author><author>Grassi, Aurora</author><author>Magliona, Gabriella</author><author>Mormile, Alberto</author><author>Ragazzoni, Federico</author><author>Ramunni, Maria Josefina</author><author>Razzore, Paola</author></authors><secondary-authors><author>Gasparri, Guido</author><author>Palestini, Nicola</author><author>Camandona, Michele</author></secondary-authors></contributors><titles><title>Etiology and Pathogenesis of Primary Hyperparathyroidism and Hypercalcemias</title><secondary-title>Primary, Secondary and Tertiary Hyperparathyroidism: Diagnostic and Therapeutic Updates</secondary-title></titles><pages>41-55</pages><dates><year>2016</year></dates><pub-location>Milano</pub-location><publisher>Springer Milan</publisher><isbn>978-88-470-5758-6</isbn><label>Limone2016</label><urls><related-urls><url>;(12).Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia in the outpatient setting. PHPT is twice to three times more common among women compared to males. The incidence is more common in subjects over 50 years of age and in postmenopausal women. The prevalence of PHPT in patients evaluated in reference centers is about 0.78% ADDIN EN.CITE <EndNote><Cite><Author>Erickson</Author><Year>2014</Year><RecNum>5496</RecNum><DisplayText>(Erickson 2014)</DisplayText><record><rec-number>5496</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5496</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Erickson, L.A.</author></authors></contributors><titles><title>Atlas of Endocrine Pathology</title></titles><dates><year>2014</year></dates><publisher>Springer New York</publisher><isbn>9781493904433</isbn><urls><related-urls><url>;(13).The parathyroid glands respond to low serum calcium levels by releasing PTH, which is an 84-amino acid peptide. PTH increases serum calcium levels through direct action on bone and the kidneys ADDIN EN.CITE <EndNote><Cite><Author>Michels</Author><Year>2013</Year><RecNum>5494</RecNum><DisplayText>(Michels et al. 2013)</DisplayText><record><rec-number>5494</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Michels, T. C.</author><author>Kelly, K. M.</author></authors></contributors><auth-address>Department of Family Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. Thomas.c.michels@us.army.mil</auth-address><titles><title>Parathyroid disorders</title><secondary-title>Am Fam Physician</secondary-title><alt-title>American family physician</alt-title></titles><periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></periodical><alt-periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></alt-periodical><pages>249-57</pages><volume>88</volume><number>4</number><edition>2013/08/16</edition><keywords><keyword>Absorptiometry, Photon</keyword><keyword>Asymptomatic Diseases</keyword><keyword>Bone Diseases, Metabolic/etiology</keyword><keyword>Calcitriol/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/etiology</keyword><keyword>Hyperparathyroidism, Primary/diagnosis/therapy</keyword><keyword>Hyperparathyroidism, Secondary/diagnosis/etiology/therapy</keyword><keyword>Hypocalcemia/etiology</keyword><keyword>Hypoparathyroidism/diagnosis/etiology/therapy</keyword><keyword>Parathyroid Diseases/*diagnosis/etiology/therapy</keyword><keyword>Renal Insufficiency, Chronic/complications</keyword></keywords><dates><year>2013</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0002-838x</isbn><accession-num>23944728</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(14).It stimulates osteoclasts to resorb bone and mobilize calcium into the blood. In the kidneys, PTH acts to reduce calcium clearance and stimulates synthesis of 1, 25-dihydroxyvitamin D, which stimulates calcium absorption in the gastrointestinal tract (Figure 2).Parathyroid disorders most commonly present with serum calcium abnormalities. The estimated incidence of primary hyperparathyroidism is approximately 25 cases per 100,000 persons per year in outpatients of Western countries, with a prevalence of one to four per 1,000 persons. Multiple endocrine neoplasia type 1 (MEN-1) and type 2 (MEN-2), which often include parathyroid neoplasia, each occur in about two per100,000 persons per year. Parathyroid cancer is rare, with an incidence of approximately four per 10 million persons per year ( ADDIN EN.CITE <EndNote><Cite><Author>Michels</Author><Year>2013</Year><RecNum>5494</RecNum><DisplayText>(Michels et al. 2013)</DisplayText><record><rec-number>5494</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Michels, T. C.</author><author>Kelly, K. M.</author></authors></contributors><auth-address>Department of Family Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. Thomas.c.michels@us.army.mil</auth-address><titles><title>Parathyroid disorders</title><secondary-title>Am Fam Physician</secondary-title><alt-title>American family physician</alt-title></titles><periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></periodical><alt-periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></alt-periodical><pages>249-57</pages><volume>88</volume><number>4</number><edition>2013/08/16</edition><keywords><keyword>Absorptiometry, Photon</keyword><keyword>Asymptomatic Diseases</keyword><keyword>Bone Diseases, Metabolic/etiology</keyword><keyword>Calcitriol/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/etiology</keyword><keyword>Hyperparathyroidism, Primary/diagnosis/therapy</keyword><keyword>Hyperparathyroidism, Secondary/diagnosis/etiology/therapy</keyword><keyword>Hypocalcemia/etiology</keyword><keyword>Hypoparathyroidism/diagnosis/etiology/therapy</keyword><keyword>Parathyroid Diseases/*diagnosis/etiology/therapy</keyword><keyword>Renal Insufficiency, Chronic/complications</keyword></keywords><dates><year>2013</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0002-838x</isbn><accession-num>23944728</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>14).Most patients suffering from primary hyperparathyroidism todays are asymptomatic, with nephrolithiasis occurring in up to 15% of patients, bone disease (formerly osteitisfbrosacystica) occurring in 2% of patients, and neuromuscular symptoms occurring rarely. Although marked symptoms are uncommon in Western countries, it is important to be aware that subtle and nonspecific symptoms may be present. Other causes of hypercalcemia are listed in Overall, 85% of patients with primary hyperparathyroidism have a single adenoma, Multiglandular hyperplasia accounts for 10% to 15% of patients with primary hyperparathyroidism, and carcinoma accounts for 1% or less. There are also uncommon familial causes, such as MEN-1 and MEN-2A; persons with these conditions may have parathyroid adenomas or asymmetric hyperplasia ADDIN EN.CITE <EndNote><Cite><Author>Michels</Author><Year>2013</Year><RecNum>5494</RecNum><DisplayText>(Michels et al. 2013)</DisplayText><record><rec-number>5494</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Michels, T. C.</author><author>Kelly, K. M.</author></authors></contributors><auth-address>Department of Family Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. Thomas.c.michels@us.army.mil</auth-address><titles><title>Parathyroid disorders</title><secondary-title>Am Fam Physician</secondary-title><alt-title>American family physician</alt-title></titles><periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></periodical><alt-periodical><full-title>Am Fam Physician</full-title><abbr-1>American family physician</abbr-1></alt-periodical><pages>249-57</pages><volume>88</volume><number>4</number><edition>2013/08/16</edition><keywords><keyword>Absorptiometry, Photon</keyword><keyword>Asymptomatic Diseases</keyword><keyword>Bone Diseases, Metabolic/etiology</keyword><keyword>Calcitriol/therapeutic use</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/etiology</keyword><keyword>Hyperparathyroidism, Primary/diagnosis/therapy</keyword><keyword>Hyperparathyroidism, Secondary/diagnosis/etiology/therapy</keyword><keyword>Hypocalcemia/etiology</keyword><keyword>Hypoparathyroidism/diagnosis/etiology/therapy</keyword><keyword>Parathyroid Diseases/*diagnosis/etiology/therapy</keyword><keyword>Renal Insufficiency, Chronic/complications</keyword></keywords><dates><year>2013</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0002-838x</isbn><accession-num>23944728</accession-num><urls></urls><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record></Cite></EndNote>(14).Risk factors for primary hyperparathyroidism include a history of neck radiation, age older than 50 years, and female sex; women are twice as likely as men to develop primary hyperparathyroidism. ( ADDIN EN.CITE <EndNote><Cite><Author>Townsend</Author><Year>2012</Year><RecNum>5490</RecNum><DisplayText>(Townsend et al. 2012)</DisplayText><record><rec-number>5490</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5490</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Townsend, C.M.</author><author>Beauchamp, R.D.</author><author>Evers, B.M.</author><author>Mattox, K.L.</author></authors></contributors><titles><title>Sabiston Textbook of Surgery E-Book</title></titles><dates><year>2012</year></dates><publisher>Elsevier Health Sciences</publisher><isbn>9781455738083</isbn><urls><related-urls><url>).A solitary adenoma may involve any one of the four glands. Multigland enlargement most often results from primary parathyroid hyperplasia and less often from multiple adenomas. Hyperplasia usually involves all four glands asymmetrically, whereas multiple adenomas may involve two or possibly three glands. An adenoma and hyperplasia cannot always be reliably distinguished histologically, and the sample may be referred to as “hypercellular parathyroid” tissue. Because of this inconsistent pattern of gland involvement, and because distinguishing hyperplasia from multiple adenomas is difficult pathologically, these two entities are often histologically considered together as “multiple gland disease” ADDIN EN.CITE <EndNote><Cite><Author>Limone</Author><Year>2016</Year><RecNum>5501</RecNum><DisplayText>(Limone et al. 2016)</DisplayText><record><rec-number>5501</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5501</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Limone, Paolo P.</author><author>Deandrea, Maurilio</author><author>Gamarra, Elena</author><author>Garino, Francesca</author><author>Grassi, Aurora</author><author>Magliona, Gabriella</author><author>Mormile, Alberto</author><author>Ragazzoni, Federico</author><author>Ramunni, Maria Josefina</author><author>Razzore, Paola</author></authors><secondary-authors><author>Gasparri, Guido</author><author>Palestini, Nicola</author><author>Camandona, Michele</author></secondary-authors></contributors><titles><title>Etiology and Pathogenesis of Primary Hyperparathyroidism and Hypercalcemias</title><secondary-title>Primary, Secondary and Tertiary Hyperparathyroidism: Diagnostic and Therapeutic Updates</secondary-title></titles><pages>41-55</pages><dates><year>2016</year></dates><pub-location>Milano</pub-location><publisher>Springer Milan</publisher><isbn>978-88-470-5758-6</isbn><label>Limone2016</label><urls><related-urls><url>;(12).Figure (2): Control of mineral metabolism by parathyroid hormone (PTH). Calcium-sensing receptors of parathyroid cells respond to serum calcium level and change with increased release (hypocalcemia) or suppression (hypercalcemia) of PTH. PTH stimulates bone resorption, which increases serum calcium and phosphorus. In the kidney, PTH stimulates reabsorption of calcium and promotes phosphorus excretion. PTH also helps convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D in the kidneys, which then increases intestinal transport of calcium and phosphorus (14).Parathyroid adenoma either occurs in the normal anatomical location of parathyroid glands, frequently in the lower ones, or can be found in ectopic sites (e.g. thymus, thyroid, and esophagus) in about 10% of cases. Ectopic parathyroid glands can significantly impact morbidity and clinical outcomes primarily due to failure during parathyroid exploration and subsequent requirement for reoperation ADDIN EN.CITE <EndNote><Cite><Author>Sfeir</Author><Year>2016</Year><RecNum>5503</RecNum><DisplayText>(Sfeir et al. 2016)</DisplayText><record><rec-number>5503</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5503</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Sfeir, Jad G.</author><author>Drake, Matthew T.</author></authors><secondary-authors><author>Kearns, Ann E.</author><author>Wermers, Robert A.</author></secondary-authors></contributors><titles><title>Ectopic Parathyroid Adenoma</title><secondary-title>Hyperparathyroidism: A Clinical Casebook</secondary-title></titles><pages>65-74</pages><dates><year>2016</year></dates><pub-location>Cham</pub-location><publisher>Springer International Publishing</publisher><isbn>978-3-319-25880-5</isbn><label>Sfeir2016</label><urls><related-urls><url>;(16).Grossly, adenomas have an oval or kidney shape, red-brown color and soft consistency. Sometimes, they are multilobated, an occurrence which occasionally requires their incomplete excision. The size ranges from less than 1 cm to over 3 cm, while the weight varies from 150 mg to several grams. Large adenomas (>800mg) replace the entire gland and foci of cystic changes are common. Microadenomas, weighing less than 0.1 g, are also well documented. Larger adenomas are generally associated with higher levels of calcium and PTH and are more likely to be symptomatic ADDIN EN.CITE <EndNote><Cite><Author>Wieneke</Author><Year>2008</Year><RecNum>5475</RecNum><DisplayText>(Wieneke et al. 2008)</DisplayText><record><rec-number>5475</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5475</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wieneke, Jacqueline A.</author><author>Smith, Alice</author></authors></contributors><titles><title>Parathyroid Adenoma</title><secondary-title>Head and Neck Pathology</secondary-title></titles><periodical><full-title>Head and Neck Pathology</full-title></periodical><pages>305-308</pages><volume>2</volume><number>4</number><dates><year>2008</year></dates><isbn>1936-0568</isbn><label>Wieneke2008</label><work-type>journal article</work-type><urls><related-urls><url>;(17).Microscopically, Diagnostic criteria for adenoma include a pushing border, lack of intralesional fibro-adipose tissue, absence of lobular growth and complete circumscription with a rim of normal parathyroid at the periphery; the latter observed in only 50–60% of cases. Microadenomas are typically non-encapsulated, whereas larger adenomas often have a fibrous capsule. The cells of adenomas are arranged in cords, nests, sheets, and follicles and frequently are arranged around blood vessels. The nuclei are generally rounded with dense chromatin; they are usually larger than those of the normal parathyroid cells. Scattered pleomorphic and hyperchromatic nuclei, as well as multinucleate cells, are relatively common ( ADDIN EN.CITE <EndNote><Cite><Author>Limone</Author><Year>2016</Year><RecNum>5501</RecNum><DisplayText>(Limone et al. 2016)</DisplayText><record><rec-number>5501</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5501</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Limone, Paolo P.</author><author>Deandrea, Maurilio</author><author>Gamarra, Elena</author><author>Garino, Francesca</author><author>Grassi, Aurora</author><author>Magliona, Gabriella</author><author>Mormile, Alberto</author><author>Ragazzoni, Federico</author><author>Ramunni, Maria Josefina</author><author>Razzore, Paola</author></authors><secondary-authors><author>Gasparri, Guido</author><author>Palestini, Nicola</author><author>Camandona, Michele</author></secondary-authors></contributors><titles><title>Etiology and Pathogenesis of Primary Hyperparathyroidism and Hypercalcemias</title><secondary-title>Primary, Secondary and Tertiary Hyperparathyroidism: Diagnostic and Therapeutic Updates</secondary-title></titles><pages>41-55</pages><dates><year>2016</year></dates><pub-location>Milano</pub-location><publisher>Springer Milan</publisher><isbn>978-88-470-5758-6</isbn><label>Limone2016</label><urls><related-urls><url>).Figure (3): Gross specimen of a cystic parathyroid adenoma. (a) Exterior view shows a smooth surface with minimal hemorrhage and no significant adhesions. The specimen ‘‘shelled out’’ easily. (b) The mass is opened to demonstrate a smooth cyst wall lining ( ADDIN EN.CITE <EndNote><Cite><Author>Erickson</Author><Year>2014</Year><RecNum>5496</RecNum><DisplayText>(Erickson 2014)</DisplayText><record><rec-number>5496</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5496</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>Erickson, L.A.</author></authors></contributors><titles><title>Atlas of Endocrine Pathology</title></titles><dates><year>2014</year></dates><publisher>Springer New York</publisher><isbn>9781493904433</isbn><urls><related-urls><url>).Figure (4): The low-power portion of this H & E stained section shows the hyper cellular parathyroid adenoma with a cystic lumen. High power examination depicts the proliferative parathyroid tissue to be composed of a population of chief cells.Parathyroid carcinoma (PTCA) was first described in 1904 by De Quervain. PTCA is an exceptionally rare malignancy, with a clinical presentation similar to benign PHPT in many cases. Parathyroid carcinoma accounts for less than 4% of cases of parathyroid disease and is seen in 0.5–1% of HPT cases. Grossly, parathyroid carcinomas are large tumors that invade the surroundings of tissues of neck, thyroid and peri-esophageal tissues. By light microscopy, they are characterized by broad fibrous bands and composed predominantly of chief cells (14).The only reliable indicators of malignancy are vascular invasion, perineural space invasion, capsular penetration with growth into surrounding tissues and distant metastases. In adenomas, which have been biopsied, trapping and pseudo invasion can be present, simulating a carcinoma. Histological clues include the presence of hemosiderin-laden macrophages, granulation tissue and the finding of linear areas of scarring ( ADDIN EN.CITE <EndNote><Cite><Author>Limone</Author><Year>2016</Year><RecNum>5501</RecNum><DisplayText>(Limone et al. 2016)</DisplayText><record><rec-number>5501</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5501</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author>Limone, Paolo P.</author><author>Deandrea, Maurilio</author><author>Gamarra, Elena</author><author>Garino, Francesca</author><author>Grassi, Aurora</author><author>Magliona, Gabriella</author><author>Mormile, Alberto</author><author>Ragazzoni, Federico</author><author>Ramunni, Maria Josefina</author><author>Razzore, Paola</author></authors><secondary-authors><author>Gasparri, Guido</author><author>Palestini, Nicola</author><author>Camandona, Michele</author></secondary-authors></contributors><titles><title>Etiology and Pathogenesis of Primary Hyperparathyroidism and Hypercalcemias</title><secondary-title>Primary, Secondary and Tertiary Hyperparathyroidism: Diagnostic and Therapeutic Updates</secondary-title></titles><pages>41-55</pages><dates><year>2016</year></dates><pub-location>Milano</pub-location><publisher>Springer Milan</publisher><isbn>978-88-470-5758-6</isbn><label>Limone2016</label><urls><related-urls><url>).Diagnostic Procedures of Parathyroid Gland TumorsThe concept of the “parathyroid incidentaloma” appeared in medical practice. It owes its emergence in the first place to ultrasound (US), magnetic resonance imaging (MRI), and computed tomography (CT) imaging. Modern surgical treatment of parathyroid pathology is based on accurate topical diagnosis of pathologic focus. That influences the choice of the method and technique of surgical intervention. All methods of topical diagnosis of abnormal parathyroid glands can be divided into three conditional groups: noninvasive preoperative, invasive preoperative, and intraoperative diagnostic methodsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXNhaWR5PC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjU0MDk8L1JlY051bT48RGlzcGxheVRleHQ+KEJ1c2FpZHkgZXQgYWwuIDIwMDQsIEtl

YmViZXcgMjAwOCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQwOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0

NWI1OTVkanJmcHR0cnh3OWF2cCI+NTQwOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBu

YW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3Jz

PjxhdXRob3I+QnVzYWlkeSwgTi4gTC48L2F1dGhvcj48YXV0aG9yPkppbWVuZXosIEMuPC9hdXRo

b3I+PGF1dGhvcj5IYWJyYSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlNjaHVsdHosIFAuIE4uPC9h

dXRob3I+PGF1dGhvcj5FbC1OYWdnYXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5DbGF5bWFuLCBH

LiBMLjwvYXV0aG9yPjxhdXRob3I+QXNwZXIsIEouIEEuPC9hdXRob3I+PGF1dGhvcj5EaWF6LCBF

LiBNLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5FdmFucywgRC4gQi48L2F1dGhvcj48YXV0aG9yPkdh

Z2VsLCBSLiBGLjwvYXV0aG9yPjxhdXRob3I+R2FyZGVuLCBBLjwvYXV0aG9yPjxhdXRob3I+SG9m

ZiwgQS4gTy48L2F1dGhvcj48YXV0aG9yPkxlZSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPk1vcnJp

c29uLCBXLiBILjwvYXV0aG9yPjxhdXRob3I+Um9zZW50aGFsLCBELiBJLjwvYXV0aG9yPjxhdXRo

b3I+U2hlcm1hbiwgUy4gSS48L2F1dGhvcj48YXV0aG9yPlN0dXJnaXMsIEUuIE0uPC9hdXRob3I+

PGF1dGhvcj5XYWd1ZXNwYWNrLCBTLiBHLjwvYXV0aG9yPjxhdXRob3I+V2ViZXIsIFIuIFMuPC9h

dXRob3I+PGF1dGhvcj5XaXJmZWwsIEsuPC9hdXRob3I+PGF1dGhvcj5WYXNzaWxvcG91bG91LVNl

bGxpbiwgUi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5q

b2ludCBCYXlsb3IgQ29sbGVnZSBvZiBNZWRpY2luZS9UaGUgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LiBELiBBbmRlcnNvbiBDYW5jZXIgQ2VudGVyIFRyYWluaW5nIFByb2dyYW0gaW4gRW5kb2NyaW5v

bG9neSwgRGlhYmV0ZXMsIGFuZCBNZXRhYm9saXNtLCBIb3VzdG9uLCBUZXhhcywgVVNBLjwvYXV0

aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBhcmF0aHlyb2lkIGNhcmNpbm9tYTogYSAyMi15ZWFy

IGV4cGVyaWVuY2U8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGVhZCBOZWNrPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5IZWFkICZhbXA7IG5lY2s8L2FsdC10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5IZWFkIE5lY2s8L2Z1bGwtdGl0bGU+PGFiYnItMT5IZWFkICZh

bXA7IG5lY2s8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkhlYWQgTmVjazwvZnVsbC10aXRsZT48YWJici0xPkhlYWQgJmFtcDsgbmVjazwvYWJici0xPjwv

YWx0LXBlcmlvZGljYWw+PHBhZ2VzPjcxNi0yNjwvcGFnZXM+PHZvbHVtZT4yNjwvdm9sdW1lPjxu

dW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxr

ZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+KkNh

cmNpbm9tYS9kaWFnbm9zaXMvbW9ydGFsaXR5L3BhdGhvbG9neS90aGVyYXB5PC9rZXl3b3JkPjxr

ZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJjYWxjZW1pYS9kcnVnIHRoZXJh

cHkvZXRpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+TmVvcGxhc20gTWV0YXN0YXNpczwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBS

ZWN1cnJlbmNlLCBMb2NhbC9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPipQYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvZGlhZ25vc2lzL21vcnRhbGl0eS9wYXRob2xvZ3kvdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5Qcm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW90aGVyYXB5LCBBZGp1dmFu

dDwva2V5d29yZD48a2V5d29yZD5SZW9wZXJhdGlvbjwva2V5d29yZD48a2V5d29yZD5SZXRyb3Nw

ZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48

a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDA0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTA0My0zMDc0IChQcmludCkmI3hEOzEwNDMtMzA3NCAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MTUyODcwMzk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTUyODcwMzk8L3VybD48

L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDIvaGVk

LjIwMDQ5PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5LZWJlYmV3PC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjU0MjE8L1JlY051

bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MjE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0

MjE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4x

NzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktlYmViZXcsIEUuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlBhcmF0aHlyb2lk

IGNhcmNpbm9tYSwgYSByYXJlIGJ1dCBpbXBvcnRhbnQgZGlzb3JkZXIgZm9yIGVuZG9jcmlub2xv

Z2lzdHMsIHByaW1hcnkgY2FyZSBwaHlzaWNpYW5zLCBhbmQgZW5kb2NyaW5lIHN1cmdlb25zPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPlRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PlRoeXJvaWQgOiBvZmZpY2lhbCBqb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBUaHlyb2lkIEFzc29j

aWF0aW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGh5cm9p

ZDwvZnVsbC10aXRsZT48YWJici0xPlRoeXJvaWQgOiBvZmZpY2lhbCBqb3VybmFsIG9mIHRoZSBB

bWVyaWNhbiBUaHlyb2lkIEFzc29jaWF0aW9uPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5UaHlyb2lkPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGh5cm9pZCA6

IG9mZmljaWFsIGpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFRoeXJvaWQgQXNzb2NpYXRpb248L2Fi

YnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zODUtNjwvcGFnZXM+PHZvbHVtZT4xODwvdm9s

dW1lPjxudW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5FbmRvY3Jpbm9sb2d5Lypt

ZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE9uY29sb2d5LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNt

cy8qZGlhZ25vc2lzLyp0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPlBoeXNpY2lhbnMsIEZhbWls

eTwva2V5d29yZD48a2V5d29yZD5QcmltYXJ5IEhlYWx0aCBDYXJlLyptZXRob2RzPC9rZXl3b3Jk

Pjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8

L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDUwLTcyNTYgKFByaW50KSYjeEQ7MTA1

MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xODM0ODcwNTwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8xODM0ODcwNTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAwOC4wMDUxPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXNhaWR5PC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjU0MDk8L1JlY051bT48RGlzcGxheVRleHQ+KEJ1c2FpZHkgZXQgYWwuIDIwMDQsIEtl

YmViZXcgMjAwOCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQwOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0

NWI1OTVkanJmcHR0cnh3OWF2cCI+NTQwOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBu

YW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3Jz

PjxhdXRob3I+QnVzYWlkeSwgTi4gTC48L2F1dGhvcj48YXV0aG9yPkppbWVuZXosIEMuPC9hdXRo

b3I+PGF1dGhvcj5IYWJyYSwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlNjaHVsdHosIFAuIE4uPC9h

dXRob3I+PGF1dGhvcj5FbC1OYWdnYXIsIEEuIEsuPC9hdXRob3I+PGF1dGhvcj5DbGF5bWFuLCBH

LiBMLjwvYXV0aG9yPjxhdXRob3I+QXNwZXIsIEouIEEuPC9hdXRob3I+PGF1dGhvcj5EaWF6LCBF

LiBNLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5FdmFucywgRC4gQi48L2F1dGhvcj48YXV0aG9yPkdh

Z2VsLCBSLiBGLjwvYXV0aG9yPjxhdXRob3I+R2FyZGVuLCBBLjwvYXV0aG9yPjxhdXRob3I+SG9m

ZiwgQS4gTy48L2F1dGhvcj48YXV0aG9yPkxlZSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPk1vcnJp

c29uLCBXLiBILjwvYXV0aG9yPjxhdXRob3I+Um9zZW50aGFsLCBELiBJLjwvYXV0aG9yPjxhdXRo

b3I+U2hlcm1hbiwgUy4gSS48L2F1dGhvcj48YXV0aG9yPlN0dXJnaXMsIEUuIE0uPC9hdXRob3I+

PGF1dGhvcj5XYWd1ZXNwYWNrLCBTLiBHLjwvYXV0aG9yPjxhdXRob3I+V2ViZXIsIFIuIFMuPC9h

dXRob3I+PGF1dGhvcj5XaXJmZWwsIEsuPC9hdXRob3I+PGF1dGhvcj5WYXNzaWxvcG91bG91LVNl

bGxpbiwgUi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5q

b2ludCBCYXlsb3IgQ29sbGVnZSBvZiBNZWRpY2luZS9UaGUgVW5pdmVyc2l0eSBvZiBUZXhhcyBN

LiBELiBBbmRlcnNvbiBDYW5jZXIgQ2VudGVyIFRyYWluaW5nIFByb2dyYW0gaW4gRW5kb2NyaW5v

bG9neSwgRGlhYmV0ZXMsIGFuZCBNZXRhYm9saXNtLCBIb3VzdG9uLCBUZXhhcywgVVNBLjwvYXV0

aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlBhcmF0aHlyb2lkIGNhcmNpbm9tYTogYSAyMi15ZWFy

IGV4cGVyaWVuY2U8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGVhZCBOZWNrPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5IZWFkICZhbXA7IG5lY2s8L2FsdC10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5IZWFkIE5lY2s8L2Z1bGwtdGl0bGU+PGFiYnItMT5IZWFkICZh

bXA7IG5lY2s8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxl

PkhlYWQgTmVjazwvZnVsbC10aXRsZT48YWJici0xPkhlYWQgJmFtcDsgbmVjazwvYWJici0xPjwv

YWx0LXBlcmlvZGljYWw+PHBhZ2VzPjcxNi0yNjwvcGFnZXM+PHZvbHVtZT4yNjwvdm9sdW1lPjxu

dW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3b3JkPjxr

ZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+KkNh

cmNpbm9tYS9kaWFnbm9zaXMvbW9ydGFsaXR5L3BhdGhvbG9neS90aGVyYXB5PC9rZXl3b3JkPjxr

ZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJjYWxjZW1pYS9kcnVnIHRoZXJh

cHkvZXRpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRk

bGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+

PGtleXdvcmQ+TmVvcGxhc20gTWV0YXN0YXNpczwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbSBS

ZWN1cnJlbmNlLCBMb2NhbC9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPipQYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvZGlhZ25vc2lzL21vcnRhbGl0eS9wYXRob2xvZ3kvdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5Qcm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW90aGVyYXB5LCBBZGp1dmFu

dDwva2V5d29yZD48a2V5d29yZD5SZW9wZXJhdGlvbjwva2V5d29yZD48a2V5d29yZD5SZXRyb3Nw

ZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48

a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVh

cj4yMDA0PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+QXVnPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTA0My0zMDc0IChQcmludCkmI3hEOzEwNDMtMzA3NCAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MTUyODcwMzk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTUyODcwMzk8L3VybD48

L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwMDIvaGVk

LjIwMDQ5PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1

dGhvcj5LZWJlYmV3PC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjU0MjE8L1JlY051

bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MjE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0

MjE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4x

NzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktlYmViZXcsIEUuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlBhcmF0aHlyb2lk

IGNhcmNpbm9tYSwgYSByYXJlIGJ1dCBpbXBvcnRhbnQgZGlzb3JkZXIgZm9yIGVuZG9jcmlub2xv

Z2lzdHMsIHByaW1hcnkgY2FyZSBwaHlzaWNpYW5zLCBhbmQgZW5kb2NyaW5lIHN1cmdlb25zPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPlRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PlRoeXJvaWQgOiBvZmZpY2lhbCBqb3VybmFsIG9mIHRoZSBBbWVyaWNhbiBUaHlyb2lkIEFzc29j

aWF0aW9uPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGh5cm9p

ZDwvZnVsbC10aXRsZT48YWJici0xPlRoeXJvaWQgOiBvZmZpY2lhbCBqb3VybmFsIG9mIHRoZSBB

bWVyaWNhbiBUaHlyb2lkIEFzc29jaWF0aW9uPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5UaHlyb2lkPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGh5cm9pZCA6

IG9mZmljaWFsIGpvdXJuYWwgb2YgdGhlIEFtZXJpY2FuIFRoeXJvaWQgQXNzb2NpYXRpb248L2Fi

YnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4zODUtNjwvcGFnZXM+PHZvbHVtZT4xODwvdm9s

dW1lPjxudW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5FbmRvY3Jpbm9sb2d5Lypt

ZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NZWRpY2Fs

IE9uY29sb2d5LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNt

cy8qZGlhZ25vc2lzLyp0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPlBoeXNpY2lhbnMsIEZhbWls

eTwva2V5d29yZD48a2V5d29yZD5QcmltYXJ5IEhlYWx0aCBDYXJlLyptZXRob2RzPC9rZXl3b3Jk

Pjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8

L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDUwLTcyNTYgKFByaW50KSYjeEQ7MTA1

MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xODM0ODcwNTwvYWNjZXNzaW9u

LW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292

L3B1Ym1lZC8xODM0ODcwNTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTA4OS90aHkuMjAwOC4wMDUxPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (18).Techniques like single photon emission computed tomography [SPECT], positron emission tomography [PET], and intraoperative gamma detection are used now more and more frequently in clinical practice PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NTM4NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oRnJhc2VyIDIwMDksIEhhcmFyaSBldCBh

bC4gMjAxMSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4NDwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1

OTVkanJmcHR0cnh3OWF2cCI+NTM4NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+RnJhc2VyLCBXLiBELjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPlVuaXQgb2YgQ2xpbmljYWwgQ2hlbWlzdHJ5LCBTY2hvb2wgb2YgQ2xpbmljYWwg

U2NpZW5jZXMsIFVuaXZlcnNpdHkgb2YgTGl2ZXJwb29sLCBMaXZlcnBvb2wsIFVLLiB3LmQuZnJh

c2VyQGxpdmVycG9vbC5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkh5cGVycGFy

YXRoeXJvaWRpc208L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+TGFuY2V0PC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5MYW5jZXQ8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5MYW5jZXQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5MYW5jZXQ8L2FiYnItMT48L3Blcmlv

ZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkxhbmNldDwvZnVsbC10aXRsZT48YWJi

ci0xPkxhbmNldDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0NS01ODwvcGFnZXM+

PHZvbHVtZT4zNzQ8L3ZvbHVtZT48bnVtYmVyPjk2ODQ8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWN1dGUgRGlzZWFzZTwva2V5d29yZD48a2V5d29yZD5BbGdvcml0aG1zPC9rZXl3b3JkPjxr

ZXl3b3JkPkNhbGNpdW0vcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5DYXVzYWxpdHk8L2tl

eXdvcmQ+PGtleXdvcmQ+RGVjaXNpb24gVHJlZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhZ25vc2lz

LCBEaWZmZXJlbnRpYWw8L2tleXdvcmQ+PGtleXdvcmQ+SG9tZW9zdGFzaXMvcGh5c2lvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+Kkh5cGVycGFyYXRoeXJv

aWRpc20sIFByaW1hcnkvZGlhZ25vc2lzL2VwaWRlbWlvbG9neS9ldGlvbG9neS90aGVyYXB5PC9r

ZXl3b3JkPjxrZXl3b3JkPipIeXBlcnBhcmF0aHlyb2lkaXNtLCBTZWNvbmRhcnkvZGlhZ25vc2lz

L2VwaWRlbWlvbG9neS9ldGlvbG9neS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkluY2lkZW5j

ZTwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy9jb21wbGljYXRpb25z

PC9rZXl3b3JkPjxrZXl3b3JkPk1hc3MgU2NyZWVuaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIEhvcm1vbmUvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVj

dG9teTwva2V5d29yZD48a2V5d29yZD5QYXRpZW50IFNlbGVjdGlvbjwva2V5d29yZD48a2V5d29y

ZD5QcmFjdGljZSBHdWlkZWxpbmVzIGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVu

Y2U8L2tleXdvcmQ+PGtleXdvcmQ+Vml0YW1pbiBEIERlZmljaWVuY3kvY29tcGxpY2F0aW9uczwv

a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRh

dGU+SnVsIDExPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3NC01NDdYIChFbGVj

dHJvbmljKSYjeEQ7MDE0MC02NzM2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTU5

NTM0OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xOTU5NTM0OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs

cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9TMDE0MC02NzM2KDA5KTYwNTA3LTk8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkhh

cmFyaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJlY051bT41NDEwPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDEwPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmksIEEuPC9hdXRob3I+PGF1

dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXotUmFudmllciwgRy48L2F1

dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3VoLCBJLjwvYXV0aG9yPjxh

dXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBXLjwvYXV0aG9yPjxhdXRo

b3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48L2F1dGhvcj48YXV0aG9y

PkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkgb2YgQ2FsaWZvcm5pYSwg

TG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFyaUBtZWRuZXQudWNsYS5l

ZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9pZCBjYXJjaW5vbWE6IGEg

NDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+

VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9s

IE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2Ny

aW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9h

YmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFnZXM+PHZvbHVtZT45Njwv

dm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5

d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9ydGFsaXR5L3BhdGhvbG9n

eS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1h

bnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9ldGlvbG9neS8qbW9ydGFs

aXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtl

eXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwg

TG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkvcGF0aG9sb2d5L3N1cmdl

cnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PGtleXdvcmQ+

UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFs

IFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3

b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ryb25pYykmI3hEOzAwMjEt

OTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2MjY8L2FjY2Vzc2lvbi1u

dW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NTM4NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oRnJhc2VyIDIwMDksIEhhcmFyaSBldCBh

bC4gMjAxMSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4NDwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1

OTVkanJmcHR0cnh3OWF2cCI+NTM4NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+RnJhc2VyLCBXLiBELjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPlVuaXQgb2YgQ2xpbmljYWwgQ2hlbWlzdHJ5LCBTY2hvb2wgb2YgQ2xpbmljYWwg

U2NpZW5jZXMsIFVuaXZlcnNpdHkgb2YgTGl2ZXJwb29sLCBMaXZlcnBvb2wsIFVLLiB3LmQuZnJh

c2VyQGxpdmVycG9vbC5hYy51azwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkh5cGVycGFy

YXRoeXJvaWRpc208L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+TGFuY2V0PC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5MYW5jZXQ8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5MYW5jZXQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5MYW5jZXQ8L2FiYnItMT48L3Blcmlv

ZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkxhbmNldDwvZnVsbC10aXRsZT48YWJi

ci0xPkxhbmNldDwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE0NS01ODwvcGFnZXM+

PHZvbHVtZT4zNzQ8L3ZvbHVtZT48bnVtYmVyPjk2ODQ8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWN1dGUgRGlzZWFzZTwva2V5d29yZD48a2V5d29yZD5BbGdvcml0aG1zPC9rZXl3b3JkPjxr

ZXl3b3JkPkNhbGNpdW0vcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5DYXVzYWxpdHk8L2tl

eXdvcmQ+PGtleXdvcmQ+RGVjaXNpb24gVHJlZXM8L2tleXdvcmQ+PGtleXdvcmQ+RGlhZ25vc2lz

LCBEaWZmZXJlbnRpYWw8L2tleXdvcmQ+PGtleXdvcmQ+SG9tZW9zdGFzaXMvcGh5c2lvbG9neTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+Kkh5cGVycGFyYXRoeXJv

aWRpc20sIFByaW1hcnkvZGlhZ25vc2lzL2VwaWRlbWlvbG9neS9ldGlvbG9neS90aGVyYXB5PC9r

ZXl3b3JkPjxrZXl3b3JkPipIeXBlcnBhcmF0aHlyb2lkaXNtLCBTZWNvbmRhcnkvZGlhZ25vc2lz

L2VwaWRlbWlvbG9neS9ldGlvbG9neS90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkluY2lkZW5j

ZTwva2V5d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy9jb21wbGljYXRpb25z

PC9rZXl3b3JkPjxrZXl3b3JkPk1hc3MgU2NyZWVuaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIEhvcm1vbmUvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVj

dG9teTwva2V5d29yZD48a2V5d29yZD5QYXRpZW50IFNlbGVjdGlvbjwva2V5d29yZD48a2V5d29y

ZD5QcmFjdGljZSBHdWlkZWxpbmVzIGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3b3JkPlByZXZhbGVu

Y2U8L2tleXdvcmQ+PGtleXdvcmQ+Vml0YW1pbiBEIERlZmljaWVuY3kvY29tcGxpY2F0aW9uczwv

a2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+PGRh

dGU+SnVsIDExPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3NC01NDdYIChFbGVj

dHJvbmljKSYjeEQ7MDE0MC02NzM2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xOTU5

NTM0OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xOTU5NTM0OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs

cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9TMDE0MC02NzM2KDA5KTYwNTA3LTk8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkhh

cmFyaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+PFJlY051bT41NDEwPC9SZWNOdW0+PHJlY29y

ZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDEwPC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmksIEEuPC9hdXRob3I+PGF1

dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXotUmFudmllciwgRy48L2F1

dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3VoLCBJLjwvYXV0aG9yPjxh

dXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBXLjwvYXV0aG9yPjxhdXRo

b3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48L2F1dGhvcj48YXV0aG9y

PkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNz

PlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkgb2YgQ2FsaWZvcm5pYSwg

TG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFyaUBtZWRuZXQudWNsYS5l

ZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9pZCBjYXJjaW5vbWE6IGEg

NDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+

VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9s

IE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2Ny

aW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9h

YmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFnZXM+PHZvbHVtZT45Njwv

dm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5

d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9ydGFsaXR5L3BhdGhvbG9n

eS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1h

bnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9ldGlvbG9neS8qbW9ydGFs

aXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtl

eXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwg

TG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkvcGF0aG9sb2d5L3N1cmdl

cnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PGtleXdvcmQ+

UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFs

IFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3

b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkRlYzwvZGF0ZT48

L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ryb25pYykmI3hEOzAwMjEt

OTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2MjY8L2FjY2Vzc2lvbi1u

dW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (19).Table (1): These methods differ from each other in their main diagnostic parameters (sensitivity and specificity). Some of these methods give objective results, while others are less objective, being operator-dependent (PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXJjb2NjaTwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+

PFJlY051bT41NDI3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihNYXJjb2NjaSBldCBhbC4gMjAwOCwg

T3Jkb25leiAyMDE0LCBLYXJhYXJzbGFuIGV0IGFsLiAyMDE1KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj41NDI3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDI3PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5NYXJjb2NjaSwgQy48L2F1dGhvcj48

YXV0aG9yPkNldGFuaSwgRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxl

cz48dGl0bGU+UGFyYWZpYnJvbWluIGFzIGEgdG9vbCBmb3IgdGhlIGRpYWdub3NpcyBvZiBwYXJh

dGh5cm9pZCB0dW1vcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QWR2IEFuYXQgUGF0aG9sPC9z

ZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5BZHZhbmNlcyBpbiBhbmF0b21pYyBwYXRob2xvZ3k8

L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BZHYgQW5hdCBQYXRo

b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5BZHZhbmNlcyBpbiBhbmF0b21pYyBwYXRob2xvZ3k8L2Fi

YnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFkdiBBbmF0IFBh

dGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFkdmFuY2VzIGluIGFuYXRvbWljIHBhdGhvbG9neTwv

YWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE3OTsgYXV0aG9yIHJlcGx5IDE3OS04MDwv

cGFnZXM+PHZvbHVtZT4xNTwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5

d29yZD5BZGVub2NhcmNpbm9tYS8qZGlhZ25vc2lzL21ldGFib2xpc20vc2Vjb25kYXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPkFkZW5vbWEvKmRpYWdub3Npcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3

b3JkPkJpb21hcmtlcnMsIFR1bW9yL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5z

PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy9tZXRhYm9saXNtL3BhdGhvbG9n

eTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKmRpYWdub3Npcy9tZXRh

Ym9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlR1bW9yIFN1cHByZXNzb3IgUHJvdGVpbnMvZ2VuZXRp

Y3MvKm1ldGFib2xpc208L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1

MzMtNDAzMSAoRWxlY3Ryb25pYykmI3hEOzEwNzItNDEwOSAoTGlua2luZyk8L2lzYm4+PGFjY2Vz

c2lvbi1udW0+MTg0MzQ3NzI8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJs

Pmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0MzQ3NzI8L3VybD48L3JlbGF0

ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvUEFQLjBiMDEz

ZTMxODE3MDlmNDc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPk9yZG9uZXo8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+NTQzMDwv

UmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQzMDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2

cCI+NTQzMDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+T3Jkb25leiwg

Ti4gRy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBh

cnRtZW50IG9mIFBhdGhvbG9neSwgVGhlIFVuaXZlcnNpdHkgb2YgVGV4YXMgTS5ELiBBbmRlcnNv

biBDYW5jZXIgQ2VudGVyLCBIb3VzdG9uLCBUWC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRs

ZT5WYWx1ZSBvZiBHQVRBMyBpbW11bm9zdGFpbmluZyBpbiB0aGUgZGlhZ25vc2lzIG9mIHBhcmF0

aHlyb2lkIHR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hl

bSBNb2wgTW9ycGhvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXBwbGllZCBpbW11bm9o

aXN0b2NoZW1pc3RyeSAmYW1wOyBtb2xlY3VsYXIgbW9ycGhvbG9neSA6IEFJTU08L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hlbSBN

b2wgTW9ycGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFwcGxpZWQgaW1tdW5vaGlzdG9jaGVtaXN0

cnkgJmFtcDsgbW9sZWN1bGFyIG1vcnBob2xvZ3kgOiBBSU1NPC9hYmJyLTE+PC9wZXJpb2RpY2Fs

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hlbSBNb2wgTW9y

cGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFwcGxpZWQgaW1tdW5vaGlzdG9jaGVtaXN0cnkgJmFt

cDsgbW9sZWN1bGFyIG1vcnBob2xvZ3kgOiBBSU1NPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48

cGFnZXM+NzU2LTYxPC9wYWdlcz48dm9sdW1lPjIyPC92b2x1bWU+PG51bWJlcj4xMDwvbnVtYmVy

PjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub21hLypkaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+

QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QmlvbWFya2VycywgVHVtb3IvKm1ldGFib2xpc208L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLypkaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2Vs

bCBOdWNsZXVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3NpcywgRGlmZmVy

ZW50aWFsPC9rZXl3b3JkPjxrZXl3b3JkPkdBVEEzIFRyYW5zY3JpcHRpb24gRmFjdG9yL2ltbXVu

b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIE5lb3BsYXNtcy8qZGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlByb3RlaW4gVHJh

bnNwb3J0PC9rZXl3b3JkPjxrZXl3b3JkPlNlbnNpdGl2aXR5IGFuZCBTcGVjaWZpY2l0eTwva2V5

d29yZD48a2V5d29yZD5TdGFpbmluZyBhbmQgTGFiZWxpbmc8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk5vdi1EZWM8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMzLTQwNTggKEVsZWN0cm9uaWMpJiN4RDsxNTMzLTQw

NTggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1MDQ2MjI5PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzI1MDQ2MjI5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMDk3L1BBSS4wMDAwMDAwMDAwMDAwMDA3PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5LYXJhYXJzbGFuPC9BdXRob3I+PFll

YXI+MjAxNTwvWWVhcj48UmVjTnVtPjU0MzE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0

MzE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6

ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0MzE8L2tleT48L2ZvcmVpZ24ta2V5cz48

cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9y

cz48YXV0aG9ycz48YXV0aG9yPkthcmFhcnNsYW4sIFMuPC9hdXRob3I+PGF1dGhvcj5ZdXJ1bSwg

Ri4gTi48L2F1dGhvcj48YXV0aG9yPkt1bWJhcmFjaSwgQi4gUy48L2F1dGhvcj48YXV0aG9yPlBh

bGEsIEUuIEUuPC9hdXRob3I+PGF1dGhvcj5TaXZyaWtveiwgTy4gTi48L2F1dGhvcj48YXV0aG9y

PkFreWlsZGl6LCBNLjwvYXV0aG9yPjxhdXRob3I+QnVnZGF5Y2ksIE0uIEguPC9hdXRob3I+PC9h

dXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+UGF0aG9sb2d5IERlcGFydG1lbnQs

IFNpZmEgVW5pdmVyc2l0eSwgSXptaXIsIFR1cmtleS4mI3hEO1ByaXZhdGUgRWdlIFBhdGhvbG9n

eSBMYWJvcmF0b3J5LCBJem1pciwgVHVya2V5LiYjeEQ7UGF0aG9sb2d5IERlcGFydG1lbnQsIEVn

ZSBVbml2ZXJzaXR5LCBJem1pciwgVHVya2V5LiYjeEQ7UGF0aG9sb2d5IERlcGFydG1lbnQsIFRl

cGVjaWsgVHJhaW5pbmcgQW5kIFJlc2VhcmNoIEhvc3BpdGFsLCBJem1pciwgVHVya2V5LiYjeEQ7

R2VuZXJhbCBTdXJnaWNhbCBEZXBhcnRtZW50LCBFZ2UgVW5pdmVyc2l0eSwgSXptaXIsIFR1cmtl

eS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UaGUgUm9sZSBvZiBQYXJhZmlicm9taW4s

IEdhbGVjdGluLTMsIEhCTUUtMSwgYW5kIEtpLTY3IGluIHRoZSBEaWZmZXJlbnRpYWwgRGlhZ25v

c2lzIG9mIFBhcmF0aHlyb2lkIFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5PbWFuIE1l

ZCBKPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5PbWFuIG1lZGljYWwgam91cm5hbDwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk9tYW4gTWVkIEo8L2Z1bGwt

dGl0bGU+PGFiYnItMT5PbWFuIG1lZGljYWwgam91cm5hbDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+T21hbiBNZWQgSjwvZnVsbC10aXRsZT48YWJici0x

Pk9tYW4gbWVkaWNhbCBqb3VybmFsPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDIx

LTc8L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjY8L251bWJlcj48ZGF0ZXM+PHll

YXI+MjAxNTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk5vdjwvZGF0ZT48L3B1Yi1kYXRlcz48L2Rh

dGVzPjxpc2JuPjE5OTktNzY4WCAoUHJpbnQpJiN4RDsxOTk5LTc2OFggKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI2Njc1MDkxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI2Njc1MDkxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPjQ2Nzg0NDg8L2N1c3RvbTI+PGVsZWN0cm9u

aWMtcmVzb3VyY2UtbnVtPjEwLjUwMDEvb21qLjIwMTUuODQ8L2VsZWN0cm9uaWMtcmVzb3VyY2Ut

bnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYXJjb2NjaTwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+

PFJlY051bT41NDI3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihNYXJjb2NjaSBldCBhbC4gMjAwOCwg

T3Jkb25leiAyMDE0LCBLYXJhYXJzbGFuIGV0IGFsLiAyMDE1KTwvRGlzcGxheVRleHQ+PHJlY29y

ZD48cmVjLW51bWJlcj41NDI3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDI3PC9rZXk+

PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10

eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5NYXJjb2NjaSwgQy48L2F1dGhvcj48

YXV0aG9yPkNldGFuaSwgRi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxl

cz48dGl0bGU+UGFyYWZpYnJvbWluIGFzIGEgdG9vbCBmb3IgdGhlIGRpYWdub3NpcyBvZiBwYXJh

dGh5cm9pZCB0dW1vcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QWR2IEFuYXQgUGF0aG9sPC9z

ZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5BZHZhbmNlcyBpbiBhbmF0b21pYyBwYXRob2xvZ3k8

L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BZHYgQW5hdCBQYXRo

b2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5BZHZhbmNlcyBpbiBhbmF0b21pYyBwYXRob2xvZ3k8L2Fi

YnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFkdiBBbmF0IFBh

dGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFkdmFuY2VzIGluIGFuYXRvbWljIHBhdGhvbG9neTwv

YWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjE3OTsgYXV0aG9yIHJlcGx5IDE3OS04MDwv

cGFnZXM+PHZvbHVtZT4xNTwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5

d29yZD5BZGVub2NhcmNpbm9tYS8qZGlhZ25vc2lzL21ldGFib2xpc20vc2Vjb25kYXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPkFkZW5vbWEvKmRpYWdub3Npcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3

b3JkPkJpb21hcmtlcnMsIFR1bW9yL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5z

PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy9tZXRhYm9saXNtL3BhdGhvbG9n

eTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKmRpYWdub3Npcy9tZXRh

Ym9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlR1bW9yIFN1cHByZXNzb3IgUHJvdGVpbnMvZ2VuZXRp

Y3MvKm1ldGFib2xpc208L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1heTwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1

MzMtNDAzMSAoRWxlY3Ryb25pYykmI3hEOzEwNzItNDEwOSAoTGlua2luZyk8L2lzYm4+PGFjY2Vz

c2lvbi1udW0+MTg0MzQ3NzI8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJs

Pmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTg0MzQ3NzI8L3VybD48L3JlbGF0

ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwOTcvUEFQLjBiMDEz

ZTMxODE3MDlmNDc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPk9yZG9uZXo8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxSZWNOdW0+NTQzMDwv

UmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQzMDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2

cCI+NTQzMDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+T3Jkb25leiwg

Ti4gRy48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBh

cnRtZW50IG9mIFBhdGhvbG9neSwgVGhlIFVuaXZlcnNpdHkgb2YgVGV4YXMgTS5ELiBBbmRlcnNv

biBDYW5jZXIgQ2VudGVyLCBIb3VzdG9uLCBUWC48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRs

ZT5WYWx1ZSBvZiBHQVRBMyBpbW11bm9zdGFpbmluZyBpbiB0aGUgZGlhZ25vc2lzIG9mIHBhcmF0

aHlyb2lkIHR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hl

bSBNb2wgTW9ycGhvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXBwbGllZCBpbW11bm9o

aXN0b2NoZW1pc3RyeSAmYW1wOyBtb2xlY3VsYXIgbW9ycGhvbG9neSA6IEFJTU08L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hlbSBN

b2wgTW9ycGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFwcGxpZWQgaW1tdW5vaGlzdG9jaGVtaXN0

cnkgJmFtcDsgbW9sZWN1bGFyIG1vcnBob2xvZ3kgOiBBSU1NPC9hYmJyLTE+PC9wZXJpb2RpY2Fs

PjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BcHBsIEltbXVub2hpc3RvY2hlbSBNb2wgTW9y

cGhvbDwvZnVsbC10aXRsZT48YWJici0xPkFwcGxpZWQgaW1tdW5vaGlzdG9jaGVtaXN0cnkgJmFt

cDsgbW9sZWN1bGFyIG1vcnBob2xvZ3kgOiBBSU1NPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48

cGFnZXM+NzU2LTYxPC9wYWdlcz48dm9sdW1lPjIyPC92b2x1bWU+PG51bWJlcj4xMDwvbnVtYmVy

PjxrZXl3b3Jkcz48a2V5d29yZD5BZGVub21hLypkaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+

QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QmlvbWFya2VycywgVHVtb3IvKm1ldGFib2xpc208L2tl

eXdvcmQ+PGtleXdvcmQ+Q2FyY2lub21hLypkaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2Vs

bCBOdWNsZXVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3NpcywgRGlmZmVy

ZW50aWFsPC9rZXl3b3JkPjxrZXl3b3JkPkdBVEEzIFRyYW5zY3JpcHRpb24gRmFjdG9yL2ltbXVu

b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0

aHlyb2lkIE5lb3BsYXNtcy8qZGlhZ25vc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlByb3RlaW4gVHJh

bnNwb3J0PC9rZXl3b3JkPjxrZXl3b3JkPlNlbnNpdGl2aXR5IGFuZCBTcGVjaWZpY2l0eTwva2V5

d29yZD48a2V5d29yZD5TdGFpbmluZyBhbmQgTGFiZWxpbmc8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAxNDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk5vdi1EZWM8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMzLTQwNTggKEVsZWN0cm9uaWMpJiN4RDsxNTMzLTQw

NTggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1MDQ2MjI5PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzI1MDQ2MjI5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMDk3L1BBSS4wMDAwMDAwMDAwMDAwMDA3PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5LYXJhYXJzbGFuPC9BdXRob3I+PFll

YXI+MjAxNTwvWWVhcj48UmVjTnVtPjU0MzE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0

MzE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6

ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0MzE8L2tleT48L2ZvcmVpZ24ta2V5cz48

cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9y

cz48YXV0aG9ycz48YXV0aG9yPkthcmFhcnNsYW4sIFMuPC9hdXRob3I+PGF1dGhvcj5ZdXJ1bSwg

Ri4gTi48L2F1dGhvcj48YXV0aG9yPkt1bWJhcmFjaSwgQi4gUy48L2F1dGhvcj48YXV0aG9yPlBh

bGEsIEUuIEUuPC9hdXRob3I+PGF1dGhvcj5TaXZyaWtveiwgTy4gTi48L2F1dGhvcj48YXV0aG9y

PkFreWlsZGl6LCBNLjwvYXV0aG9yPjxhdXRob3I+QnVnZGF5Y2ksIE0uIEguPC9hdXRob3I+PC9h

dXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+UGF0aG9sb2d5IERlcGFydG1lbnQs

IFNpZmEgVW5pdmVyc2l0eSwgSXptaXIsIFR1cmtleS4mI3hEO1ByaXZhdGUgRWdlIFBhdGhvbG9n

eSBMYWJvcmF0b3J5LCBJem1pciwgVHVya2V5LiYjeEQ7UGF0aG9sb2d5IERlcGFydG1lbnQsIEVn

ZSBVbml2ZXJzaXR5LCBJem1pciwgVHVya2V5LiYjeEQ7UGF0aG9sb2d5IERlcGFydG1lbnQsIFRl

cGVjaWsgVHJhaW5pbmcgQW5kIFJlc2VhcmNoIEhvc3BpdGFsLCBJem1pciwgVHVya2V5LiYjeEQ7

R2VuZXJhbCBTdXJnaWNhbCBEZXBhcnRtZW50LCBFZ2UgVW5pdmVyc2l0eSwgSXptaXIsIFR1cmtl

eS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UaGUgUm9sZSBvZiBQYXJhZmlicm9taW4s

IEdhbGVjdGluLTMsIEhCTUUtMSwgYW5kIEtpLTY3IGluIHRoZSBEaWZmZXJlbnRpYWwgRGlhZ25v

c2lzIG9mIFBhcmF0aHlyb2lkIFR1bW9yczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5PbWFuIE1l

ZCBKPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5PbWFuIG1lZGljYWwgam91cm5hbDwvYWx0

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk9tYW4gTWVkIEo8L2Z1bGwt

dGl0bGU+PGFiYnItMT5PbWFuIG1lZGljYWwgam91cm5hbDwvYWJici0xPjwvcGVyaW9kaWNhbD48

YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+T21hbiBNZWQgSjwvZnVsbC10aXRsZT48YWJici0x

Pk9tYW4gbWVkaWNhbCBqb3VybmFsPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NDIx

LTc8L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjY8L251bWJlcj48ZGF0ZXM+PHll

YXI+MjAxNTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk5vdjwvZGF0ZT48L3B1Yi1kYXRlcz48L2Rh

dGVzPjxpc2JuPjE5OTktNzY4WCAoUHJpbnQpJiN4RDsxOTk5LTc2OFggKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI2Njc1MDkxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI2Njc1MDkxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPjQ2Nzg0NDg8L2N1c3RvbTI+PGVsZWN0cm9u

aWMtcmVzb3VyY2UtbnVtPjEwLjUwMDEvb21qLjIwMTUuODQ8L2VsZWN0cm9uaWMtcmVzb3VyY2Ut

bnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 20).Noninvasive preoperativeInvasive preoperativeIntraoperativeUltrasoundThermographyScanning with 131I or 99mTcScintigraphy with 201Tl – 99mTcScintigraphy with 99mTc-sestamibiSPECTCTMRIPETFine needle aspiration biopsy (FNAB) with Cytology.Determination of PTH and thyroglobulin in needle washout.Selective arteriography and subtraction angiography.Selective venous blood sampling with PTH test.Selenium-methionine arterial injection.Ultrasound.Intravenous infusion of toluidine or methylene Blue.Cyclic adenosine monophosphate urine test.Quick intraoperative blood PTH test.Gamma detection.Ultrasound Examination (US):US recommended as a first-line method in the diagnosis of PHPT. The majority of authors emphasize the advantages of US, which is a noninvasiveness approach, which gives the opportunity to utilize it repeatedly in the same patient at different stages of examination and treatment ( ADDIN EN.CITE <EndNote><Cite><Author>Taillandier</Author><Year>1994</Year><RecNum>5519</RecNum><DisplayText>(Taillandier et al. 1994)</DisplayText><record><rec-number>5519</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5519</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taillandier, J.</author><author>Kauffman, P.</author><author>Raynaud, F.</author><author>Ptak, Y.</author><author>Dauplat, J.</author></authors></contributors><auth-address>Service d&apos;Urologie, Hopital Gabriel-Montpied, Clermont-Ferrand.</auth-address><titles><title>[Preoperative localization of parathyroid adenomas. Role of cervical ultrasonography]</title><secondary-title>Presse Med</secondary-title><alt-title>Presse medicale</alt-title></titles><periodical><full-title>Presse Med</full-title><abbr-1>Presse medicale</abbr-1></periodical><alt-periodical><full-title>Presse Med</full-title><abbr-1>Presse medicale</abbr-1></alt-periodical><pages>116-20</pages><volume>23</volume><number>3</number><keywords><keyword>Adenoma/complications/*diagnostic imaging/surgery</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/*etiology</keyword><keyword>Hyperplasia/diagnostic imaging</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Glands/diagnostic imaging/pathology</keyword><keyword>Parathyroid Neoplasms/complications/*diagnostic imaging/surgery</keyword><keyword>Preoperative Care</keyword><keyword>Ultrasonography</keyword></keywords><dates><year>1994</year><pub-dates><date>Jan 29</date></pub-dates></dates><orig-pub>Localisation pre-operatoire des adenomes parathyroidiens. Place de l&apos;echographie cervicale.</orig-pub><isbn>0755-4982 (Print)&#xD;0755-4982 (Linking)</isbn><accession-num>8177843</accession-num><urls><related-urls><url>).Many authors emphasize that the main problem of sonography is a significant number of both false-negative and false-positive results. The sensitivity of US varies depending on the experience and skill of the specialist, the class of scanner, types and frequencies of probes, and the size and location of the parathyroid glands. In addition, detection of abnormal parathyroid glands is difficult in obese patients. showed that the sensitivity of parathyroid US conducted by an experienced specialist is higher as compared with that of a general practitioner in an outpatient department (79 vs. 33 % respectively) (22).US is necessary in patients with concomitant pathology of parathyroid glands and other neck organs. Many studies have shown that the incidence of thyroid cancer in patients with parathyroid adenoma is about 2%. Therefore, US of the thyroid and parathyroid glands aims to exclude thyroid nodules prior to the surgery on the parathyroidsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MdjwvQXV0aG9yPjxZZWFyPjIwMTg8L1llYXI+PFJlY051

bT41NTIxPC9SZWNOdW0+PERpc3BsYXlUZXh0PihMdiBldCBhbC4gMjAxOCwgWHVlIGV0IGFsLiAy

MDE4KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NTIxPC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NTIxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5MdiwgWi4gWS48L2F1dGhvcj48YXV0aG9yPkNhbywgVy48L2F1dGhvcj48YXV0aG9yPkx1LCBS

LiBHLjwvYXV0aG9yPjxhdXRob3I+U2hlbiwgSC48L2F1dGhvcj48YXV0aG9yPldlaSwgQi4gSi48

L2F1dGhvcj48YXV0aG9yPkd1bywgUi4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFVsdHJhc291bmQsIEJlaWppbmcgQ2hhb3lh

bmcgSG9zcGl0YWwsQ2FwaXRhbCBNZWRpY2FsIFVuaXZlcnNpdHksQmVpamluZywgMTAwMDIwLENo

aW5hLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPltWYWx1ZSBhbmFseXNpcyBvZiBwcmVv

cGVyYXRpdmUgYW5kIGludHJhLW9wZXJhdGl2ZSB1bHRyYXNvdW5kIGluIGRpYWdub3NpcyBhbmQg

dHJlYXRtZW50IG9mIHBhcmF0aHlyb2lkIGFkZW5vbWFdPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl

PkxpbiBDaHVuZyBFciBCaSBZYW4gSG91IFRvdSBKaW5nIFdhaSBLZSBaYSBaaGk8L3NlY29uZGFy

eS10aXRsZT48YWx0LXRpdGxlPkxpbiBjaHVhbmcgZXIgYmkgeWFuIGhvdSB0b3UgamluZyB3YWkg

a2UgemEgemhpID0gSm91cm5hbCBvZiBjbGluaWNhbCBvdG9yaGlub2xhcnluZ29sb2d5LCBoZWFk

LCBhbmQgbmVjayBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+TGluIENodW5nIEVyIEJpIFlhbiBIb3UgVG91IEppbmcgV2FpIEtlIFphIFpoaTwvZnVs

bC10aXRsZT48YWJici0xPkxpbiBjaHVhbmcgZXIgYmkgeWFuIGhvdSB0b3UgamluZyB3YWkga2Ug

emEgemhpID0gSm91cm5hbCBvZiBjbGluaWNhbCBvdG9yaGlub2xhcnluZ29sb2d5LCBoZWFkLCBh

bmQgbmVjayBzdXJnZXJ5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5MaW4gQ2h1bmcgRXIgQmkgWWFuIEhvdSBUb3UgSmluZyBXYWkgS2UgWmEgWmhpPC9m

dWxsLXRpdGxlPjxhYmJyLTE+TGluIGNodWFuZyBlciBiaSB5YW4gaG91IHRvdSBqaW5nIHdhaSBr

ZSB6YSB6aGkgPSBKb3VybmFsIG9mIGNsaW5pY2FsIG90b3JoaW5vbGFyeW5nb2xvZ3ksIGhlYWQs

IGFuZCBuZWNrIHN1cmdlcnk8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMzM5LTEx

MzQyPC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4xNzwvbnVtYmVyPjxkYXRlcz48

eWVhcj4yMDE4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MTAwMS0xNzgxIChQcmludCkmI3hEOzEwMDEtMTc4MSAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MzAyODIxOTA8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQt

dXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMzAyODIxOTA8L3Vy

bD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEzMjAx

L2ouaXNzbi4xMDAxLTE3ODEuMjAxOC4xNy4wMTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwv

cmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlh1ZTwvQXV0aG9yPjxZZWFyPjIwMTg8L1llYXI+

PFJlY051bT41NTIyPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NTIyPC9yZWMtbnVtYmVy

Pjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5

NWRqcmZwdHRyeHc5YXZwIj41NTIyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9

IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1

dGhvcj5YdWUsIEouPC9hdXRob3I+PGF1dGhvcj5MaXUsIFkuPC9hdXRob3I+PGF1dGhvcj5KaSwg

VC48L2F1dGhvcj48YXV0aG9yPlpoYW8sIEEuPC9hdXRob3I+PGF1dGhvcj5MaWFuZywgWS48L2F1

dGhvcj48YXV0aG9yPkRlbmcsIEguPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBRLjwvYXV0aG9yPjxh

dXRob3I+WmhhbmcsIFkuPC9hdXRob3I+PGF1dGhvcj5ZYW5nLCBMLjwvYXV0aG9yPjxhdXRob3I+

WWFuZywgQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+

Q29tcGFyaXNvbiBiZXR3ZWVuIHRlY2huZXRpdW0tOTltIG1ldGhveHlpc29idXR5bGlzb25pdHJp

bGUgc2NpbnRpZ3JhcGh5IGFuZCB1bHRyYXNvdW5kIGluIHRoZSBkaWFnbm9zaXMgb2YgcGFyYXRo

eXJvaWQgYWRlbm9tYSBhbmQgcGFyYXRoeXJvaWQgaHlwZXJwbGFzaWE8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5OdWNs

ZWFyIG1lZGljaW5lIGNvbW11bmljYXRpb25zPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+TnVjbGVh

ciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+TnVj

bGVhciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBh

Z2VzPjExMjktMTEzNzwvcGFnZXM+PHZvbHVtZT4zOTwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qZGlhZ25vc3RpYyBpbWFnaW5nPC9rZXl3b3Jk

PjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtl

eXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5d29yZD48

a2V5d29yZD5DaGlsZDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGxhc2lhL2RpYWdub3N0aWMgaW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3

b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFnaW5nLypwYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zLypkaWFnbm9zdGlj

IGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPipTaW5nbGUgUGhvdG9uIEVtaXNzaW9uIENvbXB1dGVkIFRvbW9ncmFwaHkgQ29t

cHV0ZWQgVG9tb2dyYXBoeTwva2V5d29yZD48a2V5d29yZD4qVGVjaG5ldGl1bSBUYyA5OW0gU2Vz

dGFtaWJpPC9rZXl3b3JkPjxrZXl3b3JkPlVsdHJhc29ub2dyYXBoeTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE4PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3

My01NjI4IChFbGVjdHJvbmljKSYjeEQ7MDE0My0zNjM2IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4zMDIzOTQ3MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+

aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8zMDIzOTQ3MjwvdXJsPjwvcmVsYXRl

ZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5Ny9NTk0uMDAwMDAw

MDAwMDAwMDkyMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MdjwvQXV0aG9yPjxZZWFyPjIwMTg8L1llYXI+PFJlY051

bT41NTIxPC9SZWNOdW0+PERpc3BsYXlUZXh0PihMdiBldCBhbC4gMjAxOCwgWHVlIGV0IGFsLiAy

MDE4KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NTIxPC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NTIxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5MdiwgWi4gWS48L2F1dGhvcj48YXV0aG9yPkNhbywgVy48L2F1dGhvcj48YXV0aG9yPkx1LCBS

LiBHLjwvYXV0aG9yPjxhdXRob3I+U2hlbiwgSC48L2F1dGhvcj48YXV0aG9yPldlaSwgQi4gSi48

L2F1dGhvcj48YXV0aG9yPkd1bywgUi4gSi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRv

cnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFVsdHJhc291bmQsIEJlaWppbmcgQ2hhb3lh

bmcgSG9zcGl0YWwsQ2FwaXRhbCBNZWRpY2FsIFVuaXZlcnNpdHksQmVpamluZywgMTAwMDIwLENo

aW5hLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPltWYWx1ZSBhbmFseXNpcyBvZiBwcmVv

cGVyYXRpdmUgYW5kIGludHJhLW9wZXJhdGl2ZSB1bHRyYXNvdW5kIGluIGRpYWdub3NpcyBhbmQg

dHJlYXRtZW50IG9mIHBhcmF0aHlyb2lkIGFkZW5vbWFdPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl

PkxpbiBDaHVuZyBFciBCaSBZYW4gSG91IFRvdSBKaW5nIFdhaSBLZSBaYSBaaGk8L3NlY29uZGFy

eS10aXRsZT48YWx0LXRpdGxlPkxpbiBjaHVhbmcgZXIgYmkgeWFuIGhvdSB0b3UgamluZyB3YWkg

a2UgemEgemhpID0gSm91cm5hbCBvZiBjbGluaWNhbCBvdG9yaGlub2xhcnluZ29sb2d5LCBoZWFk

LCBhbmQgbmVjayBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+TGluIENodW5nIEVyIEJpIFlhbiBIb3UgVG91IEppbmcgV2FpIEtlIFphIFpoaTwvZnVs

bC10aXRsZT48YWJici0xPkxpbiBjaHVhbmcgZXIgYmkgeWFuIGhvdSB0b3UgamluZyB3YWkga2Ug

emEgemhpID0gSm91cm5hbCBvZiBjbGluaWNhbCBvdG9yaGlub2xhcnluZ29sb2d5LCBoZWFkLCBh

bmQgbmVjayBzdXJnZXJ5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5MaW4gQ2h1bmcgRXIgQmkgWWFuIEhvdSBUb3UgSmluZyBXYWkgS2UgWmEgWmhpPC9m

dWxsLXRpdGxlPjxhYmJyLTE+TGluIGNodWFuZyBlciBiaSB5YW4gaG91IHRvdSBqaW5nIHdhaSBr

ZSB6YSB6aGkgPSBKb3VybmFsIG9mIGNsaW5pY2FsIG90b3JoaW5vbGFyeW5nb2xvZ3ksIGhlYWQs

IGFuZCBuZWNrIHN1cmdlcnk8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMzM5LTEx

MzQyPC9wYWdlcz48dm9sdW1lPjMyPC92b2x1bWU+PG51bWJlcj4xNzwvbnVtYmVyPjxkYXRlcz48

eWVhcj4yMDE4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHViLWRhdGVzPjwv

ZGF0ZXM+PGlzYm4+MTAwMS0xNzgxIChQcmludCkmI3hEOzEwMDEtMTc4MSAoTGlua2luZyk8L2lz

Ym4+PGFjY2Vzc2lvbi1udW0+MzAyODIxOTA8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQt

dXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMzAyODIxOTA8L3Vy

bD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEzMjAx

L2ouaXNzbi4xMDAxLTE3ODEuMjAxOC4xNy4wMTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwv

cmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlh1ZTwvQXV0aG9yPjxZZWFyPjIwMTg8L1llYXI+

PFJlY051bT41NTIyPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NTIyPC9yZWMtbnVtYmVy

Pjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5

NWRqcmZwdHRyeHc5YXZwIj41NTIyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9

IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1

dGhvcj5YdWUsIEouPC9hdXRob3I+PGF1dGhvcj5MaXUsIFkuPC9hdXRob3I+PGF1dGhvcj5KaSwg

VC48L2F1dGhvcj48YXV0aG9yPlpoYW8sIEEuPC9hdXRob3I+PGF1dGhvcj5MaWFuZywgWS48L2F1

dGhvcj48YXV0aG9yPkRlbmcsIEguPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBRLjwvYXV0aG9yPjxh

dXRob3I+WmhhbmcsIFkuPC9hdXRob3I+PGF1dGhvcj5ZYW5nLCBMLjwvYXV0aG9yPjxhdXRob3I+

WWFuZywgQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+

Q29tcGFyaXNvbiBiZXR3ZWVuIHRlY2huZXRpdW0tOTltIG1ldGhveHlpc29idXR5bGlzb25pdHJp

bGUgc2NpbnRpZ3JhcGh5IGFuZCB1bHRyYXNvdW5kIGluIHRoZSBkaWFnbm9zaXMgb2YgcGFyYXRo

eXJvaWQgYWRlbm9tYSBhbmQgcGFyYXRoeXJvaWQgaHlwZXJwbGFzaWE8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5OdWNs

ZWFyIG1lZGljaW5lIGNvbW11bmljYXRpb25zPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+TnVjbGVh

ciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+TnVjbCBNZWQgQ29tbXVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+TnVj

bGVhciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBh

Z2VzPjExMjktMTEzNzwvcGFnZXM+PHZvbHVtZT4zOTwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qZGlhZ25vc3RpYyBpbWFnaW5nPC9rZXl3b3Jk

PjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtl

eXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4MCBhbmQgb3Zlcjwva2V5d29yZD48

a2V5d29yZD5DaGlsZDwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGxhc2lhL2RpYWdub3N0aWMgaW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3

b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFnaW5nLypwYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zLypkaWFnbm9zdGlj

IGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPipTaW5nbGUgUGhvdG9uIEVtaXNzaW9uIENvbXB1dGVkIFRvbW9ncmFwaHkgQ29t

cHV0ZWQgVG9tb2dyYXBoeTwva2V5d29yZD48a2V5d29yZD4qVGVjaG5ldGl1bSBUYyA5OW0gU2Vz

dGFtaWJpPC9rZXl3b3JkPjxrZXl3b3JkPlVsdHJhc29ub2dyYXBoeTwva2V5d29yZD48a2V5d29y

ZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE4PC95ZWFy

PjxwdWItZGF0ZXM+PGRhdGU+RGVjPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTQ3

My01NjI4IChFbGVjdHJvbmljKSYjeEQ7MDE0My0zNjM2IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4zMDIzOTQ3MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+

aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8zMDIzOTQ3MjwvdXJsPjwvcmVsYXRl

ZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA5Ny9NTk0uMDAwMDAw

MDAwMDAwMDkyMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT4A

ADDIN EN.CITE.DATA (23).Computed Tomography and Magnetic Resonance Imaging (CT):CT of the neck and mediastinum is used to specify the localization of pathologic parathyroid glands together with the methods of radionuclide diagnostics and US. CT is a more objective (though less sensitive) diagnostic method (as compared with US) in revealing enlarged and orthotopically located parathyroid glands.Additionally, CT is a more informative method (as compared with US) for topical diagnosis of the ectopias, adenomas, and hyperplastic parathyroid glands in areas inaccessible to US. CT is advantageous in providing more complete information not only about organs under study and relations between the pathologic process and surrounding tissues but also about the condition of the adjacent organs (PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYXphdmk8L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxS

ZWNOdW0+NTUyNjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oS2x1aWpmaG91dCBldCBhbC4gMjAxNywg

UmF6YXZpIGV0IGFsLiAyMDE4KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NTI2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5

dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NTI2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJl

Zi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+

PGF1dGhvcnM+PGF1dGhvcj5SYXphdmksIFMuPC9hdXRob3I+PGF1dGhvcj5aaWViYXJ0aCwgQi48

L2F1dGhvcj48YXV0aG9yPktsZWluLCBSLjwvYXV0aG9yPjxhdXRob3I+WmVuZywgVy48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EaXZpc2lvbiBvZiBOdWNs

ZWFyIE1lZGljaW5lLCBUaGUgT3R0YXdhIEhvc3BpdGFsLCBPdHRhd2EsIE9udGFyaW8sIENhbmFk

YS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EdWFsIHRpbWUtcG9pbnQgcXVhbnRpdGF0

aXZlIFNQRUNULUNUIHBhcmF0aHlyb2lkIGltYWdpbmcgdXNpbmcgYSBzaW5nbGUgY29tcHV0ZWQg

dG9tb2dyYXBoeTogZmVhc2liaWxpdHkgYW5kIG9wZXJhdG9yIHZhcmlhYmlsaXR5PC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPk51Y2wgTWVkIENvbW11bjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+TnVjbGVhciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk51Y2wgTWVkIENvbW11bjwvZnVsbC10aXRsZT48YWJici0x

Pk51Y2xlYXIgbWVkaWNpbmUgY29tbXVuaWNhdGlvbnM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs

dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk51Y2wgTWVkIENvbW11bjwvZnVsbC10aXRsZT48YWJi

ci0xPk51Y2xlYXIgbWVkaWNpbmUgY29tbXVuaWNhdGlvbnM8L2FiYnItMT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4zLTk8L3BhZ2VzPjx2b2x1bWU+Mzk8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29y

ZD48a2V5d29yZD5GZWFzaWJpbGl0eSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW1hZ2UgUHJvY2Vzc2lu

ZywgQ29tcHV0ZXItQXNzaXN0ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5

d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PYnNlcnZlciBWYXJpYXRpb248L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLypkaWFnbm9zdGljIGltYWdpbmc8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zL2RpYWdub3N0aWMgaW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

U2luZ2xlIFBob3RvbiBFbWlzc2lvbiBDb21wdXRlZCBUb21vZ3JhcGh5IENvbXB1dGVkIFRvbW9n

cmFwaHkvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+VGltZSBGYWN0b3JzPC9rZXl3b3JkPjwv

a2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2Rh

dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDczLTU2MjggKEVsZWN0cm9uaWMpJiN4RDsw

MTQzLTM2MzYgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI5MDk5NDEyPC9hY2Nlc3Np

b24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5n

b3YvcHVibWVkLzI5MDk5NDEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmlj

LXJlc291cmNlLW51bT4xMC4xMDk3L01OTS4wMDAwMDAwMDAwMDAwNzYxPC9lbGVjdHJvbmljLXJl

c291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5LbHVpamZob3V0PC9BdXRo

b3I+PFllYXI+MjAxNzwvWWVhcj48UmVjTnVtPjU1Mjc8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjU1Mjc8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1

MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU1Mjc8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktsdWlqZmhvdXQsIFcuIFAuPC9hdXRob3I+PGF1dGhv

cj5QYXN0ZXJuYWssIEouIEQuPC9hdXRob3I+PGF1dGhvcj5CZW5pbmF0bywgVC48L2F1dGhvcj48

YXV0aG9yPkRyYWtlLCBGLiBULjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi4gRS48L2F1dGhv

cj48YXV0aG9yPlNoZW4sIFcuIFQuPC9hdXRob3I+PGF1dGhvcj5EdWgsIFEuIFkuPC9hdXRob3I+

PGF1dGhvcj5BbGxlbiwgSS4gRS48L2F1dGhvcj48YXV0aG9yPlZyaWVucywgTS4gUi48L2F1dGhv

cj48YXV0aG9yPmRlIEtlaXplciwgQi48L2F1dGhvcj48YXV0aG9yPkhvcGUsIFQuIEEuPC9hdXRo

b3I+PGF1dGhvcj5TdWgsIEkuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBVbml2ZXJzaXR5IG9mIENhbGlmb3JuaWEg

U2FuIEZyYW5jaXNjbywgVW5pdGVkIFN0YXRlczsgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBVbml2

ZXJzaXR5IE1lZGljYWwgQ2VudGVyIFV0cmVjaHQsIFRoZSBOZXRoZXJsYW5kcy4gRWxlY3Ryb25p

YyBhZGRyZXNzOiBXUEtsdWlqZmhvdXRAZ21haWwuY29tLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJn

ZXJ5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrIFRvcm9udG8sIENhbmFkYS4mI3hEO0RlcGFy

dG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28s

IFVuaXRlZCBTdGF0ZXMuJiN4RDtEZXBhcnRtZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgQmlvc3Rh

dGlzdGljcywgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28sIFVTQS4mI3hE

O0RlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBNZWRpY2FsIENlbnRlciBVdHJlY2h0

LCBUaGUgTmV0aGVybGFuZHMuJiN4RDtEZXBhcnRtZW50IG9mIFJhZGlvbG9neSwgVW5pdmVyc2l0

eSBNZWRpY2FsIENlbnRlciBVdHJlY2h0LCBUaGUgTmV0aGVybGFuZHMuJiN4RDtEZXBhcnRtZW50

IG9mIFJhZGlvbG9neSwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28sIFVT

QS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EaWFnbm9zdGljIHBlcmZvcm1hbmNlIG9m

IGNvbXB1dGVkIHRvbW9ncmFwaHkgZm9yIHBhcmF0aHlyb2lkIGFkZW5vbWEgbG9jYWxpemF0aW9u

OyBhIHN5c3RlbWF0aWMgcmV2aWV3IGFuZCBtZXRhLWFuYWx5c2lzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkV1ciBKIFJhZGlvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+RXVyb3BlYW4g

am91cm5hbCBvZiByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5FdXIgSiBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5FdXJvcGVhbiBqb3VybmFs

IG9mIHJhZGlvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+RXVyIEogUmFkaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+RXVyb3BlYW4gam91cm5hbCBv

ZiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMTctMTI4PC9wYWdl

cz48dm9sdW1lPjg4PC92b2x1bWU+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vbWEvKmRpYWdub3N0

aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkRhdGFiYXNlcywgRmFjdHVhbDwv

a2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk

PjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtl

eXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzL2RpYWdub3N0aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy8qZGlhZ25vc3RpYyBpbWFnaW5nL3N1

cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5IG9mIFJlc3VsdHM8L2tleXdv

cmQ+PGtleXdvcmQ+U2Vuc2l0aXZpdHkgYW5kIFNwZWNpZmljaXR5PC9rZXl3b3JkPjxrZXl3b3Jk

PlRvbW9ncmFwaHksIFgtUmF5IENvbXB1dGVkLyptZXRob2RzPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXI8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xODcyLTc3MjcgKEVsZWN0cm9uaWMpJiN4RDswNzIwLTA0OFgg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI4MTg5MTk2PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzI4MTg5MTk2PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDE2L2ouZWpyYWQuMjAxNy4wMS4wMDQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SYXphdmk8L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxS

ZWNOdW0+NTUyNjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oS2x1aWpmaG91dCBldCBhbC4gMjAxNywg

UmF6YXZpIGV0IGFsLiAyMDE4KTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NTI2

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5

dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NTI2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJl

Zi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+

PGF1dGhvcnM+PGF1dGhvcj5SYXphdmksIFMuPC9hdXRob3I+PGF1dGhvcj5aaWViYXJ0aCwgQi48

L2F1dGhvcj48YXV0aG9yPktsZWluLCBSLjwvYXV0aG9yPjxhdXRob3I+WmVuZywgVy48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EaXZpc2lvbiBvZiBOdWNs

ZWFyIE1lZGljaW5lLCBUaGUgT3R0YXdhIEhvc3BpdGFsLCBPdHRhd2EsIE9udGFyaW8sIENhbmFk

YS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EdWFsIHRpbWUtcG9pbnQgcXVhbnRpdGF0

aXZlIFNQRUNULUNUIHBhcmF0aHlyb2lkIGltYWdpbmcgdXNpbmcgYSBzaW5nbGUgY29tcHV0ZWQg

dG9tb2dyYXBoeTogZmVhc2liaWxpdHkgYW5kIG9wZXJhdG9yIHZhcmlhYmlsaXR5PC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPk51Y2wgTWVkIENvbW11bjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+TnVjbGVhciBtZWRpY2luZSBjb21tdW5pY2F0aW9uczwvYWx0LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk51Y2wgTWVkIENvbW11bjwvZnVsbC10aXRsZT48YWJici0x

Pk51Y2xlYXIgbWVkaWNpbmUgY29tbXVuaWNhdGlvbnM8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs

dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk51Y2wgTWVkIENvbW11bjwvZnVsbC10aXRsZT48YWJi

ci0xPk51Y2xlYXIgbWVkaWNpbmUgY29tbXVuaWNhdGlvbnM8L2FiYnItMT48L2FsdC1wZXJpb2Rp

Y2FsPjxwYWdlcz4zLTk8L3BhZ2VzPjx2b2x1bWU+Mzk8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29y

ZD48a2V5d29yZD5GZWFzaWJpbGl0eSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwv

a2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SW1hZ2UgUHJvY2Vzc2lu

ZywgQ29tcHV0ZXItQXNzaXN0ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5

d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5PYnNlcnZlciBWYXJpYXRpb248L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLypkaWFnbm9zdGljIGltYWdpbmc8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zL2RpYWdub3N0aWMgaW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD5SZXRyb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

U2luZ2xlIFBob3RvbiBFbWlzc2lvbiBDb21wdXRlZCBUb21vZ3JhcGh5IENvbXB1dGVkIFRvbW9n

cmFwaHkvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+VGltZSBGYWN0b3JzPC9rZXl3b3JkPjwv

a2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2Rh

dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDczLTU2MjggKEVsZWN0cm9uaWMpJiN4RDsw

MTQzLTM2MzYgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI5MDk5NDEyPC9hY2Nlc3Np

b24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5n

b3YvcHVibWVkLzI5MDk5NDEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmlj

LXJlc291cmNlLW51bT4xMC4xMDk3L01OTS4wMDAwMDAwMDAwMDAwNzYxPC9lbGVjdHJvbmljLXJl

c291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5LbHVpamZob3V0PC9BdXRo

b3I+PFllYXI+MjAxNzwvWWVhcj48UmVjTnVtPjU1Mjc8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjU1Mjc8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1

MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU1Mjc8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktsdWlqZmhvdXQsIFcuIFAuPC9hdXRob3I+PGF1dGhv

cj5QYXN0ZXJuYWssIEouIEQuPC9hdXRob3I+PGF1dGhvcj5CZW5pbmF0bywgVC48L2F1dGhvcj48

YXV0aG9yPkRyYWtlLCBGLiBULjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi4gRS48L2F1dGhv

cj48YXV0aG9yPlNoZW4sIFcuIFQuPC9hdXRob3I+PGF1dGhvcj5EdWgsIFEuIFkuPC9hdXRob3I+

PGF1dGhvcj5BbGxlbiwgSS4gRS48L2F1dGhvcj48YXV0aG9yPlZyaWVucywgTS4gUi48L2F1dGhv

cj48YXV0aG9yPmRlIEtlaXplciwgQi48L2F1dGhvcj48YXV0aG9yPkhvcGUsIFQuIEEuPC9hdXRo

b3I+PGF1dGhvcj5TdWgsIEkuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRo

LWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBVbml2ZXJzaXR5IG9mIENhbGlmb3JuaWEg

U2FuIEZyYW5jaXNjbywgVW5pdGVkIFN0YXRlczsgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBVbml2

ZXJzaXR5IE1lZGljYWwgQ2VudGVyIFV0cmVjaHQsIFRoZSBOZXRoZXJsYW5kcy4gRWxlY3Ryb25p

YyBhZGRyZXNzOiBXUEtsdWlqZmhvdXRAZ21haWwuY29tLiYjeEQ7RGVwYXJ0bWVudCBvZiBTdXJn

ZXJ5LCBVbml2ZXJzaXR5IEhlYWx0aCBOZXR3b3JrIFRvcm9udG8sIENhbmFkYS4mI3hEO0RlcGFy

dG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28s

IFVuaXRlZCBTdGF0ZXMuJiN4RDtEZXBhcnRtZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgQmlvc3Rh

dGlzdGljcywgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28sIFVTQS4mI3hE

O0RlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBNZWRpY2FsIENlbnRlciBVdHJlY2h0

LCBUaGUgTmV0aGVybGFuZHMuJiN4RDtEZXBhcnRtZW50IG9mIFJhZGlvbG9neSwgVW5pdmVyc2l0

eSBNZWRpY2FsIENlbnRlciBVdHJlY2h0LCBUaGUgTmV0aGVybGFuZHMuJiN4RDtEZXBhcnRtZW50

IG9mIFJhZGlvbG9neSwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhIFNhbiBGcmFuY2lzY28sIFVT

QS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EaWFnbm9zdGljIHBlcmZvcm1hbmNlIG9m

IGNvbXB1dGVkIHRvbW9ncmFwaHkgZm9yIHBhcmF0aHlyb2lkIGFkZW5vbWEgbG9jYWxpemF0aW9u

OyBhIHN5c3RlbWF0aWMgcmV2aWV3IGFuZCBtZXRhLWFuYWx5c2lzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkV1ciBKIFJhZGlvbDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+RXVyb3BlYW4g

am91cm5hbCBvZiByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs

bC10aXRsZT5FdXIgSiBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5FdXJvcGVhbiBqb3VybmFs

IG9mIHJhZGlvbG9neTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+RXVyIEogUmFkaW9sPC9mdWxsLXRpdGxlPjxhYmJyLTE+RXVyb3BlYW4gam91cm5hbCBv

ZiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xMTctMTI4PC9wYWdl

cz48dm9sdW1lPjg4PC92b2x1bWU+PGtleXdvcmRzPjxrZXl3b3JkPkFkZW5vbWEvKmRpYWdub3N0

aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkRhdGFiYXNlcywgRmFjdHVhbDwv

a2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk

PjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtl

eXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzL2RpYWdub3N0aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy8qZGlhZ25vc3RpYyBpbWFnaW5nL3N1

cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5IG9mIFJlc3VsdHM8L2tleXdv

cmQ+PGtleXdvcmQ+U2Vuc2l0aXZpdHkgYW5kIFNwZWNpZmljaXR5PC9rZXl3b3JkPjxrZXl3b3Jk

PlRvbW9ncmFwaHksIFgtUmF5IENvbXB1dGVkLyptZXRob2RzPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXI8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xODcyLTc3MjcgKEVsZWN0cm9uaWMpJiN4RDswNzIwLTA0OFgg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI4MTg5MTk2PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzI4MTg5MTk2PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC4xMDE2L2ouZWpyYWQuMjAxNy4wMS4wMDQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA 24).MRI has advantages over CT: Radiation load is absent, X-ray contrast agents are not needed, and artifacts are rare. Its expensiveness is the greatest difficulty slowing its implementation. The principal indication for MRI (as for CT) is an ectopia of a pathologic parathyroid gland – initially, location of the tumor in the mediastinum, preliminarily revealed with a 99m Tc-sestamibi scan (PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcmdpcm88L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxS

ZWNOdW0+NTUzMjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oV2FkYSBldCBhbC4gMTk5OSwgV2FycmVu

IEZydW56YWMgZXQgYWwuIDIwMTYsIEFyZ2lybyBldCBhbC4gMjAxOCk8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+NTUzMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw

PSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTUzMjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QXJnaXJvLCBSLjwvYXV0aG9y

PjxhdXRob3I+RGlhY2ludGksIEQuPC9hdXRob3I+PGF1dGhvcj5TYWNjb25pLCBCLjwvYXV0aG9y

PjxhdXRob3I+SWFubmFyZWxsaSwgQS48L2F1dGhvcj48YXV0aG9yPkRpYWNpbnRpLCBELjwvYXV0

aG9yPjxhdXRob3I+Q2lwcmlhbmksIEMuPC9hdXRob3I+PGF1dGhvcj5QaXNhbmksIEQuPC9hdXRo

b3I+PGF1dGhvcj5Sb21hZ25vbGksIEUuPC9hdXRob3I+PGF1dGhvcj5CaWZmb25pLCBNLjwvYXV0

aG9yPjxhdXRob3I+RGkgR2lvaWEsIEMuPC9hdXRob3I+PGF1dGhvcj5QZXBlLCBKLjwvYXV0aG9y

PjxhdXRob3I+QmV6emksIE0uPC9hdXRob3I+PGF1dGhvcj5MZXRpemlhLCBDLjwvYXV0aG9yPjxh

dXRob3I+TWluaXNvbGEsIFMuPC9hdXRob3I+PGF1dGhvcj5DYXRhbGFubywgQy48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFJhZGlv

bG9neSwgSW50ZXJ2ZW50aW9uYWwgUmFkaW9sb2d5IFVuaXQsIE9zcGVkYWxlIE0uRy4gVmFubmlu

aSAtIEZpZ2xpZSBkaSBTYW4gQ2FtaWxsbywgVmlhIGRlbGwmYXBvczthY3F1YSBCdWxsaWNhbnRl

LCAwMDEwMCwgUm9tYSwgSXRhbHkuJiN4RDtEZXBhcnRtZW50IG9mIFJhZGlvbG9naWNhbCBTY2ll

bmNlcywgT25jb2xvZ3kgYW5kIFBhdGhvbG9neSwgU2FwaWVuemEgVW5pdmVyc2l0eSwgdmlhbGUg

UmVnaW5hIEVsZW5hIDMyNCwgMDAxNjEsIFJvbWUsIEl0YWx5LiYjeEQ7RGVwYXJ0bWVudCBvZiBS

YWRpb2xvZ2ljYWwgU2NpZW5jZXMsIE9uY29sb2d5IGFuZCBQYXRob2xvZ3ksIFNhcGllbnphIFVu

aXZlcnNpdHksIHZpYWxlIFJlZ2luYSBFbGVuYSAzMjQsIDAwMTYxLCBSb21lLCBJdGFseS4gZGFu

aWVsZS5kaWFjaW50aUB1bmlyb21hMS5pdC4mI3hEO0NlbnRlciBmb3IgTGlmZSBOYW5vIFNjaWVu

Y2UgU2FwaWVuemEsIElzdGl0dXRvIEl0YWxpYW5vIGRpIFRlY25vbG9naWEsIFZpYWxlIFJlZ2lu

YSBFbGVuYSwgMjkxLCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2Np

ZW5jZXMsIFNhcGllbnphIFVuaXZlcnNpdHksIHZpYWxlIGRlbCBQb2xpY2xpbmljbyAxNTUsIDAw

MTYxLCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIE1vbGVjdWxh

ciBNZWRpY2luZSwgU2FwaWVuemEgVW5pdmVyc2l0eSwgdmlhIEdyb3R0YXJvc3NhIDEwMzUsIDAw

MTg5LCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgRXhwZXJpbWVudGFsIE1lZGljaW5l

LCBTYXBpZW56YSBVbml2ZXJzaXR5LCB2aWFsZSBkZWwgUG9saWNsaW5pY28gMTU1LCAwMDE2MSwg

Um9tZSwgSXRhbHkuJiN4RDtEZXBhcnRtZW50IG9mIFN1cmdlcnkgU2NpZW5jZXMsIFNhcGllbnph

IFVuaXZlcnNpdHksIHZpYWxlIGRlbCBQb2xpY2xpbmljbyAxNTUsIDAwMTYxLCBSb21lLCBJdGFs

eS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EaWFnbm9zdGljIGFjY3VyYWN5IG9mIDNU

IG1hZ25ldGljIHJlc29uYW5jZSBpbWFnaW5nIGluIHRoZSBwcmVvcGVyYXRpdmUgbG9jYWxpc2F0

aW9uIG9mIHBhcmF0aHlyb2lkIGFkZW5vbWFzOiBjb21wYXJpc29uIHdpdGggdWx0cmFzb3VuZCBh

bmQgOTltVGMtc2VzdGFtaWJpIHNjYW5zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkV1ciBSYWRp

b2w8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1cm9wZWFuIHJhZGlvbG9neTwvYWx0LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBSYWRpb2w8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiByYWRpb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1w

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5FdXJv

cGVhbiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxkYXRlcz48eWVhcj4yMDE4

PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWF5IDc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTEwODQgKEVsZWN0cm9uaWMpJiN4RDswOTM4LTc5OTQgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI5NzM2ODQ5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI5NzM2ODQ5PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDMzMC0wMTgtNTQzNy04PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PENpdGU+PEF1dGhvcj5XYXJyZW4gRnJ1bnphYzwvQXV0aG9yPjxZZWFyPjIwMTY8L1llYXI+PFJl

Y051bT41NTMzPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NTMzPC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NTMzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5XYXJyZW4gRnJ1bnphYywgUi48L2F1dGhvcj48YXV0aG9yPlJpY2hhcmRzLCBNLjwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Db21wdXRlZCBUb21vZ3Jh

cGh5IGFuZCBNYWduZXRpYyBSZXNvbmFuY2UgSW1hZ2luZyBvZiB0aGUgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgR2xhbmRzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkZyb250IEhvcm0gUmVzPC9z

ZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Gcm9udGllcnMgb2YgaG9ybW9uZSByZXNlYXJjaDwv

YWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkZyb250IEhvcm0gUmVz

PC9mdWxsLXRpdGxlPjxhYmJyLTE+RnJvbnRpZXJzIG9mIGhvcm1vbmUgcmVzZWFyY2g8L2FiYnIt

MT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkZyb250IEhvcm0gUmVz

PC9mdWxsLXRpdGxlPjxhYmJyLTE+RnJvbnRpZXJzIG9mIGhvcm1vbmUgcmVzZWFyY2g8L2FiYnIt

MT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNi0yMzwvcGFnZXM+PHZvbHVtZT40NTwvdm9sdW1l

PjxrZXl3b3Jkcz48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFnbmV0aWMgUmVz

b25hbmNlIEltYWdpbmcvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+TXVsdGltb2RhbCBJbWFn

aW5nLyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25v

c3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKmRpYWdub3N0aWMg

aW1hZ2luZzwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBYLVJheSBDb21wdXRlZC8qbWV0

aG9kczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFyPjwvZGF0ZXM+

PGlzYm4+MTY2Mi0zNzYyIChFbGVjdHJvbmljKSYjeEQ7MDMwMS0zMDczIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4yNzAwMjk4OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNzAwMjk4OTwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTE1OS8w

MDA0NDIyNzQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48

QXV0aG9yPldhZGE8L0F1dGhvcj48WWVhcj4xOTk5PC9ZZWFyPjxSZWNOdW0+NTUzNDwvUmVjTnVt

PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTUzNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkg

YXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTUz

NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FkYSwgQS48L2F1dGhv

cj48YXV0aG9yPlN1Z2loYXJhLCBNLjwvYXV0aG9yPjxhdXRob3I+U3VnaW11cmEsIEsuPC9hdXRo

b3I+PGF1dGhvcj5LdXJvZGEsIEguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBSYWRpb2xvZ3ksIFNoaW1hbmUgTWVkaWNhbCBVbml2

ZXJzaXR5LCBJenVtbywgSmFwYW4uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TWFnbmV0

aWMgcmVzb25hbmNlIGltYWdpbmcgKE1SSSkgYW5kIHRlY2huZXRpdW0tOTltLW1ldGhveHlpc29u

aXRyaWxlIChNSUJJKSBzY2ludGlncmFwaHkgdG8gZXZhbHVhdGUgdGhlIGFibm9ybWFsIHBhcmF0

aHlyb2lkIGdsYW5kIGFuZCBQRUlUIGVmZmljYWN5IGZvciBzZWNvbmRhcnkgaHlwZXJwYXJhdGh5

cm9pZGlzbTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SYWRpYXQgTWVkPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5SYWRpYXRpb24gbWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5SYWRpYXQgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmFkaWF0

aW9uIG1lZGljaW5lPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5SYWRpYXQgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmFkaWF0aW9uIG1lZGljaW5lPC9h

YmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+Mjc1LTgyPC9wYWdlcz48dm9sdW1lPjE3PC92

b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+RXRoYW5vbC8qdGhlcmFwZXV0aWMgdXNl

PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdv

cmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbSwgU2Vjb25kYXJ5L2NvbXBsaWNhdGlvbnMv

KmRpYWdub3Npcy9kcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SW5qZWN0aW9uczwva2V5

d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy9jb21wbGljYXRpb25zPC9rZXl3

b3JkPjxrZXl3b3JkPipNYWduZXRpYyBSZXNvbmFuY2UgSW1hZ2luZzwva2V5d29yZD48a2V5d29y

ZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBh

cmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFnaW5nL2RydWcgZWZmZWN0cy8qcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvbnVjbGlkZSBJbWFnaW5nPC9rZXl3b3JkPjxrZXl3

b3JkPipSYWRpb3BoYXJtYWNldXRpY2Fsczwva2V5d29yZD48a2V5d29yZD5TZW5zaXRpdml0eSBh

bmQgU3BlY2lmaWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+KlRlY2huZXRpdW0gVGMgOTltIFNlc3Rh

bWliaTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdv

cmRzPjxkYXRlcz48eWVhcj4xOTk5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsLUF1ZzwvZGF0

ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAyODgtMjA0MyAoUHJpbnQpJiN4RDswMjg4LTIw

NDMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjEwNTEwOTAwPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzEwNTEwOTAwPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48

L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcmdpcm88L0F1dGhvcj48WWVhcj4yMDE4PC9ZZWFyPjxS

ZWNOdW0+NTUzMjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oV2FkYSBldCBhbC4gMTk5OSwgV2FycmVu

IEZydW56YWMgZXQgYWwuIDIwMTYsIEFyZ2lybyBldCBhbC4gMjAxOCk8L0Rpc3BsYXlUZXh0Pjxy

ZWNvcmQ+PHJlYy1udW1iZXI+NTUzMjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw

PSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTUzMjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QXJnaXJvLCBSLjwvYXV0aG9y

PjxhdXRob3I+RGlhY2ludGksIEQuPC9hdXRob3I+PGF1dGhvcj5TYWNjb25pLCBCLjwvYXV0aG9y

PjxhdXRob3I+SWFubmFyZWxsaSwgQS48L2F1dGhvcj48YXV0aG9yPkRpYWNpbnRpLCBELjwvYXV0

aG9yPjxhdXRob3I+Q2lwcmlhbmksIEMuPC9hdXRob3I+PGF1dGhvcj5QaXNhbmksIEQuPC9hdXRo

b3I+PGF1dGhvcj5Sb21hZ25vbGksIEUuPC9hdXRob3I+PGF1dGhvcj5CaWZmb25pLCBNLjwvYXV0

aG9yPjxhdXRob3I+RGkgR2lvaWEsIEMuPC9hdXRob3I+PGF1dGhvcj5QZXBlLCBKLjwvYXV0aG9y

PjxhdXRob3I+QmV6emksIE0uPC9hdXRob3I+PGF1dGhvcj5MZXRpemlhLCBDLjwvYXV0aG9yPjxh

dXRob3I+TWluaXNvbGEsIFMuPC9hdXRob3I+PGF1dGhvcj5DYXRhbGFubywgQy48L2F1dGhvcj48

L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFJhZGlv

bG9neSwgSW50ZXJ2ZW50aW9uYWwgUmFkaW9sb2d5IFVuaXQsIE9zcGVkYWxlIE0uRy4gVmFubmlu

aSAtIEZpZ2xpZSBkaSBTYW4gQ2FtaWxsbywgVmlhIGRlbGwmYXBvczthY3F1YSBCdWxsaWNhbnRl

LCAwMDEwMCwgUm9tYSwgSXRhbHkuJiN4RDtEZXBhcnRtZW50IG9mIFJhZGlvbG9naWNhbCBTY2ll

bmNlcywgT25jb2xvZ3kgYW5kIFBhdGhvbG9neSwgU2FwaWVuemEgVW5pdmVyc2l0eSwgdmlhbGUg

UmVnaW5hIEVsZW5hIDMyNCwgMDAxNjEsIFJvbWUsIEl0YWx5LiYjeEQ7RGVwYXJ0bWVudCBvZiBS

YWRpb2xvZ2ljYWwgU2NpZW5jZXMsIE9uY29sb2d5IGFuZCBQYXRob2xvZ3ksIFNhcGllbnphIFVu

aXZlcnNpdHksIHZpYWxlIFJlZ2luYSBFbGVuYSAzMjQsIDAwMTYxLCBSb21lLCBJdGFseS4gZGFu

aWVsZS5kaWFjaW50aUB1bmlyb21hMS5pdC4mI3hEO0NlbnRlciBmb3IgTGlmZSBOYW5vIFNjaWVu

Y2UgU2FwaWVuemEsIElzdGl0dXRvIEl0YWxpYW5vIGRpIFRlY25vbG9naWEsIFZpYWxlIFJlZ2lu

YSBFbGVuYSwgMjkxLCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgQ2xpbmljYWwgU2Np

ZW5jZXMsIFNhcGllbnphIFVuaXZlcnNpdHksIHZpYWxlIGRlbCBQb2xpY2xpbmljbyAxNTUsIDAw

MTYxLCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIE1vbGVjdWxh

ciBNZWRpY2luZSwgU2FwaWVuemEgVW5pdmVyc2l0eSwgdmlhIEdyb3R0YXJvc3NhIDEwMzUsIDAw

MTg5LCBSb21lLCBJdGFseS4mI3hEO0RlcGFydG1lbnQgb2YgRXhwZXJpbWVudGFsIE1lZGljaW5l

LCBTYXBpZW56YSBVbml2ZXJzaXR5LCB2aWFsZSBkZWwgUG9saWNsaW5pY28gMTU1LCAwMDE2MSwg

Um9tZSwgSXRhbHkuJiN4RDtEZXBhcnRtZW50IG9mIFN1cmdlcnkgU2NpZW5jZXMsIFNhcGllbnph

IFVuaXZlcnNpdHksIHZpYWxlIGRlbCBQb2xpY2xpbmljbyAxNTUsIDAwMTYxLCBSb21lLCBJdGFs

eS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5EaWFnbm9zdGljIGFjY3VyYWN5IG9mIDNU

IG1hZ25ldGljIHJlc29uYW5jZSBpbWFnaW5nIGluIHRoZSBwcmVvcGVyYXRpdmUgbG9jYWxpc2F0

aW9uIG9mIHBhcmF0aHlyb2lkIGFkZW5vbWFzOiBjb21wYXJpc29uIHdpdGggdWx0cmFzb3VuZCBh

bmQgOTltVGMtc2VzdGFtaWJpIHNjYW5zPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkV1ciBSYWRp

b2w8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkV1cm9wZWFuIHJhZGlvbG9neTwvYWx0LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBSYWRpb2w8L2Z1bGwtdGl0

bGU+PGFiYnItMT5FdXJvcGVhbiByYWRpb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1w

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5FdXJv

cGVhbiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxkYXRlcz48eWVhcj4yMDE4

PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWF5IDc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTEwODQgKEVsZWN0cm9uaWMpJiN4RDswOTM4LTc5OTQgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjI5NzM2ODQ5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI5NzM2ODQ5PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDMzMC0wMTgtNTQzNy04PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PENpdGU+PEF1dGhvcj5XYXJyZW4gRnJ1bnphYzwvQXV0aG9yPjxZZWFyPjIwMTY8L1llYXI+PFJl

Y051bT41NTMzPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NTMzPC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NTMzPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5XYXJyZW4gRnJ1bnphYywgUi48L2F1dGhvcj48YXV0aG9yPlJpY2hhcmRzLCBNLjwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Db21wdXRlZCBUb21vZ3Jh

cGh5IGFuZCBNYWduZXRpYyBSZXNvbmFuY2UgSW1hZ2luZyBvZiB0aGUgVGh5cm9pZCBhbmQgUGFy

YXRoeXJvaWQgR2xhbmRzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkZyb250IEhvcm0gUmVzPC9z

ZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5Gcm9udGllcnMgb2YgaG9ybW9uZSByZXNlYXJjaDwv

YWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkZyb250IEhvcm0gUmVz

PC9mdWxsLXRpdGxlPjxhYmJyLTE+RnJvbnRpZXJzIG9mIGhvcm1vbmUgcmVzZWFyY2g8L2FiYnIt

MT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkZyb250IEhvcm0gUmVz

PC9mdWxsLXRpdGxlPjxhYmJyLTE+RnJvbnRpZXJzIG9mIGhvcm1vbmUgcmVzZWFyY2g8L2FiYnIt

MT48L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNi0yMzwvcGFnZXM+PHZvbHVtZT40NTwvdm9sdW1l

PjxrZXl3b3Jkcz48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFnbmV0aWMgUmVz

b25hbmNlIEltYWdpbmcvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+TXVsdGltb2RhbCBJbWFn

aW5nLyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25v

c3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKmRpYWdub3N0aWMg

aW1hZ2luZzwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBYLVJheSBDb21wdXRlZC8qbWV0

aG9kczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDE2PC95ZWFyPjwvZGF0ZXM+

PGlzYm4+MTY2Mi0zNzYyIChFbGVjdHJvbmljKSYjeEQ7MDMwMS0zMDczIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4yNzAwMjk4OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNzAwMjk4OTwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTE1OS8w

MDA0NDIyNzQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48

QXV0aG9yPldhZGE8L0F1dGhvcj48WWVhcj4xOTk5PC9ZZWFyPjxSZWNOdW0+NTUzNDwvUmVjTnVt

PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTUzNDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkg

YXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTUz

NDwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FkYSwgQS48L2F1dGhv

cj48YXV0aG9yPlN1Z2loYXJhLCBNLjwvYXV0aG9yPjxhdXRob3I+U3VnaW11cmEsIEsuPC9hdXRo

b3I+PGF1dGhvcj5LdXJvZGEsIEguPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxh

dXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBSYWRpb2xvZ3ksIFNoaW1hbmUgTWVkaWNhbCBVbml2

ZXJzaXR5LCBJenVtbywgSmFwYW4uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TWFnbmV0

aWMgcmVzb25hbmNlIGltYWdpbmcgKE1SSSkgYW5kIHRlY2huZXRpdW0tOTltLW1ldGhveHlpc29u

aXRyaWxlIChNSUJJKSBzY2ludGlncmFwaHkgdG8gZXZhbHVhdGUgdGhlIGFibm9ybWFsIHBhcmF0

aHlyb2lkIGdsYW5kIGFuZCBQRUlUIGVmZmljYWN5IGZvciBzZWNvbmRhcnkgaHlwZXJwYXJhdGh5

cm9pZGlzbTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5SYWRpYXQgTWVkPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5SYWRpYXRpb24gbWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVy

aW9kaWNhbD48ZnVsbC10aXRsZT5SYWRpYXQgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmFkaWF0

aW9uIG1lZGljaW5lPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5SYWRpYXQgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+UmFkaWF0aW9uIG1lZGljaW5lPC9h

YmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+Mjc1LTgyPC9wYWdlcz48dm9sdW1lPjE3PC92

b2x1bWU+PG51bWJlcj40PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk

PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+RXRoYW5vbC8qdGhlcmFwZXV0aWMgdXNl

PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdv

cmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbSwgU2Vjb25kYXJ5L2NvbXBsaWNhdGlvbnMv

KmRpYWdub3Npcy9kcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SW5qZWN0aW9uczwva2V5

d29yZD48a2V5d29yZD5LaWRuZXkgRmFpbHVyZSwgQ2hyb25pYy9jb21wbGljYXRpb25zPC9rZXl3

b3JkPjxrZXl3b3JkPipNYWduZXRpYyBSZXNvbmFuY2UgSW1hZ2luZzwva2V5d29yZD48a2V5d29y

ZD5NYWxlPC9rZXl3b3JkPjxrZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPlBh

cmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFnaW5nL2RydWcgZWZmZWN0cy8qcGF0aG9s

b2d5PC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvbnVjbGlkZSBJbWFnaW5nPC9rZXl3b3JkPjxrZXl3

b3JkPipSYWRpb3BoYXJtYWNldXRpY2Fsczwva2V5d29yZD48a2V5d29yZD5TZW5zaXRpdml0eSBh

bmQgU3BlY2lmaWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+KlRlY2huZXRpdW0gVGMgOTltIFNlc3Rh

bWliaTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48L2tleXdv

cmRzPjxkYXRlcz48eWVhcj4xOTk5PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsLUF1ZzwvZGF0

ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAyODgtMjA0MyAoUHJpbnQpJiN4RDswMjg4LTIw

NDMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjEwNTEwOTAwPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzEwNTEwOTAwPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjwvcmVjb3JkPjwvQ2l0ZT48

L0VuZE5vdGU+

ADDIN EN.CITE.DATA 25).Radionuclide Imaging (RNI):The majority of scientists have confirmed that scintigraphy with 99mTcsestamibi is the most informative in revealing pathologically changed parathyroid glands. The continuation of this research has led to the discovery that isotope clearance rates in the thyroid and parathyroid glands are different. Mononuclide technology has achieved good results to general surprise. This gave Taillifer et al., a chance to create a new dual-phase technology of scintigraphy with 99mTc-sestamibi PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbmFuZDwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT41NDY0PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbmFuZCBldCBhbC4gMjAwNSwgU2luZ2gg

ZXQgYWwuIDIwMDcsIE1vcmFsaWRpcyAyMDEzKTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51

bWJlcj41NDY0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

NTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDY0PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BbmFuZCwgUy4gUy48L2F1dGhvcj48YXV0aG9yPkNo

YXVoYW4sIE0uIFMuPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgSi48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5TZW5pb3IgQWR2aXNlciAoTnVjbGVhciBNZWRp

Y2luZSlBcm15IEhvc3BpdGFsIChSICZhbXA7IFIpLCBEZWxoaSBDYW50dC0xMC4mI3hEO0NsYXNz

aWZpZWQgU3BlY2lhbGlzdCAoTWVkaWNpbmUpLCBDb21tYW5kIEhvc3BpdGFsIChTb3V0aGVybiBD

b21tYW5kKSwgUHVuZSAtNDAuJiN4RDtTY2llbnRpc3QgJmFwb3M7RSZhcG9zOywgQXJteSBIb3Nw

aXRhbCAoUiAmYW1wOyBSKSwgRGVsaGkgQ2FudHQtMTAuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+UHJlb3BlcmF0aXZlIFBhcmF0aHlyb2lkIFJhZGlvbnVjbGlkZSBTY2ludGlncmFwaHkg

aW4gSHlwZXJwYXJhdGh5cm9pZGlzbTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5NZWQgSiBBcm1l

ZCBGb3JjZXMgSW5kaWE8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPk1lZGljYWwgam91cm5h

bCwgQXJtZWQgRm9yY2VzIEluZGlhPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+TWVkIEogQXJtZWQgRm9yY2VzIEluZGlhPC9mdWxsLXRpdGxlPjxhYmJyLTE+TWVk

aWNhbCBqb3VybmFsLCBBcm1lZCBGb3JjZXMgSW5kaWE8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs

dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk1lZCBKIEFybWVkIEZvcmNlcyBJbmRpYTwvZnVsbC10

aXRsZT48YWJici0xPk1lZGljYWwgam91cm5hbCwgQXJtZWQgRm9yY2VzIEluZGlhPC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NzQtNTwvcGFnZXM+PHZvbHVtZT42MTwvdm9sdW1lPjxu

dW1iZXI+MTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDM3Ny0xMjM3IChQcmludCkmI3hE

OzAzNzctMTIzNyAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+Mjc0MDc3MDk8L2FjY2Vz

c2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmlo

Lmdvdi9wdWJtZWQvMjc0MDc3MDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+

NDkyMzM3MTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9TMDM3Ny0x

MjM3KDA1KTgwMTI2LTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

Q2l0ZT48QXV0aG9yPlNpbmdoPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVjTnVtPjU0NzM8

L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0NzM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlh

dnAiPjU0NzM8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRp

Y2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNpbmdoLCBO

LjwvYXV0aG9yPjxhdXRob3I+S3Jpc2huYSwgQi4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE51Y2xlYXIgTWVkaWNpbmUsIFAu

IEQuIEhpbmR1amEgTmF0aW9uYWwgSG9zcGl0YWwgYW5kIE1SQywgTXVtYmFpLCBJbmRpYS4gZHJu

YXRhc2hhX3NpbmdoQHlhaG9vLmNvbTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJvbGUg

b2YgcmFkaW9udWNsaWRlIHNjaW50aWdyYXBoeSBpbiB0aGUgZGV0ZWN0aW9uIG9mIHBhcmF0aHly

b2lkIGFkZW5vbWE8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW5kaWFuIEogQ2FuY2VyPC9zZWNv

bmRhcnktdGl0bGU+PGFsdC10aXRsZT5JbmRpYW4gam91cm5hbCBvZiBjYW5jZXI8L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5JbmRpYW4gSiBDYW5jZXI8L2Z1bGwt

dGl0bGU+PGFiYnItMT5JbmRpYW4gam91cm5hbCBvZiBjYW5jZXI8L2FiYnItMT48L3BlcmlvZGlj

YWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkluZGlhbiBKIENhbmNlcjwvZnVsbC10aXRs

ZT48YWJici0xPkluZGlhbiBqb3VybmFsIG9mIGNhbmNlcjwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjEyLTY8L3BhZ2VzPjx2b2x1bWU+NDQ8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qZGlhZ25vc3RpYyBpbWFnaW5nL3N1cmdlcnk8

L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1lZGlhc3RpbmFsIE5l

b3BsYXNtcy9kaWFnbm9zdGljIGltYWdpbmcvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBOZW9wbGFzbXMvKmRpYWdub3N0aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3b3JkPjxr

ZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5d29yZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+

U2Vuc2l0aXZpdHkgYW5kIFNwZWNpZmljaXR5PC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVt

IFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VG9tb2dyYXBoeSwgWC1SYXkgQ29t

cHV0ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW4tTWFyPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAxOS01MDlYIChQcmludCkmI3hEOzAwMTktNTA5

WCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTc0MDEyMTk8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTc0MDEyMTk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxD

aXRlPjxBdXRob3I+TW9yYWxpZGlzPC9BdXRob3I+PFllYXI+MjAxMzwvWWVhcj48UmVjTnVtPjU0

OTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0OTU8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjU0OTU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1vcmFs

aWRpcywgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5E

ZXBhcnRtZW50IG9mIE51Y2xlYXIgTWVkaWNpbmUgQUhFUEEgVW5pdmVyc2l0eSBIb3NwaXRhbCwg

VGhlc3NhbG9uaWtpLCBHcmVlY2UuIGVtb3JhbEBob2wuZ3I8L2F1dGgtYWRkcmVzcz48dGl0bGVz

Pjx0aXRsZT5SYWRpb251Y2xpZGUgcGFyYXRoeXJvaWQgaW1hZ2luZzogYSBjb25jaXNlLCB1cGRh

dGVkIHJldmlldzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5IZWxsIEogTnVjbCBNZWQ8L3NlY29u

ZGFyeS10aXRsZT48YWx0LXRpdGxlPkhlbGxlbmljIGpvdXJuYWwgb2YgbnVjbGVhciBtZWRpY2lu

ZTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkhlbGwgSiBOdWNs

IE1lZDwvZnVsbC10aXRsZT48YWJici0xPkhlbGxlbmljIGpvdXJuYWwgb2YgbnVjbGVhciBtZWRp

Y2luZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SGVs

bCBKIE51Y2wgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+SGVsbGVuaWMgam91cm5hbCBvZiBudWNs

ZWFyIG1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTI1LTMzPC9wYWdl

cz48dm9sdW1lPjE2PC92b2x1bWU+PG51bWJlcj4yPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLypkaWFnbm9zdGlj

IGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+SW1hZ2UgRW5oYW5jZW1lbnQvKm1ldGhvZHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLypkaWFnbm9zdGljIGltYWdpbmc8L2tl

eXdvcmQ+PGtleXdvcmQ+UmFkaW9udWNsaWRlIEltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UmFk

aW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+KlRlY2huZXRpdW0gVGMgOTltIFNl

c3RhbWliaTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+TWF5LUF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE3OTAt

NTQyNyAoUHJpbnQpJiN4RDsxNzkwLTU0MjcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjIzNjg3NjQzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIzNjg3NjQzPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xOTY3L3MwMDI0NDk5MTAwODM8L2Vs

ZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbmFuZDwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+PFJl

Y051bT41NDY0PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbmFuZCBldCBhbC4gMjAwNSwgU2luZ2gg

ZXQgYWwuIDIwMDcsIE1vcmFsaWRpcyAyMDEzKTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51

bWJlcj41NDY0PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0i

NTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5YXZwIj41NDY0PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BbmFuZCwgUy4gUy48L2F1dGhvcj48YXV0aG9yPkNo

YXVoYW4sIE0uIFMuPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgSi48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5TZW5pb3IgQWR2aXNlciAoTnVjbGVhciBNZWRp

Y2luZSlBcm15IEhvc3BpdGFsIChSICZhbXA7IFIpLCBEZWxoaSBDYW50dC0xMC4mI3hEO0NsYXNz

aWZpZWQgU3BlY2lhbGlzdCAoTWVkaWNpbmUpLCBDb21tYW5kIEhvc3BpdGFsIChTb3V0aGVybiBD

b21tYW5kKSwgUHVuZSAtNDAuJiN4RDtTY2llbnRpc3QgJmFwb3M7RSZhcG9zOywgQXJteSBIb3Nw

aXRhbCAoUiAmYW1wOyBSKSwgRGVsaGkgQ2FudHQtMTAuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+UHJlb3BlcmF0aXZlIFBhcmF0aHlyb2lkIFJhZGlvbnVjbGlkZSBTY2ludGlncmFwaHkg

aW4gSHlwZXJwYXJhdGh5cm9pZGlzbTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5NZWQgSiBBcm1l

ZCBGb3JjZXMgSW5kaWE8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPk1lZGljYWwgam91cm5h

bCwgQXJtZWQgRm9yY2VzIEluZGlhPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+TWVkIEogQXJtZWQgRm9yY2VzIEluZGlhPC9mdWxsLXRpdGxlPjxhYmJyLTE+TWVk

aWNhbCBqb3VybmFsLCBBcm1lZCBGb3JjZXMgSW5kaWE8L2FiYnItMT48L3BlcmlvZGljYWw+PGFs

dC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPk1lZCBKIEFybWVkIEZvcmNlcyBJbmRpYTwvZnVsbC10

aXRsZT48YWJici0xPk1lZGljYWwgam91cm5hbCwgQXJtZWQgRm9yY2VzIEluZGlhPC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NzQtNTwvcGFnZXM+PHZvbHVtZT42MTwvdm9sdW1lPjxu

dW1iZXI+MTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+

SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDM3Ny0xMjM3IChQcmludCkmI3hE

OzAzNzctMTIzNyAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+Mjc0MDc3MDk8L2FjY2Vz

c2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmlo

Lmdvdi9wdWJtZWQvMjc0MDc3MDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+

NDkyMzM3MTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9TMDM3Ny0x

MjM3KDA1KTgwMTI2LTE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

Q2l0ZT48QXV0aG9yPlNpbmdoPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVjTnVtPjU0NzM8

L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0NzM8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5

cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlh

dnAiPjU0NzM8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRp

Y2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNpbmdoLCBO

LjwvYXV0aG9yPjxhdXRob3I+S3Jpc2huYSwgQi4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIE51Y2xlYXIgTWVkaWNpbmUsIFAu

IEQuIEhpbmR1amEgTmF0aW9uYWwgSG9zcGl0YWwgYW5kIE1SQywgTXVtYmFpLCBJbmRpYS4gZHJu

YXRhc2hhX3NpbmdoQHlhaG9vLmNvbTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJvbGUg

b2YgcmFkaW9udWNsaWRlIHNjaW50aWdyYXBoeSBpbiB0aGUgZGV0ZWN0aW9uIG9mIHBhcmF0aHly

b2lkIGFkZW5vbWE8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SW5kaWFuIEogQ2FuY2VyPC9zZWNv

bmRhcnktdGl0bGU+PGFsdC10aXRsZT5JbmRpYW4gam91cm5hbCBvZiBjYW5jZXI8L2FsdC10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5JbmRpYW4gSiBDYW5jZXI8L2Z1bGwt

dGl0bGU+PGFiYnItMT5JbmRpYW4gam91cm5hbCBvZiBjYW5jZXI8L2FiYnItMT48L3BlcmlvZGlj

YWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkluZGlhbiBKIENhbmNlcjwvZnVsbC10aXRs

ZT48YWJici0xPkluZGlhbiBqb3VybmFsIG9mIGNhbmNlcjwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjEyLTY8L3BhZ2VzPjx2b2x1bWU+NDQ8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qZGlhZ25vc3RpYyBpbWFnaW5nL3N1cmdlcnk8

L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1lZGlhc3RpbmFsIE5l

b3BsYXNtcy9kaWFnbm9zdGljIGltYWdpbmcvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBOZW9wbGFzbXMvKmRpYWdub3N0aWMgaW1hZ2luZy9zdXJnZXJ5PC9rZXl3b3JkPjxr

ZXl3b3JkPlByb2dub3Npczwva2V5d29yZD48a2V5d29yZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwv

a2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+

U2Vuc2l0aXZpdHkgYW5kIFNwZWNpZmljaXR5PC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVt

IFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VG9tb2dyYXBoeSwgWC1SYXkgQ29t

cHV0ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW4tTWFyPC9kYXRl

PjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAxOS01MDlYIChQcmludCkmI3hEOzAwMTktNTA5

WCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTc0MDEyMTk8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTc0MDEyMTk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PC9yZWNvcmQ+PC9DaXRlPjxD

aXRlPjxBdXRob3I+TW9yYWxpZGlzPC9BdXRob3I+PFllYXI+MjAxMzwvWWVhcj48UmVjTnVtPjU0

OTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjU0OTU8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjU0OTU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk1vcmFs

aWRpcywgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5E

ZXBhcnRtZW50IG9mIE51Y2xlYXIgTWVkaWNpbmUgQUhFUEEgVW5pdmVyc2l0eSBIb3NwaXRhbCwg

VGhlc3NhbG9uaWtpLCBHcmVlY2UuIGVtb3JhbEBob2wuZ3I8L2F1dGgtYWRkcmVzcz48dGl0bGVz

Pjx0aXRsZT5SYWRpb251Y2xpZGUgcGFyYXRoeXJvaWQgaW1hZ2luZzogYSBjb25jaXNlLCB1cGRh

dGVkIHJldmlldzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5IZWxsIEogTnVjbCBNZWQ8L3NlY29u

ZGFyeS10aXRsZT48YWx0LXRpdGxlPkhlbGxlbmljIGpvdXJuYWwgb2YgbnVjbGVhciBtZWRpY2lu

ZTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkhlbGwgSiBOdWNs

IE1lZDwvZnVsbC10aXRsZT48YWJici0xPkhlbGxlbmljIGpvdXJuYWwgb2YgbnVjbGVhciBtZWRp

Y2luZTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SGVs

bCBKIE51Y2wgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+SGVsbGVuaWMgam91cm5hbCBvZiBudWNs

ZWFyIG1lZGljaW5lPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTI1LTMzPC9wYWdl

cz48dm9sdW1lPjE2PC92b2x1bWU+PG51bWJlcj4yPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLypkaWFnbm9zdGlj

IGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+SW1hZ2UgRW5oYW5jZW1lbnQvKm1ldGhvZHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLypkaWFnbm9zdGljIGltYWdpbmc8L2tl

eXdvcmQ+PGtleXdvcmQ+UmFkaW9udWNsaWRlIEltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+UmFk

aW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+KlRlY2huZXRpdW0gVGMgOTltIFNl

c3RhbWliaTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+TWF5LUF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE3OTAt

NTQyNyAoUHJpbnQpJiN4RDsxNzkwLTU0MjcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjIzNjg3NjQzPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIzNjg3NjQzPC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xOTY3L3MwMDI0NDk5MTAwODM8L2Vs

ZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (26).Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have been created on principles of scintigraphy with radionuclides and computer technologies. We can confidently claim that the principle of functional and anatomic determination of tissues, which underlies scintigraphy, has good prospects in endocrine surgery. It allows for the finding and obviation (removing, destroying, evaporating, freezing, blocking the circulation, etc.) of the foci of PTH hypersecretion with minimal injury to adjacent tissues ADDIN EN.CITE <EndNote><Cite><Author>Moralidis</Author><Year>2013</Year><RecNum>5495</RecNum><DisplayText>(Moralidis 2013)</DisplayText><record><rec-number>5495</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5495</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Moralidis, E.</author></authors></contributors><auth-address>Department of Nuclear Medicine AHEPA University Hospital, Thessaloniki, Greece. emoral@hol.gr</auth-address><titles><title>Radionuclide parathyroid imaging: a concise, updated review</title><secondary-title>Hell J Nucl Med</secondary-title><alt-title>Hellenic journal of nuclear medicine</alt-title></titles><periodical><full-title>Hell J Nucl Med</full-title><abbr-1>Hellenic journal of nuclear medicine</abbr-1></periodical><alt-periodical><full-title>Hell J Nucl Med</full-title><abbr-1>Hellenic journal of nuclear medicine</abbr-1></alt-periodical><pages>125-33</pages><volume>16</volume><number>2</number><keywords><keyword>Humans</keyword><keyword>Hyperparathyroidism/*diagnostic imaging</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Parathyroid Glands/*diagnostic imaging</keyword><keyword>Radionuclide Imaging</keyword><keyword>Radiopharmaceuticals</keyword><keyword>*Technetium Tc 99m Sestamibi</keyword></keywords><dates><year>2013</year><pub-dates><date>May-Aug</date></pub-dates></dates><isbn>1790-5427 (Print)&#xD;1790-5427 (Linking)</isbn><accession-num>23687643</accession-num><urls><related-urls><url>;(26).Indications for Radionuclide ImagingIt is necessary to notice that indications for performance of radionuclide diagnostic procedures are strictly limited. The majority of publications recommend that radionuclide methods should be used only for topical diagnosis, and not for revealing or confirming PHPT. These methods are applied only in patients with already known hyperparathyroidism diagnosed by clinical observation and laboratory tests. It means that the patient must undergo at least two preliminary laboratory studies: determination of PTH and ionized calcium (Ca2+) levels in blood serum ( ADDIN EN.CITE <EndNote><Cite><Author>Moralidis</Author><Year>2013</Year><RecNum>5495</RecNum><DisplayText>(Moralidis 2013)</DisplayText><record><rec-number>5495</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5495</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Moralidis, E.</author></authors></contributors><auth-address>Department of Nuclear Medicine AHEPA University Hospital, Thessaloniki, Greece. emoral@hol.gr</auth-address><titles><title>Radionuclide parathyroid imaging: a concise, updated review</title><secondary-title>Hell J Nucl Med</secondary-title><alt-title>Hellenic journal of nuclear medicine</alt-title></titles><periodical><full-title>Hell J Nucl Med</full-title><abbr-1>Hellenic journal of nuclear medicine</abbr-1></periodical><alt-periodical><full-title>Hell J Nucl Med</full-title><abbr-1>Hellenic journal of nuclear medicine</abbr-1></alt-periodical><pages>125-33</pages><volume>16</volume><number>2</number><keywords><keyword>Humans</keyword><keyword>Hyperparathyroidism/*diagnostic imaging</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Parathyroid Glands/*diagnostic imaging</keyword><keyword>Radionuclide Imaging</keyword><keyword>Radiopharmaceuticals</keyword><keyword>*Technetium Tc 99m Sestamibi</keyword></keywords><dates><year>2013</year><pub-dates><date>May-Aug</date></pub-dates></dates><isbn>1790-5427 (Print)&#xD;1790-5427 (Linking)</isbn><accession-num>23687643</accession-num><urls><related-urls><url>).The indications for RNI in patients with hyperparathyroidism are the following:Primary hyperparathyroidism confirmed by laboratory research;Recurrent and persistent hyperparathyroidism;Suspicion of a parathyroid tumor;Differential diagnosis of mediastinal masses;Planning and controlling the surgical treatment of hyperparathyroidism;Osseous form of hyperparathyroidism: osteoporosis of unclear etiology, fibrocystic osteodystrophy, frequent pathologic bone fractures;Recurrent and coral-like kidney stones;Differential diagnosis of PHPT and SHPT;Assessment of multiple lesions of the parathyroid glands PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYWxlc3RybzwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+

PFJlY051bT41NDY3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihQYWxlc3RybyBldCBhbC4gMjAwNSwg

TW9yYWxpZGlzIDIwMTMpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0Njc8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVy

N2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0Njc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0

aG9ycz48YXV0aG9yPlBhbGVzdHJvLCBDLiBKLjwvYXV0aG9yPjxhdXRob3I+VG9tYXMsIE0uIEIu

PC9hdXRob3I+PGF1dGhvcj5Ucm9uY28sIEcuIEcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBOdWNsZWFyIE1lZGljaW5lIGFuZCBS

YWRpb2xvZ3ksIEFsYmVydCBFaW5zdGVpbiBDb2xsZWdlIG9mIE1lZGljaW5lLCBCcm9ueCwgTlks

IFVTQS4gcGFsZXN0cm9AbGlqLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJhZGlv

bnVjbGlkZSBpbWFnaW5nIG9mIHRoZSBwYXJhdGh5cm9pZCBnbGFuZHM8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+U2VtaW4gTnVjbCBNZWQ8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlNlbWlu

YXJzIGluIG51Y2xlYXIgbWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5TZW1pbiBOdWNsIE1lZDwvZnVsbC10aXRsZT48YWJici0xPlNlbWluYXJzIGlu

IG51Y2xlYXIgbWVkaWNpbmU8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPlNlbWluIE51Y2wgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+U2VtaW5hcnMgaW4g

bnVjbGVhciBtZWRpY2luZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjI2Ni03Njwv

cGFnZXM+PHZvbHVtZT4zNTwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5

d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlhZ25v

c3RpYyBpbWFnaW5nL2V0aW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5k

cy8qZGlhZ25vc3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3Bs

YXNtcy9jb21wbGljYXRpb25zLypkaWFnbm9zdGljIGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+

UG9zaXRyb24tRW1pc3Npb24gVG9tb2dyYXBoeS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5Q

cmFjdGljZSBHdWlkZWxpbmVzIGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3b3JkPlByYWN0aWNlIFBh

dHRlcm5zLCBQaHlzaWNpYW5zJmFwb3M7PC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Npczwva2V5

d29yZD48a2V5d29yZD5SYWRpb3BoYXJtYWNldXRpY2Fsczwva2V5d29yZD48a2V5d29yZD4qVGVj

aG5ldGl1bSBUYyA5OW0gU2VzdGFtaWJpPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFy

PjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4wMDAxLTI5OTggKFByaW50KSYjeEQ7MDAwMS0yOTk4IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4xNjE1MDI0NzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxz

Pjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNjE1MDI0NzwvdXJsPjwv

cmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1My9qLnNl

bW51Y2xtZWQuMjAwNS4wNi4wMDE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwv

Q2l0ZT48Q2l0ZT48QXV0aG9yPk1vcmFsaWRpczwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl

Y051bT41NDk1PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NDk1PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NDk1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5Nb3JhbGlkaXMsIEUuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RGVwYXJ0bWVudCBvZiBOdWNsZWFyIE1lZGljaW5lIEFIRVBBIFVuaXZlcnNpdHkgSG9z

cGl0YWwsIFRoZXNzYWxvbmlraSwgR3JlZWNlLiBlbW9yYWxAaG9sLmdyPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UmFkaW9udWNsaWRlIHBhcmF0aHlyb2lkIGltYWdpbmc6IGEgY29uY2lz

ZSwgdXBkYXRlZCByZXZpZXc8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGVsbCBKIE51Y2wgTWVk

PC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5IZWxsZW5pYyBqb3VybmFsIG9mIG51Y2xlYXIg

bWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IZWxs

IEogTnVjbCBNZWQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5IZWxsZW5pYyBqb3VybmFsIG9mIG51Y2xl

YXIgbWVkaWNpbmU8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkhlbGwgSiBOdWNsIE1lZDwvZnVsbC10aXRsZT48YWJici0xPkhlbGxlbmljIGpvdXJuYWwg

b2YgbnVjbGVhciBtZWRpY2luZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjEyNS0z

MzwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxrZXl3b3Jkcz48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlh

Z25vc3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPkltYWdlIEVuaGFuY2VtZW50LyptZXRo

b2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFn

aW5nPC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvbnVjbGlkZSBJbWFnaW5nPC9rZXl3b3JkPjxrZXl3

b3JkPlJhZGlvcGhhcm1hY2V1dGljYWxzPC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVtIFRj

IDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMzwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1heS1BdWc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4xNzkwLTU0MjcgKFByaW50KSYjeEQ7MTc5MC01NDI3IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yMzY4NzY0MzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+

aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMzY4NzY0MzwvdXJsPjwvcmVsYXRl

ZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTk2Ny9zMDAyNDQ5OTEw

MDgzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYWxlc3RybzwvQXV0aG9yPjxZZWFyPjIwMDU8L1llYXI+

PFJlY051bT41NDY3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihQYWxlc3RybyBldCBhbC4gMjAwNSwg

TW9yYWxpZGlzIDIwMTMpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0Njc8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVy

N2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0Njc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0

aG9ycz48YXV0aG9yPlBhbGVzdHJvLCBDLiBKLjwvYXV0aG9yPjxhdXRob3I+VG9tYXMsIE0uIEIu

PC9hdXRob3I+PGF1dGhvcj5Ucm9uY28sIEcuIEcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBOdWNsZWFyIE1lZGljaW5lIGFuZCBS

YWRpb2xvZ3ksIEFsYmVydCBFaW5zdGVpbiBDb2xsZWdlIG9mIE1lZGljaW5lLCBCcm9ueCwgTlks

IFVTQS4gcGFsZXN0cm9AbGlqLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJhZGlv

bnVjbGlkZSBpbWFnaW5nIG9mIHRoZSBwYXJhdGh5cm9pZCBnbGFuZHM8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+U2VtaW4gTnVjbCBNZWQ8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPlNlbWlu

YXJzIGluIG51Y2xlYXIgbWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5TZW1pbiBOdWNsIE1lZDwvZnVsbC10aXRsZT48YWJici0xPlNlbWluYXJzIGlu

IG51Y2xlYXIgbWVkaWNpbmU8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPlNlbWluIE51Y2wgTWVkPC9mdWxsLXRpdGxlPjxhYmJyLTE+U2VtaW5hcnMgaW4g

bnVjbGVhciBtZWRpY2luZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjI2Ni03Njwv

cGFnZXM+PHZvbHVtZT4zNTwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5

d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlhZ25v

c3RpYyBpbWFnaW5nL2V0aW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5k

cy8qZGlhZ25vc3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3Bs

YXNtcy9jb21wbGljYXRpb25zLypkaWFnbm9zdGljIGltYWdpbmc8L2tleXdvcmQ+PGtleXdvcmQ+

UG9zaXRyb24tRW1pc3Npb24gVG9tb2dyYXBoeS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5Q

cmFjdGljZSBHdWlkZWxpbmVzIGFzIFRvcGljPC9rZXl3b3JkPjxrZXl3b3JkPlByYWN0aWNlIFBh

dHRlcm5zLCBQaHlzaWNpYW5zJmFwb3M7PC9rZXl3b3JkPjxrZXl3b3JkPlByb2dub3Npczwva2V5

d29yZD48a2V5d29yZD5SYWRpb3BoYXJtYWNldXRpY2Fsczwva2V5d29yZD48a2V5d29yZD4qVGVj

aG5ldGl1bSBUYyA5OW0gU2VzdGFtaWJpPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFy

PjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRl

cz48aXNibj4wMDAxLTI5OTggKFByaW50KSYjeEQ7MDAwMS0yOTk4IChMaW5raW5nKTwvaXNibj48

YWNjZXNzaW9uLW51bT4xNjE1MDI0NzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxz

Pjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNjE1MDI0NzwvdXJsPjwv

cmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1My9qLnNl

bW51Y2xtZWQuMjAwNS4wNi4wMDE8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwv

Q2l0ZT48Q2l0ZT48QXV0aG9yPk1vcmFsaWRpczwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl

Y051bT41NDk1PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj41NDk1PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRq

cmZwdHRyeHc5YXZwIj41NDk1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv

dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv

cj5Nb3JhbGlkaXMsIEUuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk

ZHJlc3M+RGVwYXJ0bWVudCBvZiBOdWNsZWFyIE1lZGljaW5lIEFIRVBBIFVuaXZlcnNpdHkgSG9z

cGl0YWwsIFRoZXNzYWxvbmlraSwgR3JlZWNlLiBlbW9yYWxAaG9sLmdyPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UmFkaW9udWNsaWRlIHBhcmF0aHlyb2lkIGltYWdpbmc6IGEgY29uY2lz

ZSwgdXBkYXRlZCByZXZpZXc8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SGVsbCBKIE51Y2wgTWVk

PC9zZWNvbmRhcnktdGl0bGU+PGFsdC10aXRsZT5IZWxsZW5pYyBqb3VybmFsIG9mIG51Y2xlYXIg

bWVkaWNpbmU8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IZWxs

IEogTnVjbCBNZWQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5IZWxsZW5pYyBqb3VybmFsIG9mIG51Y2xl

YXIgbWVkaWNpbmU8L2FiYnItMT48L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkhlbGwgSiBOdWNsIE1lZDwvZnVsbC10aXRsZT48YWJici0xPkhlbGxlbmljIGpvdXJuYWwg

b2YgbnVjbGVhciBtZWRpY2luZTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjEyNS0z

MzwvcGFnZXM+PHZvbHVtZT4xNjwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxrZXl3b3Jkcz48

a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlh

Z25vc3RpYyBpbWFnaW5nPC9rZXl3b3JkPjxrZXl3b3JkPkltYWdlIEVuaGFuY2VtZW50LyptZXRo

b2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEdsYW5kcy8qZGlhZ25vc3RpYyBpbWFn

aW5nPC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvbnVjbGlkZSBJbWFnaW5nPC9rZXl3b3JkPjxrZXl3

b3JkPlJhZGlvcGhhcm1hY2V1dGljYWxzPC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVtIFRj

IDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMzwveWVh

cj48cHViLWRhdGVzPjxkYXRlPk1heS1BdWc8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNi

bj4xNzkwLTU0MjcgKFByaW50KSYjeEQ7MTc5MC01NDI3IChMaW5raW5nKTwvaXNibj48YWNjZXNz

aW9uLW51bT4yMzY4NzY0MzwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+

aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMzY4NzY0MzwvdXJsPjwvcmVsYXRl

ZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTk2Ny9zMDAyNDQ5OTEw

MDgzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (26).Treatment Modalities of Parathyroid Gland TumorsManagement of primary hyperparathyroidism:Patients with serum calcium levels of 12.14 mg/dL (33.5 mmol/L) may not require immediate treatment if this elevation is chronically well tolerated. However, an acute rise in calcium levels may lead to dehydration or cardiovascular or neurologic complications, which require more aggressive measures. In addition, patients with serum calcium levels of >14 mg/dL (3.5 mmol/L) require treatment, regardless of symptoms. Thus, patients with severe hyperparathyroidism-induced hypercalcemia should be hospitalized, and urinary catheterization and central venous pressure monitoring should be considered. Initial treatment should include intravenous saline solution to gradually replace lost ?uids and increase urinary calcium excretion ADDIN EN.CITE <EndNote><Cite><Author>Bilezikian</Author><Year>2009</Year><RecNum>5383</RecNum><DisplayText>(Bilezikian et al. 2009)</DisplayText><record><rec-number>5383</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5383</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bilezikian, J. P.</author><author>Khan, A. A.</author><author>Potts, J. T., Jr.</author><author>Third International Workshop on the Management of Asymptomatic Primary, Hyperthyroidism</author></authors></contributors><auth-address>Columbia University, College of Physicians &amp; Surgeons, New York, New York 10032, USA. jpb2@columbia.edu</auth-address><titles><title>Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop</title><secondary-title>J Clin Endocrinol Metab</secondary-title><alt-title>The Journal of clinical endocrinology and metabolism</alt-title></titles><periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></periodical><alt-periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></alt-periodical><pages>335-9</pages><volume>94</volume><number>2</number><keywords><keyword>Consensus</keyword><keyword>*Guidelines as Topic</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism, Primary/diagnosis/*therapy</keyword><keyword>Monitoring, Physiologic/methods</keyword><keyword>Parathyroidectomy/methods</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0021-972X (Print)&#xD;0021-972X (Linking)</isbn><accession-num>19193908</accession-num><urls><related-urls><url>;(27).Once ?uid repletion is accomplished, loop diuretics may be used to decrease renal calcium reabsorption and promote urinary excretion. Calcitonin 200 IU once every 8 h may help to decrease albumin-adjusted calcium. Bisphosphonates, corticosteroids, calcium chelators, or dialysis are occasionally indicated in severe cases ADDIN EN.CITE <EndNote><Cite><Author>Bilezikian</Author><Year>2009</Year><RecNum>5383</RecNum><DisplayText>(Bilezikian et al. 2009)</DisplayText><record><rec-number>5383</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5383</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bilezikian, J. P.</author><author>Khan, A. A.</author><author>Potts, J. T., Jr.</author><author>Third International Workshop on the Management of Asymptomatic Primary, Hyperthyroidism</author></authors></contributors><auth-address>Columbia University, College of Physicians &amp; Surgeons, New York, New York 10032, USA. jpb2@columbia.edu</auth-address><titles><title>Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop</title><secondary-title>J Clin Endocrinol Metab</secondary-title><alt-title>The Journal of clinical endocrinology and metabolism</alt-title></titles><periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></periodical><alt-periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></alt-periodical><pages>335-9</pages><volume>94</volume><number>2</number><keywords><keyword>Consensus</keyword><keyword>*Guidelines as Topic</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism, Primary/diagnosis/*therapy</keyword><keyword>Monitoring, Physiologic/methods</keyword><keyword>Parathyroidectomy/methods</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0021-972X (Print)&#xD;0021-972X (Linking)</isbn><accession-num>19193908</accession-num><urls><related-urls><url>;(27).Patients must be closely monitored for complications caused by aggressive diuresis, including hypokalemia, hypomagnesemia, and acute renal insufficiency PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NTM4NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oRnJhc2VyIDIwMDkpPC9EaXNwbGF5VGV4

dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUz

ODQ8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4x

NzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkZyYXNlciwgVy4gRC48

L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Vbml0IG9mIENs

aW5pY2FsIENoZW1pc3RyeSwgU2Nob29sIG9mIENsaW5pY2FsIFNjaWVuY2VzLCBVbml2ZXJzaXR5

IG9mIExpdmVycG9vbCwgTGl2ZXJwb29sLCBVSy4gdy5kLmZyYXNlckBsaXZlcnBvb2wuYWMudWs8

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5IeXBlcnBhcmF0aHlyb2lkaXNtPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkxhbmNldDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+TGFuY2V0

PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+TGFuY2V0PC9mdWxs

LXRpdGxlPjxhYmJyLTE+TGFuY2V0PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5MYW5jZXQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5MYW5jZXQ8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNDUtNTg8L3BhZ2VzPjx2b2x1bWU+Mzc0PC92b2x1bWU+

PG51bWJlcj45Njg0PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFjdXRlIERpc2Vhc2U8L2tl

eXdvcmQ+PGtleXdvcmQ+QWxnb3JpdGhtczwva2V5d29yZD48a2V5d29yZD5DYWxjaXVtL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2F1c2FsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkRlY2lz

aW9uIFRyZWVzPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3NpcywgRGlmZmVyZW50aWFsPC9rZXl3

b3JkPjxrZXl3b3JkPkhvbWVvc3Rhc2lzL3BoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SHVt

YW5zPC9rZXl3b3JkPjxrZXl3b3JkPipIeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5L2RpYWdu

b3Npcy9lcGlkZW1pb2xvZ3kvZXRpb2xvZ3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD4qSHlw

ZXJwYXJhdGh5cm9pZGlzbSwgU2Vjb25kYXJ5L2RpYWdub3Npcy9lcGlkZW1pb2xvZ3kvZXRpb2xv

Z3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+

S2lkbmV5IEZhaWx1cmUsIENocm9uaWMvY29tcGxpY2F0aW9uczwva2V5d29yZD48a2V5d29yZD5N

YXNzIFNjcmVlbmluZzwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBIb3Jtb25lL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PGtleXdv

cmQ+UGF0aWVudCBTZWxlY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+UHJhY3RpY2UgR3VpZGVsaW5l

cyBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5QcmV2YWxlbmNlPC9rZXl3b3JkPjxrZXl3b3Jk

PlZpdGFtaW4gRCBEZWZpY2llbmN5L2NvbXBsaWNhdGlvbnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bCAxMTwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NzQtNTQ3WCAoRWxlY3Ryb25pYykmI3hEOzAxNDAtNjcz

NiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTk1OTUzNDk8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTk1OTUzNDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEwMTYvUzAxNDAtNjczNigwOSk2MDUwNy05PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+NTM4NDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oRnJhc2VyIDIwMDkpPC9EaXNwbGF5VGV4

dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODQ8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5

IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUz

ODQ8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4x

NzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkZyYXNlciwgVy4gRC48

L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Vbml0IG9mIENs

aW5pY2FsIENoZW1pc3RyeSwgU2Nob29sIG9mIENsaW5pY2FsIFNjaWVuY2VzLCBVbml2ZXJzaXR5

IG9mIExpdmVycG9vbCwgTGl2ZXJwb29sLCBVSy4gdy5kLmZyYXNlckBsaXZlcnBvb2wuYWMudWs8

L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5IeXBlcnBhcmF0aHlyb2lkaXNtPC90aXRsZT48

c2Vjb25kYXJ5LXRpdGxlPkxhbmNldDwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+TGFuY2V0

PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+TGFuY2V0PC9mdWxs

LXRpdGxlPjxhYmJyLTE+TGFuY2V0PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5MYW5jZXQ8L2Z1bGwtdGl0bGU+PGFiYnItMT5MYW5jZXQ8L2FiYnItMT48

L2FsdC1wZXJpb2RpY2FsPjxwYWdlcz4xNDUtNTg8L3BhZ2VzPjx2b2x1bWU+Mzc0PC92b2x1bWU+

PG51bWJlcj45Njg0PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFjdXRlIERpc2Vhc2U8L2tl

eXdvcmQ+PGtleXdvcmQ+QWxnb3JpdGhtczwva2V5d29yZD48a2V5d29yZD5DYWxjaXVtL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+Q2F1c2FsaXR5PC9rZXl3b3JkPjxrZXl3b3JkPkRlY2lz

aW9uIFRyZWVzPC9rZXl3b3JkPjxrZXl3b3JkPkRpYWdub3NpcywgRGlmZmVyZW50aWFsPC9rZXl3

b3JkPjxrZXl3b3JkPkhvbWVvc3Rhc2lzL3BoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SHVt

YW5zPC9rZXl3b3JkPjxrZXl3b3JkPipIeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5L2RpYWdu

b3Npcy9lcGlkZW1pb2xvZ3kvZXRpb2xvZ3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD4qSHlw

ZXJwYXJhdGh5cm9pZGlzbSwgU2Vjb25kYXJ5L2RpYWdub3Npcy9lcGlkZW1pb2xvZ3kvZXRpb2xv

Z3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+

S2lkbmV5IEZhaWx1cmUsIENocm9uaWMvY29tcGxpY2F0aW9uczwva2V5d29yZD48a2V5d29yZD5N

YXNzIFNjcmVlbmluZzwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBIb3Jtb25lL3BoeXNp

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tleXdvcmQ+PGtleXdv

cmQ+UGF0aWVudCBTZWxlY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+UHJhY3RpY2UgR3VpZGVsaW5l

cyBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5QcmV2YWxlbmNlPC9rZXl3b3JkPjxrZXl3b3Jk

PlZpdGFtaW4gRCBEZWZpY2llbmN5L2NvbXBsaWNhdGlvbnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48

ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkp1bCAxMTwvZGF0ZT48L3B1

Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE0NzQtNTQ3WCAoRWxlY3Ryb25pYykmI3hEOzAxNDAtNjcz

NiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTk1OTUzNDk8L2FjY2Vzc2lvbi1udW0+

PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTk1OTUzNDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEwMTYvUzAxNDAtNjczNigwOSk2MDUwNy05PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (2).However, parathyroidectomy is the only curative therapy, with a success rate of 95–98%. To prevent the progression of systemic complications of PHPT ADDIN EN.CITE <EndNote><Cite><Author>Suliburk</Author><Year>2007</Year><RecNum>5385</RecNum><DisplayText>(Suliburk et al. 2007)</DisplayText><record><rec-number>5385</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5385</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Suliburk, J. W.</author><author>Perrier, N. D.</author></authors></contributors><auth-address>University of Texas Medical School at Houston, Department of General Surgery, Houston, Texas, USA.</auth-address><titles><title>Primary hyperparathyroidism</title><secondary-title>Oncologist</secondary-title><alt-title>The oncologist</alt-title></titles><alt-periodical><full-title>The oncologist</full-title></alt-periodical><pages>644-53</pages><volume>12</volume><number>6</number><keywords><keyword>Calcium/urine</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism, Primary/*diagnosis/*surgery/urine</keyword><keyword>Middle Aged</keyword><keyword>Minimally Invasive Surgical Procedures/methods</keyword><keyword>Parathyroidectomy/methods</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1083-7159 (Print)&#xD;1083-7159 (Linking)</isbn><accession-num>17602056</accession-num><urls><related-urls><url>;(28).The NIH’s 2008 modified guidelines recommend surgery for asymptomatic patients who have a serum calcium that is >1.0 mg/dL (0.25 mmol/L) above the upper limit of normal, a CrCl of <60 mL/min, a T-score of ≤ 2.5 at any site, a previous low-trauma fracture, or an age of <50 years PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+

PFJlY051bT41Mzg2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxMSk8

L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4NjwvcmVjLW51bWJlcj48Zm9yZWln

bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0

cnh3OWF2cCI+NTM4Njwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxo

ZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5QaW5jaG90LCBTLiBOLjwvYXV0aG9yPjxhdXRob3I+

RGF2aXMsIFIuPC9hdXRob3I+PGF1dGhvcj5TaXBwZWwsIFIuIFMuPC9hdXRob3I+PGF1dGhvcj5D

aGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNl

Y3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVy

c2l0eSBvZiBXaXNjb25zaW4sIEg0LzcyMiBDU0MgNjAwIEhpZ2hsYW5kIEF2ZW51ZSwgTWFkaXNv

biwgV0kgNTM3OTIsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UaGUgbmVjZXNz

aXR5IGFuZCByZWxpYWJpbGl0eSBvZiBpbnRyYW9wZXJhdGl2ZSBwYXJhdGh5cm9pZCBob3Jtb25l

IChQVEgpIHRlc3RpbmcgaW4gcGF0aWVudHMgd2l0aCBtaWxkIGh5cGVycGFyYXRoeXJvaWRpc20g

YW5kIFBUSCBsZXZlbHMgaW4gdGhlIG5vcm1hbCByYW5nZTwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwg

b2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldv

cmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBT

dXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjAwNi05PC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+

PG51bWJlcj45PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtl

eXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qYmxvb2QvZGlhZ25vc2lzLypzdXJnZXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TW9uaXRvcmluZywgSW50cmFvcGVyYXRpdmUvKm1ldGhvZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS8qYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRo

eXJvaWRlY3RvbXkvYWR2ZXJzZSBlZmZlY3RzLyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBv

c3RvcGVyYXRpdmUgQ2FyZS9tZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlZmVyZW5jZSBWYWx1

ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5IG9mIFJlc3VsdHM8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgQXNz

ZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXZlcml0eSBvZiBJbGxuZXNzIEluZGV4PC9rZXl3

b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVz

Pjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+

PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtp

bmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxNzEzNTczPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxy

ZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIxNzEz

NTczPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMDA3L3MwMDI2OC0wMTEtMTE3OS0zPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29y

ZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+

PFJlY051bT41Mzg2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxMSk8

L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4NjwvcmVjLW51bWJlcj48Zm9yZWln

bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0

cnh3OWF2cCI+NTM4Njwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxo

ZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5QaW5jaG90LCBTLiBOLjwvYXV0aG9yPjxhdXRob3I+

RGF2aXMsIFIuPC9hdXRob3I+PGF1dGhvcj5TaXBwZWwsIFIuIFMuPC9hdXRob3I+PGF1dGhvcj5D

aGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNl

Y3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVy

c2l0eSBvZiBXaXNjb25zaW4sIEg0LzcyMiBDU0MgNjAwIEhpZ2hsYW5kIEF2ZW51ZSwgTWFkaXNv

biwgV0kgNTM3OTIsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5UaGUgbmVjZXNz

aXR5IGFuZCByZWxpYWJpbGl0eSBvZiBpbnRyYW9wZXJhdGl2ZSBwYXJhdGh5cm9pZCBob3Jtb25l

IChQVEgpIHRlc3RpbmcgaW4gcGF0aWVudHMgd2l0aCBtaWxkIGh5cGVycGFyYXRoeXJvaWRpc20g

YW5kIFBUSCBsZXZlbHMgaW4gdGhlIG5vcm1hbCByYW5nZTwvdGl0bGU+PHNlY29uZGFyeS10aXRs

ZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwg

b2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldv

cmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwv

YWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBT

dXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+

PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjAwNi05PC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+

PG51bWJlcj45PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkNvaG9ydCBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtl

eXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qYmxvb2QvZGlhZ25vc2lzLypzdXJnZXJ5PC9rZXl3

b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+

PGtleXdvcmQ+TW9uaXRvcmluZywgSW50cmFvcGVyYXRpdmUvKm1ldGhvZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS8qYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRo

eXJvaWRlY3RvbXkvYWR2ZXJzZSBlZmZlY3RzLyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBv

c3RvcGVyYXRpdmUgQ2FyZS9tZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlZmVyZW5jZSBWYWx1

ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5IG9mIFJlc3VsdHM8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgQXNz

ZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXZlcml0eSBvZiBJbGxuZXNzIEluZGV4PC9rZXl3

b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVz

Pjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+

PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtp

bmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxNzEzNTczPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxy

ZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIxNzEz

NTczPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMDA3L3MwMDI2OC0wMTEtMTE3OS0zPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29y

ZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (29).Surgical options (Parathyroidectomy):AnaesthesiaEither general or local anesthesia can be used for patients undergoing parathyroidectomy. Local anesthesia, via a subcutaneous injection of 1% lidocaine over the intended incision and along the anterior and the posterior borders of the sternocleidomastoid muscle, ipsilateral or bilateral, is used for patient preference or comorbidities. For complications such as technical complications or toxic reactions to lidocaine, unexpected findings, or patient discomfort, general anesthesia should be considered ADDIN EN.CITE <EndNote><Cite><Author>Padmanabhan</Author><Year>2011</Year><RecNum>5388</RecNum><DisplayText>(Padmanabhan 2011)</DisplayText><record><rec-number>5388</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5388</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Padmanabhan, H.</author></authors></contributors><auth-address>Department of Medicine, Veterans Affairs Medical Center, Salem, VA, USA. ramayana48@</auth-address><titles><title>Outpatient management of primary hyperparathyroidism</title><secondary-title>Am J Med</secondary-title><alt-title>The American journal of medicine</alt-title></titles><periodical><full-title>Am J Med</full-title><abbr-1>The American journal of medicine</abbr-1></periodical><alt-periodical><full-title>Am J Med</full-title><abbr-1>The American journal of medicine</abbr-1></alt-periodical><pages>911-4</pages><volume>124</volume><number>10</number><keywords><keyword>Adenoma/*complications/surgery</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/etiology</keyword><keyword>Hyperparathyroidism/complications/etiology/*surgery</keyword><keyword>Outpatients</keyword><keyword>Parathyroid Neoplasms/*complications/surgery</keyword><keyword>Parathyroidectomy</keyword></keywords><dates><year>2011</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1555-7162 (Electronic)&#xD;0002-9343 (Linking)</isbn><accession-num>21816381</accession-num><urls><related-urls><url>;(30).TechniquesParathyroidectomy may be performed using di?erent techniques. 1-The standard procedure for PHPT is bilateral neck exploration, performed under general anesthesia, which is the best choice for patients with inherited hyperparathyroidism or multigland disease. Subtotal parathyroidectomy (i.e., removal of 3.5 glands) or total parathyroidectomy with autotransplantation of parathyroid tissue at a distant site (e.g., the forearm or sternocleidomastoid muscle) may be performed. A transverse incision of 2–4 cm in length above the sternal notch is made, following the skin lines across the anterior neck. The tracheoesophageal groove, the paraesophageal area, the carotid sheath, and the thymus should be explored if a gland is missing. Cervical thymectomy can be performed if a gland is missing in the first surgery, but mediastinum exploration should only be performed in patients who have a gland clearly localized to the mediastinum PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGVuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj

TnVtPjUzODk8L1JlY051bT48RGlzcGxheVRleHQ+KENoZW4gZXQgYWwuIDIwMDUpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjUzODk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoZW4sIEguPC9h

dXRob3I+PGF1dGhvcj5NYWNrLCBFLjwvYXV0aG9yPjxhdXRob3I+U3RhcmxpbmcsIEouIFIuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+U2VjdGlvbiBvZiBF

bmRvY3JpbmUgU3VyZ2VyeSwgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBUaGUgVW5pdmVyc2l0eSBv

ZiBXaXNjb25zaW4gTWVkaWNhbCBTY2hvb2wsIE1hZGlzb24sIFdJIDUzNzkyLCBVU0EuIGNoZW5A

c3VyZ2VyeS53aXNjLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY29tcHJlaGVu

c2l2ZSBldmFsdWF0aW9uIG9mIHBlcmlvcGVyYXRpdmUgYWRqdW5jdHMgZHVyaW5nIG1pbmltYWxs

eSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTogd2hpY2ggaXMgbW9zdCByZWxpYWJsZT88L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PkFubmFscyBvZiBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+QW5uIFN1cmc8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFN1cmc8L2Z1

bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjM3NS04MDsgZGlzY3Vzc2lvbiAzODAtMzwvcGFnZXM+PHZvbHVtZT4yNDI8L3Zv

bHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS9ibG9vZC8q

ZGlhZ25vc2lzL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48

a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5p

bWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBIb3Jtb25lLypibG9vZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9w

bGFzbXMvYmxvb2QvKmRpYWdub3Npcy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHly

b2lkZWN0b215LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmlvcGVyYXRpdmUgQ2FyZTwv

a2V5d29yZD48a2V5d29yZD5QcmVkaWN0aXZlIFZhbHVlIG9mIFRlc3RzPC9rZXl3b3JkPjxrZXl3

b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9zdXJnZXJ5LyptZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlRlY2hu

ZXRpdW0gVGMgOTltIFNlc3RhbWliaTwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBFbWlz

c2lvbi1Db21wdXRlZCwgU2luZ2xlLVBob3Rvbi8qbWV0aG9kczwva2V5d29yZD48L2tleXdvcmRz

PjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwMy00OTMyIChQcmludCkmI3hEOzAwMDMtNDkzMiAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTYxMzU5MjM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTYx

MzU5MjM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+MTM1Nzc0NTwvY3VzdG9t

Mj48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGVuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj

TnVtPjUzODk8L1JlY051bT48RGlzcGxheVRleHQ+KENoZW4gZXQgYWwuIDIwMDUpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjUzODk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoZW4sIEguPC9h

dXRob3I+PGF1dGhvcj5NYWNrLCBFLjwvYXV0aG9yPjxhdXRob3I+U3RhcmxpbmcsIEouIFIuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+U2VjdGlvbiBvZiBF

bmRvY3JpbmUgU3VyZ2VyeSwgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBUaGUgVW5pdmVyc2l0eSBv

ZiBXaXNjb25zaW4gTWVkaWNhbCBTY2hvb2wsIE1hZGlzb24sIFdJIDUzNzkyLCBVU0EuIGNoZW5A

c3VyZ2VyeS53aXNjLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY29tcHJlaGVu

c2l2ZSBldmFsdWF0aW9uIG9mIHBlcmlvcGVyYXRpdmUgYWRqdW5jdHMgZHVyaW5nIG1pbmltYWxs

eSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTogd2hpY2ggaXMgbW9zdCByZWxpYWJsZT88L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PkFubmFscyBvZiBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+QW5uIFN1cmc8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFN1cmc8L2Z1

bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjM3NS04MDsgZGlzY3Vzc2lvbiAzODAtMzwvcGFnZXM+PHZvbHVtZT4yNDI8L3Zv

bHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS9ibG9vZC8q

ZGlhZ25vc2lzL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48

a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5p

bWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBIb3Jtb25lLypibG9vZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9w

bGFzbXMvYmxvb2QvKmRpYWdub3Npcy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHly

b2lkZWN0b215LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmlvcGVyYXRpdmUgQ2FyZTwv

a2V5d29yZD48a2V5d29yZD5QcmVkaWN0aXZlIFZhbHVlIG9mIFRlc3RzPC9rZXl3b3JkPjxrZXl3

b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9zdXJnZXJ5LyptZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlRlY2hu

ZXRpdW0gVGMgOTltIFNlc3RhbWliaTwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBFbWlz

c2lvbi1Db21wdXRlZCwgU2luZ2xlLVBob3Rvbi8qbWV0aG9kczwva2V5d29yZD48L2tleXdvcmRz

PjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwMy00OTMyIChQcmludCkmI3hEOzAwMDMtNDkzMiAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTYxMzU5MjM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTYx

MzU5MjM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+MTM1Nzc0NTwvY3VzdG9t

Mj48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (31).2-Minimally invasive parathyroidectomy (MIP)MIP allows patients to undergo focused parathyroidectomy and has the benefits of a smaller incision, a shorter operation duration, a shorter length of hospital stay, and fewer complications; it is also more cost-e?ective than the standard four-gland exploration. A small incision is usually made ipsilateral to the preoperative localized adenoma. MIP surgery can be performed through central or lateral neck incisions and has a 97% success rate with minimal morbidity and no procedure-specific complications PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48

UmVjTnVtPjUzOTA8L1JlY051bT48RGlzcGxheVRleHQ+KE5leWNoZXYgZXQgYWwuIDIwMTEpPC9E

aXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzOTA8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5leWNo

ZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5Lb3VuaWF2c2t5LCBHLjwvYXV0aG9yPjxhdXRob3I+

U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5VZGFsbCwgRC4gTi48L2F1dGhvcj48YXV0aG9yPlNv

bWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9yPlVtYnJpY2h0LCBDLiBCLjwvYXV0aG9yPjxhdXRo

b3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVGhlIEpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0

eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRpbW9yZSwgTUQgMjEyMDUsIFVTQS48L2F1dGgtYWRk

cmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5nICZxdW90O3NoYWRvd3MmcXVvdDs6IGRpc2NvdmVy

aW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3RhbWliaSBzY2FucyB0byBmYWNpbGl0YXRlIG1pbmlt

YWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5X

b3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Yg

c3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldvcmxk

IEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJn

PC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8L3BhZ2VzPjx2b2x1bWU+MzU8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5Lypk

aWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29y

ZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5pbWFsbHkgSW52YXNp

dmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVjdG9t

eS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwva2V5d29y

ZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9z

cGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVtIFRjIDk5bSBTZXN0

YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIz

MTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwODg2MjExPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAtMDgwMC0xPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48

UmVjTnVtPjUzOTA8L1JlY051bT48RGlzcGxheVRleHQ+KE5leWNoZXYgZXQgYWwuIDIwMTEpPC9E

aXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzOTA8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5leWNo

ZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5Lb3VuaWF2c2t5LCBHLjwvYXV0aG9yPjxhdXRob3I+

U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5VZGFsbCwgRC4gTi48L2F1dGhvcj48YXV0aG9yPlNv

bWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9yPlVtYnJpY2h0LCBDLiBCLjwvYXV0aG9yPjxhdXRo

b3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1h

ZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVGhlIEpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0

eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRpbW9yZSwgTUQgMjEyMDUsIFVTQS48L2F1dGgtYWRk

cmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5nICZxdW90O3NoYWRvd3MmcXVvdDs6IGRpc2NvdmVy

aW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3RhbWliaSBzY2FucyB0byBmYWNpbGl0YXRlIG1pbmlt

YWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5X

b3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Yg

c3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldvcmxk

IEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJn

PC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8L3BhZ2VzPjx2b2x1bWU+MzU8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5Lypk

aWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29y

ZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5pbWFsbHkgSW52YXNp

dmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVjdG9t

eS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwva2V5d29y

ZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9z

cGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipUZWNobmV0aXVtIFRjIDk5bSBTZXN0

YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIz

MTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIwODg2MjExPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAtMDgwMC0xPC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (32).Preoperative localization is critical in this situation, because most of the neck is not explored, given the focused nature of the procedure ADDIN EN.CITE <EndNote><Cite><Author>Terris</Author><Year>2007</Year><RecNum>5391</RecNum><DisplayText>(Terris et al. 2007)</DisplayText><record><rec-number>5391</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5391</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Terris, D. J.</author><author>Stack, B. C., Jr.</author><author>Gourin, C. G.</author></authors></contributors><auth-address>Department of Otolaryngology-Head and Neck Surgery, Medical College of Georgia, Augusta, GA 30912-4060, USA. dterris@mcg.edu</auth-address><titles><title>Contemporary parathyroidectomy: exploiting technology</title><secondary-title>Am J Otolaryngol</secondary-title><alt-title>American journal of otolaryngology</alt-title></titles><periodical><full-title>Am J Otolaryngol</full-title><abbr-1>American journal of otolaryngology</abbr-1></periodical><alt-periodical><full-title>Am J Otolaryngol</full-title><abbr-1>American journal of otolaryngology</abbr-1></alt-periodical><pages>408-14</pages><volume>28</volume><number>6</number><keywords><keyword>Endoscopy</keyword><keyword>Humans</keyword><keyword>Monitoring, Intraoperative</keyword><keyword>Parathyroidectomy/*methods</keyword><keyword>Radionuclide Imaging</keyword><keyword>Surgery, Computer-Assisted</keyword><keyword>Thyroid Diseases/diagnostic imaging/*surgery</keyword><keyword>Ultrasonography</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>0196-0709 (Print)&#xD;0196-0709 (Linking)</isbn><accession-num>17980774</accession-num><urls><related-urls><url>;(33).3-Endscopic parathyroidectomyVideo-guided (endoscopic) parathyroidectomy is comparable to MIP in operative success, incision length, postoperative pain, cosmetic results, and complication rates. This approach facilitates recognition of recurrent laryngeal nerve and blood vessels surrounding the parathyroid glands, but it is slower. It is contraindicated in patients with previous neck surgery, negative preoperative localization, or a large goiter, or in patients who need local anesthesia PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BcmRpdG88L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTM5MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oQXJkaXRvIGV0IGFsLiAyMDEyKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41MzkyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41MzkyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BcmRpdG8s

IEcuPC9hdXRob3I+PGF1dGhvcj5SZXZlbGxpLCBMLjwvYXV0aG9yPjxhdXRob3I+R2l1c3Rvenpp

LCBFLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29u

dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBFbmRvY3JpbmUgU3VyZ2VyeSwg

Q2F0aG9saWMgVW5pdmVyc2l0eSBvZiBTYWNyZWQgSGVhcnQsIFJvbWUsIEl0YWx5LiBhcmRpdG9n

QGxpYmVyby5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJhZGlvZ3VpZGVkIHBhcmF0

aHlyb2lkZWN0b215IGluIGZvcmVhcm0gZ3JhZnQgZm9yIHJlY3VycmVudCBoeXBlcnBhcmF0aHly

b2lkaXNtPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkJyIEogUmFkaW9sPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5UaGUgQnJpdGlzaCBqb3VybmFsIG9mIHJhZGlvbG9neTwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJyIEogUmFkaW9sPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEJyaXRpc2ggam91cm5hbCBvZiByYWRpb2xvZ3k8L2FiYnItMT48L3Blcmlv

ZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJyIEogUmFkaW9sPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEJyaXRpc2ggam91cm5hbCBvZiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1w

ZXJpb2RpY2FsPjxwYWdlcz5lMS0zPC9wYWdlcz48dm9sdW1lPjg1PC92b2x1bWU+PG51bWJlcj4x

MDA5PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkZv

cmVhcm0vKnBhdGhvbG9neS8qc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdv

cmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlhZ25vc3RpYyBpbWFnaW5nLypzdXJn

ZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGxhc2lhL2RpYWdub3N0aWMgaW1hZ2luZy9zdXJn

ZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRl

Y3RvbXkvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+UG9zdG9wZXJhdGl2ZSBDb21wbGljYXRp

b25zLypkaWFnbm9zdGljIGltYWdpbmcvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5SYWRpb251

Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVjdXJyZW5jZTwva2V5d29yZD48a2V5d29yZD4qVGVjaG5ldGl1bSBU

YyA5OW0gU2VzdGFtaWJpPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKnRyYW5zcGxh

bnRhdGlvbjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTc0OC04ODBY

IChFbGVjdHJvbmljKSYjeEQ7MDAwNy0xMjg1IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51

bT4yMjE5MDc1NDwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMjE5MDc1NDwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48Y3VzdG9tMj4zNDczOTMxPC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51

bT4xMC4xMjU5L2Jqci82NDM0ODAxOTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+

PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BcmRpdG88L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTM5MjwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oQXJkaXRvIGV0IGFsLiAyMDEyKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41MzkyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41MzkyPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5BcmRpdG8s

IEcuPC9hdXRob3I+PGF1dGhvcj5SZXZlbGxpLCBMLjwvYXV0aG9yPjxhdXRob3I+R2l1c3Rvenpp

LCBFLjwvYXV0aG9yPjxhdXRob3I+R2lvcmRhbm8sIEEuPC9hdXRob3I+PC9hdXRob3JzPjwvY29u

dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBvZiBFbmRvY3JpbmUgU3VyZ2VyeSwg

Q2F0aG9saWMgVW5pdmVyc2l0eSBvZiBTYWNyZWQgSGVhcnQsIFJvbWUsIEl0YWx5LiBhcmRpdG9n

QGxpYmVyby5pdDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPlJhZGlvZ3VpZGVkIHBhcmF0

aHlyb2lkZWN0b215IGluIGZvcmVhcm0gZ3JhZnQgZm9yIHJlY3VycmVudCBoeXBlcnBhcmF0aHly

b2lkaXNtPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkJyIEogUmFkaW9sPC9zZWNvbmRhcnktdGl0

bGU+PGFsdC10aXRsZT5UaGUgQnJpdGlzaCBqb3VybmFsIG9mIHJhZGlvbG9neTwvYWx0LXRpdGxl

PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJyIEogUmFkaW9sPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEJyaXRpc2ggam91cm5hbCBvZiByYWRpb2xvZ3k8L2FiYnItMT48L3Blcmlv

ZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkJyIEogUmFkaW9sPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEJyaXRpc2ggam91cm5hbCBvZiByYWRpb2xvZ3k8L2FiYnItMT48L2FsdC1w

ZXJpb2RpY2FsPjxwYWdlcz5lMS0zPC9wYWdlcz48dm9sdW1lPjg1PC92b2x1bWU+PG51bWJlcj4x

MDA5PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkZv

cmVhcm0vKnBhdGhvbG9neS8qc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdv

cmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qZGlhZ25vc3RpYyBpbWFnaW5nLypzdXJn

ZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGxhc2lhL2RpYWdub3N0aWMgaW1hZ2luZy9zdXJn

ZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRl

Y3RvbXkvKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+UG9zdG9wZXJhdGl2ZSBDb21wbGljYXRp

b25zLypkaWFnbm9zdGljIGltYWdpbmcvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5SYWRpb251

Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVjdXJyZW5jZTwva2V5d29yZD48a2V5d29yZD4qVGVjaG5ldGl1bSBU

YyA5OW0gU2VzdGFtaWJpPC9rZXl3b3JkPjxrZXl3b3JkPlRoeXJvaWQgR2xhbmQvKnRyYW5zcGxh

bnRhdGlvbjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEyPC95ZWFyPjxwdWIt

ZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTc0OC04ODBY

IChFbGVjdHJvbmljKSYjeEQ7MDAwNy0xMjg1IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51

bT4yMjE5MDc1NDwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDov

L3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMjE5MDc1NDwvdXJsPjwvcmVsYXRlZC11cmxz

PjwvdXJscz48Y3VzdG9tMj4zNDczOTMxPC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51

bT4xMC4xMjU5L2Jqci82NDM0ODAxOTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+

PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (34).Video-guided parathyroidectomy can be performed by using several techniques. The anterior approach permits bilateral exploration and does not need gas insufflation. Camera and endoscopic instruments can be used through a 10–15-mm incision just above the sternal notch. The lateral approach uses camera and endoscopic instruments through one 5-mm and two 2-mm incisions near the sternocleidomastoid muscle, allowing the surgeon to visualize the glands located posteriorly in the tracheoesophageal groove. The lateral approach requires low pressures of gas insufflation of the neck to avoid significant subcutaneous emphysema ADDIN EN.CITE <EndNote><Cite><Author>Henry</Author><Year>2001</Year><RecNum>5393</RecNum><DisplayText>(Henry et al. 2001)</DisplayText><record><rec-number>5393</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5393</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Henry, J. F.</author><author>Iacobone, M.</author><author>Mirallie, E.</author><author>Deveze, A.</author><author>Pili, S.</author></authors></contributors><auth-address>Department of General and Endocrine Surgery, University Hospital La Timone, Marseilles, France.</auth-address><titles><title>Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism</title><secondary-title>Surgery</secondary-title><alt-title>Surgery</alt-title></titles><periodical><full-title>Surgery</full-title><abbr-1>Surgery</abbr-1></periodical><alt-periodical><full-title>Surgery</full-title><abbr-1>Surgery</abbr-1></alt-periodical><pages>999-1004</pages><volume>130</volume><number>6</number><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/*surgery</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Hormone/blood</keyword><keyword>Parathyroidectomy/*methods</keyword><keyword>Retrospective Studies</keyword><keyword>*Video-Assisted Surgery</keyword></keywords><dates><year>2001</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0039-6060 (Print)&#xD;0039-6060 (Linking)</isbn><accession-num>11742329</accession-num><urls><related-urls><url>;(35).Post-parathyroidectomy management:It is vital to ensure that there is no expanding hematoma in the surgical wound. Antiemetics should be used to limit nausea and vomiting, which can lead to suture dislodgement. The majority of endocrine surgeons prescribe oral calcium supplements for a few weeks or vitamin D supplements in patients with very low postoperative PTH or a high risk of postoperative hungry bone syndrome. Patients should be re-evaluated 1-2 weeks after discharge to check the surgical site and serum calcium and PTH levels. Serum calcium and PTH levels should be reassessed after 6 months to confirm cure, and then annually to ensure that they remain normal and that abnormal tissue has not regrown. A follow-up bone density test is suggested at 1 year after surgery to guide the treatment of bone loss PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGVuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj

TnVtPjUzODk8L1JlY051bT48RGlzcGxheVRleHQ+KENoZW4gZXQgYWwuIDIwMDUpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjUzODk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoZW4sIEguPC9h

dXRob3I+PGF1dGhvcj5NYWNrLCBFLjwvYXV0aG9yPjxhdXRob3I+U3RhcmxpbmcsIEouIFIuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+U2VjdGlvbiBvZiBF

bmRvY3JpbmUgU3VyZ2VyeSwgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBUaGUgVW5pdmVyc2l0eSBv

ZiBXaXNjb25zaW4gTWVkaWNhbCBTY2hvb2wsIE1hZGlzb24sIFdJIDUzNzkyLCBVU0EuIGNoZW5A

c3VyZ2VyeS53aXNjLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY29tcHJlaGVu

c2l2ZSBldmFsdWF0aW9uIG9mIHBlcmlvcGVyYXRpdmUgYWRqdW5jdHMgZHVyaW5nIG1pbmltYWxs

eSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTogd2hpY2ggaXMgbW9zdCByZWxpYWJsZT88L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PkFubmFscyBvZiBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+QW5uIFN1cmc8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFN1cmc8L2Z1

bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjM3NS04MDsgZGlzY3Vzc2lvbiAzODAtMzwvcGFnZXM+PHZvbHVtZT4yNDI8L3Zv

bHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS9ibG9vZC8q

ZGlhZ25vc2lzL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48

a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5p

bWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBIb3Jtb25lLypibG9vZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9w

bGFzbXMvYmxvb2QvKmRpYWdub3Npcy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHly

b2lkZWN0b215LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmlvcGVyYXRpdmUgQ2FyZTwv

a2V5d29yZD48a2V5d29yZD5QcmVkaWN0aXZlIFZhbHVlIG9mIFRlc3RzPC9rZXl3b3JkPjxrZXl3

b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9zdXJnZXJ5LyptZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlRlY2hu

ZXRpdW0gVGMgOTltIFNlc3RhbWliaTwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBFbWlz

c2lvbi1Db21wdXRlZCwgU2luZ2xlLVBob3Rvbi8qbWV0aG9kczwva2V5d29yZD48L2tleXdvcmRz

PjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwMy00OTMyIChQcmludCkmI3hEOzAwMDMtNDkzMiAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTYxMzU5MjM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTYx

MzU5MjM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+MTM1Nzc0NTwvY3VzdG9t

Mj48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaGVuPC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48UmVj

TnVtPjUzODk8L1JlY051bT48RGlzcGxheVRleHQ+KENoZW4gZXQgYWwuIDIwMDUpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzODk8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjUzODk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNoZW4sIEguPC9h

dXRob3I+PGF1dGhvcj5NYWNrLCBFLjwvYXV0aG9yPjxhdXRob3I+U3RhcmxpbmcsIEouIFIuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+U2VjdGlvbiBvZiBF

bmRvY3JpbmUgU3VyZ2VyeSwgRGVwYXJ0bWVudCBvZiBTdXJnZXJ5LCBUaGUgVW5pdmVyc2l0eSBv

ZiBXaXNjb25zaW4gTWVkaWNhbCBTY2hvb2wsIE1hZGlzb24sIFdJIDUzNzkyLCBVU0EuIGNoZW5A

c3VyZ2VyeS53aXNjLmVkdTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY29tcHJlaGVu

c2l2ZSBldmFsdWF0aW9uIG9mIHBlcmlvcGVyYXRpdmUgYWRqdW5jdHMgZHVyaW5nIG1pbmltYWxs

eSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTogd2hpY2ggaXMgbW9zdCByZWxpYWJsZT88L3Rp

dGxlPjxzZWNvbmRhcnktdGl0bGU+QW5uIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxl

PkFubmFscyBvZiBzdXJnZXJ5PC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+QW5uIFN1cmc8L2Z1bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+QW5uIFN1cmc8L2Z1

bGwtdGl0bGU+PGFiYnItMT5Bbm5hbHMgb2Ygc3VyZ2VyeTwvYWJici0xPjwvYWx0LXBlcmlvZGlj

YWw+PHBhZ2VzPjM3NS04MDsgZGlzY3Vzc2lvbiAzODAtMzwvcGFnZXM+PHZvbHVtZT4yNDI8L3Zv

bHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS9ibG9vZC8q

ZGlhZ25vc2lzL3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48

a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5NaW5p

bWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5d29yZD5QYXJh

dGh5cm9pZCBIb3Jtb25lLypibG9vZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9w

bGFzbXMvYmxvb2QvKmRpYWdub3Npcy9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHly

b2lkZWN0b215LyptZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBlcmlvcGVyYXRpdmUgQ2FyZTwv

a2V5d29yZD48a2V5d29yZD5QcmVkaWN0aXZlIFZhbHVlIG9mIFRlc3RzPC9rZXl3b3JkPjxrZXl3

b3JkPlByb3NwZWN0aXZlIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmFkaW9zdXJnZXJ5LyptZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlcHJvZHVjaWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPlRlY2hu

ZXRpdW0gVGMgOTltIFNlc3RhbWliaTwva2V5d29yZD48a2V5d29yZD5Ub21vZ3JhcGh5LCBFbWlz

c2lvbi1Db21wdXRlZCwgU2luZ2xlLVBob3Rvbi8qbWV0aG9kczwva2V5d29yZD48L2tleXdvcmRz

PjxkYXRlcz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+U2VwPC9kYXRlPjwvcHVi

LWRhdGVzPjwvZGF0ZXM+PGlzYm4+MDAwMy00OTMyIChQcmludCkmI3hEOzAwMDMtNDkzMiAoTGlu

a2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTYxMzU5MjM8L2FjY2Vzc2lvbi1udW0+PHVybHM+

PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTYx

MzU5MjM8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+MTM1Nzc0NTwvY3VzdG9t

Mj48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (31).Complications:Despite a low incidence rate of 1%, bleeding and hematoma formation are fatal complications of neck surgery, as a rapidly expanding hematoma can lead to venous congestion and airway compromise. Careful intraoperative hemostasis is vital, as well as immediate bedside evacuation with subsequent exploration and closure. Temporary or permanent recurrent laryngeal nerve injury and hoarseness are caused mainly by errors surrounding the varied anatomy of the recurrent laryngeal nerve and its relationship to the thyroid gland. ( ADDIN EN.CITE <EndNote><Cite><Author>Abbas</Author><Year>2001</Year><RecNum>5395</RecNum><DisplayText>(Abbas et al. 2001)</DisplayText><record><rec-number>5395</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5395</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Abbas, G.</author><author>Dubner, S.</author><author>Heller, K. S.</author></authors></contributors><auth-address>Division of Head and Neck Surgery, Department of Surgery, Long Island Jewish Medical Center, The Long Island Campus of the Albert Einstein College of Medicine, New Hyde Park, New York, USA.</auth-address><titles><title>Re-operation for bleeding after thyroidectomy and parathyroidectomy</title><secondary-title>Head Neck</secondary-title><alt-title>Head &amp; neck</alt-title></titles><periodical><full-title>Head Neck</full-title><abbr-1>Head &amp; neck</abbr-1></periodical><alt-periodical><full-title>Head Neck</full-title><abbr-1>Head &amp; neck</abbr-1></alt-periodical><pages>544-6</pages><volume>23</volume><number>7</number><keywords><keyword>Hemorrhage/*etiology/surgery</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Neck</keyword><keyword>Parathyroidectomy/*adverse effects</keyword><keyword>Reoperation</keyword><keyword>Thyroidectomy/*adverse effects</keyword><keyword>Time Factors</keyword></keywords><dates><year>2001</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1043-3074 (Print)&#xD;1043-3074 (Linking)</isbn><accession-num>11400242</accession-num><urls><related-urls><url>).Transient or permanent hypoparathyroidism and hypocalcemia occur frequently after subtotal or total parathyroidectomy because of ischemic injury to healthy parathyroid gland (s). Preservation of one gland is sufficient to maintain normocalcemia. The immediate primary treatment of postoperative biochemical hypocalcemia is calcium and/or vitamin D supplementation. Appropriate patient education on the symptoms of hypocalcemia and the liberal use of calcium replacement therapy is necessary prior to discharge ( ADDIN EN.CITE <EndNote><Cite><Author>Westerdahl</Author><Year>2000</Year><RecNum>5396</RecNum><DisplayText>(Westerdahl et al. 2000)</DisplayText><record><rec-number>5396</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5396</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westerdahl, J.</author><author>Lindblom, P.</author><author>Valdemarsson, S.</author><author>Tibblin, S.</author><author>Bergenfelz, A.</author></authors></contributors><auth-address>Department of Surgery, Lund University Hospital, Sweden. johan.westerdahl@kir.lu.se</auth-address><titles><title>Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism</title><secondary-title>Arch Surg</secondary-title><alt-title>Archives of surgery</alt-title></titles><periodical><full-title>Arch Surg</full-title><abbr-1>Archives of surgery</abbr-1></periodical><alt-periodical><full-title>Arch Surg</full-title><abbr-1>Archives of surgery</abbr-1></alt-periodical><pages>142-7</pages><volume>135</volume><number>2</number><keywords><keyword>Adenoma/surgery</keyword><keyword>Calcium/blood</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/*surgery</keyword><keyword>Hypocalcemia/*epidemiology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Neoplasms/surgery</keyword><keyword>*Parathyroidectomy</keyword><keyword>Postoperative Complications/*epidemiology</keyword><keyword>Prognosis</keyword><keyword>Prospective Studies</keyword><keyword>Time Factors</keyword></keywords><dates><year>2000</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0004-0010 (Print)&#xD;0004-0010 (Linking)</isbn><accession-num>10668870</accession-num><urls><related-urls><url>).Parathyroid cryopreservation can be used in patients who have a high risk of severe postoperative hypocalcemia. Persistent or recurrent disease has an incidence ranging from 1% to 10%. Following parathyroidectomy, hypercalcemia within 6 months is defined as persistent disease and hypercalcemia after 6 months is defined as recurrent disease. Persistent or recurrent disease may be caused by surgeon inexperience, incomplete exploration, or supernumerary glands. Preoperative parathyroid surgery in these cases presents a challenge, as dense scar tissue and distorted tissue planes obscure intraoperative localization PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+

PFJlY051bT41Mzk3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxNCk8

L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM5NzwvcmVjLW51bWJlcj48Zm9yZWln

bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0

cnh3OWF2cCI+NTM5Nzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxo

ZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5TY2huZWlkZXIsIEQuIEYuPC9hdXRob3I+PGF1dGhv

cj5TaXBwZWwsIFIuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnks

IERlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIE1hZGlzb24s

IFdpc2NvbnNpbi4mI3hEO1NlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1lbnQg

b2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIE1hZGlzb24sIFdpc2NvbnNpbi4g

RWxlY3Ryb25pYyBhZGRyZXNzOiBjaGVuQHN1cmdlcnkud2lzYy5lZHUuPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UmVjdXJyZW50IGFuZCBwZXJzaXN0ZW5jZSBwcmltYXJ5IGh5cGVycGFy

YXRoeXJvaWRpc20gb2NjdXJzIG1vcmUgZnJlcXVlbnRseSBpbiBwYXRpZW50cyB3aXRoIGRvdWJs

ZSBhZGVub21hczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIFN1cmcgUmVzPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5UaGUgSm91cm5hbCBvZiBzdXJnaWNhbCByZXNlYXJjaDwvYWx0LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogU3VyZyBSZXM8L2Z1bGwtdGl0

bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBzdXJnaWNhbCByZXNlYXJjaDwvYWJici0xPjwvcGVy

aW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBTdXJnIFJlczwvZnVsbC10aXRs

ZT48YWJici0xPlRoZSBKb3VybmFsIG9mIHN1cmdpY2FsIHJlc2VhcmNoPC9hYmJyLTE+PC9hbHQt

cGVyaW9kaWNhbD48cGFnZXM+MTk4LTIwMjwvcGFnZXM+PHZvbHVtZT4xOTA8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qY29tcGxpY2F0aW9uczwv

a2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxr

ZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0vYmxvb2Q8

L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29y

ZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5L2Jsb29kLypldGlvbG9neS9z

dXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFn

ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zLypjb21wbGljYXRpb25z

PC9rZXl3b3JkPjxrZXl3b3JkPlJlY3VycmVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDk1

LTg2NzMgKEVsZWN0cm9uaWMpJiN4RDswMDIyLTQ4MDQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjI0NjU2Mzk4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI0NjU2Mzk4PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ouanNzLjIwMTQu

MDIuMDI0PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+

PFJlY051bT41Mzk3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxNCk8

L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM5NzwvcmVjLW51bWJlcj48Zm9yZWln

bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0

cnh3OWF2cCI+NTM5Nzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QWxo

ZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5TY2huZWlkZXIsIEQuIEYuPC9hdXRob3I+PGF1dGhv

cj5TaXBwZWwsIFIuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnks

IERlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIE1hZGlzb24s

IFdpc2NvbnNpbi4mI3hEO1NlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1lbnQg

b2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIE1hZGlzb24sIFdpc2NvbnNpbi4g

RWxlY3Ryb25pYyBhZGRyZXNzOiBjaGVuQHN1cmdlcnkud2lzYy5lZHUuPC9hdXRoLWFkZHJlc3M+

PHRpdGxlcz48dGl0bGU+UmVjdXJyZW50IGFuZCBwZXJzaXN0ZW5jZSBwcmltYXJ5IGh5cGVycGFy

YXRoeXJvaWRpc20gb2NjdXJzIG1vcmUgZnJlcXVlbnRseSBpbiBwYXRpZW50cyB3aXRoIGRvdWJs

ZSBhZGVub21hczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIFN1cmcgUmVzPC9zZWNvbmRhcnkt

dGl0bGU+PGFsdC10aXRsZT5UaGUgSm91cm5hbCBvZiBzdXJnaWNhbCByZXNlYXJjaDwvYWx0LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogU3VyZyBSZXM8L2Z1bGwtdGl0

bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBzdXJnaWNhbCByZXNlYXJjaDwvYWJici0xPjwvcGVy

aW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBTdXJnIFJlczwvZnVsbC10aXRs

ZT48YWJici0xPlRoZSBKb3VybmFsIG9mIHN1cmdpY2FsIHJlc2VhcmNoPC9hYmJyLTE+PC9hbHQt

cGVyaW9kaWNhbD48cGFnZXM+MTk4LTIwMjwvcGFnZXM+PHZvbHVtZT4xOTA8L3ZvbHVtZT48bnVt

YmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8qY29tcGxpY2F0aW9uczwv

a2V5d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxr

ZXl3b3JkPkFnZWQsIDgwIGFuZCBvdmVyPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0vYmxvb2Q8

L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29y

ZD48a2V5d29yZD5IeXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5L2Jsb29kLypldGlvbG9neS9z

dXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFn

ZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zLypjb21wbGljYXRpb25z

PC9rZXl3b3JkPjxrZXl3b3JkPlJlY3VycmVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVj

dGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDk1

LTg2NzMgKEVsZWN0cm9uaWMpJiN4RDswMDIyLTQ4MDQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjI0NjU2Mzk4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI0NjU2Mzk4PC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ouanNzLjIwMTQu

MDIuMDI0PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE.DATA (29).Medical therapy options:In patients who are not candidates for surgery or those unwilling to undergo parathyroidectomy, treatment recommendations include annual serum calcium and creatinine testing and BMD measurement every 1–2 years. Patients should be encouraged to maintain a normal intake of calcium. Medical management includes:1) Bisphosphonates and hormone replacement therapy to decrease bone turnover and improve BMD, although they do not decrease serum calcium or PTH levels ADDIN EN.CITE <EndNote><Cite><Author>Caron</Author><Year>2004</Year><RecNum>5403</RecNum><DisplayText>(Caron et al. 2004)</DisplayText><record><rec-number>5403</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5403</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caron, N. R.</author><author>Sturgeon, C.</author><author>Clark, O. H.</author></authors></contributors><auth-address>Department of Surgery, University of California San Francisco and UCSF Comprehensive Cancer Center at Mount Zion, 1600 Divisadero Street, Hellman Building, Room C3-47, San Francisco, CA 94143, USA.</auth-address><titles><title>Persistent and recurrent hyperparathyroidism</title><secondary-title>Curr Treat Options Oncol</secondary-title><alt-title>Current treatment options in oncology</alt-title></titles><periodical><full-title>Curr Treat Options Oncol</full-title><abbr-1>Current treatment options in oncology</abbr-1></periodical><alt-periodical><full-title>Curr Treat Options Oncol</full-title><abbr-1>Current treatment options in oncology</abbr-1></alt-periodical><pages>335-45</pages><volume>5</volume><number>4</number><keywords><keyword>Diet</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/*etiology/surgery</keyword><keyword>Life Style</keyword><keyword>Male</keyword><keyword>Neoplasm Staging</keyword><keyword>Parathyroid Neoplasms/diagnostic imaging/pathology/*surgery</keyword><keyword>Parathyroidectomy/*methods</keyword><keyword>Postoperative Complications</keyword><keyword>Radionuclide Imaging</keyword><keyword>Recurrence</keyword><keyword>Risk Assessment</keyword></keywords><dates><year>2004</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1527-2729 (Print)&#xD;1534-6277 (Linking)</isbn><accession-num>15233910</accession-num><urls><related-urls><url>;(38).2) Cinacalcet to reduce serum calcium and PTH levels and raises serum phosphorus levels, although it does not reduce bone turnover or improve BMD ADDIN EN.CITE <EndNote><Cite><Author>Caron</Author><Year>2004</Year><RecNum>5403</RecNum><DisplayText>(Caron et al. 2004)</DisplayText><record><rec-number>5403</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5403</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caron, N. R.</author><author>Sturgeon, C.</author><author>Clark, O. H.</author></authors></contributors><auth-address>Department of Surgery, University of California San Francisco and UCSF Comprehensive Cancer Center at Mount Zion, 1600 Divisadero Street, Hellman Building, Room C3-47, San Francisco, CA 94143, USA.</auth-address><titles><title>Persistent and recurrent hyperparathyroidism</title><secondary-title>Curr Treat Options Oncol</secondary-title><alt-title>Current treatment options in oncology</alt-title></titles><periodical><full-title>Curr Treat Options Oncol</full-title><abbr-1>Current treatment options in oncology</abbr-1></periodical><alt-periodical><full-title>Curr Treat Options Oncol</full-title><abbr-1>Current treatment options in oncology</abbr-1></alt-periodical><pages>335-45</pages><volume>5</volume><number>4</number><keywords><keyword>Diet</keyword><keyword>Female</keyword><keyword>Follow-Up Studies</keyword><keyword>Humans</keyword><keyword>Hyperparathyroidism/*etiology/surgery</keyword><keyword>Life Style</keyword><keyword>Male</keyword><keyword>Neoplasm Staging</keyword><keyword>Parathyroid Neoplasms/diagnostic imaging/pathology/*surgery</keyword><keyword>Parathyroidectomy/*methods</keyword><keyword>Postoperative Complications</keyword><keyword>Radionuclide Imaging</keyword><keyword>Recurrence</keyword><keyword>Risk Assessment</keyword></keywords><dates><year>2004</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1527-2729 (Print)&#xD;1534-6277 (Linking)</isbn><accession-num>15233910</accession-num><urls><related-urls><url>;(38).3) Vitamin D should be measured and replaced if the pre-parathyroidectomy vitamin D level is <20 ng/mL or <50 nmol/L PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LaGFuPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj

TnVtPjU0MDU8L1JlY051bT48RGlzcGxheVRleHQ+KEtoYW4gZXQgYWwuIDIwMDkpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjU0MDU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktoYW4sIEEuPC9h

dXRob3I+PGF1dGhvcj5HcmV5LCBBLjwvYXV0aG9yPjxhdXRob3I+U2hvYmFjaywgRC48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5NY01hc3RlciBVbml2ZXJz

aXR5LCBIYW1pbHRvbiwgT250YXJpbywgQ2FuYWRhLiBhbGl5YUBtY21hc3Rlci5jYTwvYXV0aC1h

ZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1lZGljYWwgbWFuYWdlbWVudCBvZiBhc3ltcHRvbWF0aWMg

cHJpbWFyeSBoeXBlcnBhcmF0aHlyb2lkaXNtOiBwcm9jZWVkaW5ncyBvZiB0aGUgdGhpcmQgaW50

ZXJuYXRpb25hbCB3b3Jrc2hvcDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2Ny

aW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xp

bmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJv

bGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBD

bGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBj

bGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9k

aWNhbD48cGFnZXM+MzczLTgxPC9wYWdlcz48dm9sdW1lPjk0PC92b2x1bWU+PG51bWJlcj4yPC9u

dW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkJvbmUgRGVuc2l0eSBDb25zZXJ2YXRpb24gQWdlbnRz

L2Vjb25vbWljcy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+Qm9uZSBEaXNlYXNl

cy9ldGlvbG9neS9wcmV2ZW50aW9uICZhbXA7IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+Q2Fs

Y2l1bS9ibG9vZDwva2V5d29yZD48a2V5d29yZD5DaW5hY2FsY2V0PC9rZXl3b3JkPjxrZXl3b3Jk

PipDb25zZW5zdXM8L2tleXdvcmQ+PGtleXdvcmQ+Q29zdC1CZW5lZml0IEFuYWx5c2lzPC9rZXl3

b3JkPjxrZXl3b3JkPkRpcGhvc3Bob25hdGVzL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5

d29yZD5Ib3Jtb25lIFJlcGxhY2VtZW50IFRoZXJhcHkvZWNvbm9taWNzL21ldGhvZHM8L2tleXdv

cmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGFyYXRoeXJvaWRpc20s

IFByaW1hcnkvYmxvb2QvY29tcGxpY2F0aW9ucy8qZHJ1ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3

b3JkPk5hcGh0aGFsZW5lcy9lY29ub21pY3MvdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkIEhvcm1vbmUvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGF0aWVudCBT

ZWxlY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9r

ZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYjwvZGF0

ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMjEtOTcyWCAoUHJpbnQpJiN4RDswMDIxLTk3

MlggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE5MTkzOTEyPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzE5MTkzOTEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMjEwL2pjLjIwMDgtMTc2MjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LaGFuPC9BdXRob3I+PFllYXI+MjAwOTwvWWVhcj48UmVj

TnVtPjU0MDU8L1JlY051bT48RGlzcGxheVRleHQ+KEtoYW4gZXQgYWwuIDIwMDkpPC9EaXNwbGF5

VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MDU8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48

a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAi

PjU0MDU8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xl

Ij4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPktoYW4sIEEuPC9h

dXRob3I+PGF1dGhvcj5HcmV5LCBBLjwvYXV0aG9yPjxhdXRob3I+U2hvYmFjaywgRC48L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5NY01hc3RlciBVbml2ZXJz

aXR5LCBIYW1pbHRvbiwgT250YXJpbywgQ2FuYWRhLiBhbGl5YUBtY21hc3Rlci5jYTwvYXV0aC1h

ZGRyZXNzPjx0aXRsZXM+PHRpdGxlPk1lZGljYWwgbWFuYWdlbWVudCBvZiBhc3ltcHRvbWF0aWMg

cHJpbWFyeSBoeXBlcnBhcmF0aHlyb2lkaXNtOiBwcm9jZWVkaW5ncyBvZiB0aGUgdGhpcmQgaW50

ZXJuYXRpb25hbCB3b3Jrc2hvcDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2Ny

aW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xp

bmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxl

PjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJv

bGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBD

bGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBj

bGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9k

aWNhbD48cGFnZXM+MzczLTgxPC9wYWdlcz48dm9sdW1lPjk0PC92b2x1bWU+PG51bWJlcj4yPC9u

dW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkJvbmUgRGVuc2l0eSBDb25zZXJ2YXRpb24gQWdlbnRz

L2Vjb25vbWljcy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+Qm9uZSBEaXNlYXNl

cy9ldGlvbG9neS9wcmV2ZW50aW9uICZhbXA7IGNvbnRyb2w8L2tleXdvcmQ+PGtleXdvcmQ+Q2Fs

Y2l1bS9ibG9vZDwva2V5d29yZD48a2V5d29yZD5DaW5hY2FsY2V0PC9rZXl3b3JkPjxrZXl3b3Jk

PipDb25zZW5zdXM8L2tleXdvcmQ+PGtleXdvcmQ+Q29zdC1CZW5lZml0IEFuYWx5c2lzPC9rZXl3

b3JkPjxrZXl3b3JkPkRpcGhvc3Bob25hdGVzL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5

d29yZD5Ib3Jtb25lIFJlcGxhY2VtZW50IFRoZXJhcHkvZWNvbm9taWNzL21ldGhvZHM8L2tleXdv

cmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVycGFyYXRoeXJvaWRpc20s

IFByaW1hcnkvYmxvb2QvY29tcGxpY2F0aW9ucy8qZHJ1ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3

b3JkPk5hcGh0aGFsZW5lcy9lY29ub21pY3MvdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkIEhvcm1vbmUvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGF0aWVudCBT

ZWxlY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8L2tleXdvcmQ+PC9r

ZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYjwvZGF0

ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMjEtOTcyWCAoUHJpbnQpJiN4RDswMDIxLTk3

MlggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE5MTkzOTEyPC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVi

bWVkLzE5MTkzOTEyPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291

cmNlLW51bT4xMC4xMjEwL2pjLjIwMDgtMTc2MjwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (39).Management of Parathyroid carcinomaSurgical treatment:-Surgery is the primary mode of therapy. Complete surgical resection with microscopically negative margins is the recommended treatment and offers the best chance of cure. Successful resection is dependent on preoperative suspicion and intraoperative recognition. Upon intraoperative recognition of malignant features, the surgeon should elect to perform en bloc resection of any involved tissues without compromising the tumor capsule. This may or may not include the thyroid, as taking out the adjacent thyroid lobe in itself has been recommended but not shown to improve survival PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).Parathyroid cancer has a high recurrence rate in up to 49–60% of cases after the initial operation. In cases of recurrence, surgical resection is still the primary mode of therapy PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXNhaWR5PC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjU0MDk8L1JlY051bT48RGlzcGxheVRleHQ+KEJ1c2FpZHkgZXQgYWwuIDIwMDQpPC9E

aXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MDk8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjU0MDk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJ1c2Fp

ZHksIE4uIEwuPC9hdXRob3I+PGF1dGhvcj5KaW1lbmV6LCBDLjwvYXV0aG9yPjxhdXRob3I+SGFi

cmEsIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5TY2h1bHR6LCBQLiBOLjwvYXV0aG9yPjxhdXRob3I+

RWwtTmFnZ2FyLCBBLiBLLjwvYXV0aG9yPjxhdXRob3I+Q2xheW1hbiwgRy4gTC48L2F1dGhvcj48

YXV0aG9yPkFzcGVyLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+RGlheiwgRS4gTS4sIEpyLjwvYXV0

aG9yPjxhdXRob3I+RXZhbnMsIEQuIEIuPC9hdXRob3I+PGF1dGhvcj5HYWdlbCwgUi4gRi48L2F1

dGhvcj48YXV0aG9yPkdhcmRlbiwgQS48L2F1dGhvcj48YXV0aG9yPkhvZmYsIEEuIE8uPC9hdXRo

b3I+PGF1dGhvcj5MZWUsIEouIEUuPC9hdXRob3I+PGF1dGhvcj5Nb3JyaXNvbiwgVy4gSC48L2F1

dGhvcj48YXV0aG9yPlJvc2VudGhhbCwgRC4gSS48L2F1dGhvcj48YXV0aG9yPlNoZXJtYW4sIFMu

IEkuPC9hdXRob3I+PGF1dGhvcj5TdHVyZ2lzLCBFLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FndWVz

cGFjaywgUy4gRy48L2F1dGhvcj48YXV0aG9yPldlYmVyLCBSLiBTLjwvYXV0aG9yPjxhdXRob3I+

V2lyZmVsLCBLLjwvYXV0aG9yPjxhdXRob3I+VmFzc2lsb3BvdWxvdS1TZWxsaW4sIFIuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+am9pbnQgQmF5bG9yIENv

bGxlZ2Ugb2YgTWVkaWNpbmUvVGhlIFVuaXZlcnNpdHkgb2YgVGV4YXMgTS4gRC4gQW5kZXJzb24g

Q2FuY2VyIENlbnRlciBUcmFpbmluZyBQcm9ncmFtIGluIEVuZG9jcmlub2xvZ3ksIERpYWJldGVz

LCBhbmQgTWV0YWJvbGlzbSwgSG91c3RvbiwgVGV4YXMsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5QYXJhdGh5cm9pZCBjYXJjaW5vbWE6IGEgMjIteWVhciBleHBlcmllbmNlPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkhlYWQgTmVjazwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+SGVhZCAmYW1wOyBuZWNrPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SGVhZCBOZWNrPC9mdWxsLXRpdGxlPjxhYmJyLTE+SGVhZCAmYW1wOyBuZWNrPC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IZWFkIE5lY2s8L2Z1

bGwtdGl0bGU+PGFiYnItMT5IZWFkICZhbXA7IG5lY2s8L2FiYnItMT48L2FsdC1wZXJpb2RpY2Fs

PjxwYWdlcz43MTYtMjY8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPipDYXJjaW5vbWEvZGlhZ25v

c2lzL21vcnRhbGl0eS9wYXRob2xvZ3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5Db2hvcnQg

U3R1ZGllczwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5z

PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVyY2FsY2VtaWEvZHJ1ZyB0aGVyYXB5L2V0aW9sb2d5PC9r

ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3Bs

YXNtIE1ldGFzdGFzaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9j

YWwvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD4qUGFyYXRoeXJvaWQgTmVvcGxhc21zL2RpYWdu

b3Npcy9tb3J0YWxpdHkvcGF0aG9sb2d5L3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25v

c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvdGhlcmFweSwgQWRqdXZhbnQ8L2tleXdvcmQ+PGtl

eXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVz

PC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRt

ZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48

cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjEwNDMt

MzA3NCAoUHJpbnQpJiN4RDsxMDQzLTMwNzQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjE1Mjg3MDM5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE1Mjg3MDM5PC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDAyL2hlZC4yMDA0OTwvZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CdXNhaWR5PC9BdXRob3I+PFllYXI+MjAwNDwvWWVhcj48

UmVjTnVtPjU0MDk8L1JlY051bT48RGlzcGxheVRleHQ+KEJ1c2FpZHkgZXQgYWwuIDIwMDQpPC9E

aXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MDk8L3JlYy1udW1iZXI+PGZvcmVpZ24t

a2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4

dzlhdnAiPjU0MDk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkJ1c2Fp

ZHksIE4uIEwuPC9hdXRob3I+PGF1dGhvcj5KaW1lbmV6LCBDLjwvYXV0aG9yPjxhdXRob3I+SGFi

cmEsIE0uIEEuPC9hdXRob3I+PGF1dGhvcj5TY2h1bHR6LCBQLiBOLjwvYXV0aG9yPjxhdXRob3I+

RWwtTmFnZ2FyLCBBLiBLLjwvYXV0aG9yPjxhdXRob3I+Q2xheW1hbiwgRy4gTC48L2F1dGhvcj48

YXV0aG9yPkFzcGVyLCBKLiBBLjwvYXV0aG9yPjxhdXRob3I+RGlheiwgRS4gTS4sIEpyLjwvYXV0

aG9yPjxhdXRob3I+RXZhbnMsIEQuIEIuPC9hdXRob3I+PGF1dGhvcj5HYWdlbCwgUi4gRi48L2F1

dGhvcj48YXV0aG9yPkdhcmRlbiwgQS48L2F1dGhvcj48YXV0aG9yPkhvZmYsIEEuIE8uPC9hdXRo

b3I+PGF1dGhvcj5MZWUsIEouIEUuPC9hdXRob3I+PGF1dGhvcj5Nb3JyaXNvbiwgVy4gSC48L2F1

dGhvcj48YXV0aG9yPlJvc2VudGhhbCwgRC4gSS48L2F1dGhvcj48YXV0aG9yPlNoZXJtYW4sIFMu

IEkuPC9hdXRob3I+PGF1dGhvcj5TdHVyZ2lzLCBFLiBNLjwvYXV0aG9yPjxhdXRob3I+V2FndWVz

cGFjaywgUy4gRy48L2F1dGhvcj48YXV0aG9yPldlYmVyLCBSLiBTLjwvYXV0aG9yPjxhdXRob3I+

V2lyZmVsLCBLLjwvYXV0aG9yPjxhdXRob3I+VmFzc2lsb3BvdWxvdS1TZWxsaW4sIFIuPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+am9pbnQgQmF5bG9yIENv

bGxlZ2Ugb2YgTWVkaWNpbmUvVGhlIFVuaXZlcnNpdHkgb2YgVGV4YXMgTS4gRC4gQW5kZXJzb24g

Q2FuY2VyIENlbnRlciBUcmFpbmluZyBQcm9ncmFtIGluIEVuZG9jcmlub2xvZ3ksIERpYWJldGVz

LCBhbmQgTWV0YWJvbGlzbSwgSG91c3RvbiwgVGV4YXMsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5QYXJhdGh5cm9pZCBjYXJjaW5vbWE6IGEgMjIteWVhciBleHBlcmllbmNlPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkhlYWQgTmVjazwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0

bGU+SGVhZCAmYW1wOyBuZWNrPC9hbHQtdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SGVhZCBOZWNrPC9mdWxsLXRpdGxlPjxhYmJyLTE+SGVhZCAmYW1wOyBuZWNrPC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5IZWFkIE5lY2s8L2Z1

bGwtdGl0bGU+PGFiYnItMT5IZWFkICZhbXA7IG5lY2s8L2FiYnItMT48L2FsdC1wZXJpb2RpY2Fs

PjxwYWdlcz43MTYtMjY8L3BhZ2VzPjx2b2x1bWU+MjY8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVsdDwv

a2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPipDYXJjaW5vbWEvZGlhZ25v

c2lzL21vcnRhbGl0eS9wYXRob2xvZ3kvdGhlcmFweTwva2V5d29yZD48a2V5d29yZD5Db2hvcnQg

U3R1ZGllczwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5z

PC9rZXl3b3JkPjxrZXl3b3JkPkh5cGVyY2FsY2VtaWEvZHJ1ZyB0aGVyYXB5L2V0aW9sb2d5PC9r

ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+TmVvcGxhc20gSW52YXNpdmVuZXNzPC9rZXl3b3JkPjxrZXl3b3JkPk5lb3Bs

YXNtIE1ldGFzdGFzaXM8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxhc20gUmVjdXJyZW5jZSwgTG9j

YWwvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD4qUGFyYXRoeXJvaWQgTmVvcGxhc21zL2RpYWdu

b3Npcy9tb3J0YWxpdHkvcGF0aG9sb2d5L3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25v

c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJhZGlvdGhlcmFweSwgQWRqdXZhbnQ8L2tleXdvcmQ+PGtl

eXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVz

PC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRt

ZW50IE91dGNvbWU8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNDwveWVhcj48

cHViLWRhdGVzPjxkYXRlPkF1ZzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjEwNDMt

MzA3NCAoUHJpbnQpJiN4RDsxMDQzLTMwNzQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVt

PjE1Mjg3MDM5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8v

d3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE1Mjg3MDM5PC91cmw+PC9yZWxhdGVkLXVybHM+

PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDAyL2hlZC4yMDA0OTwvZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (40).However, reoperation is rarely curative and eventual relapse is likely. Typically, these patients require repeated operations that predispose them to up to 60% life-time accumulated surgical risks from all subsequent surgical interventions PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).Initial neck explorationStandard procedure:En bloc resection is defined as careful removal of the parathyroid lesion while preserving its capsule and resecting all tissues immediately involved with the parathyroid cancer, which can include the ipsilateral thyroid lobe, the trachea, and/or the esophageal wall. Any suspicious or enlarged ipsilateral regional lymph nodes should also be removed, especially those draining the central neck compartment. When the recurrent laryngeal nerve is involved, most surgeons recommend resection to ensure adequate tumor resection, especially if the nerve is not functioning preoperatively. En bloc resection offers the best chance at complete removal of cancerous tissue while reducing risks of tumor spillage ADDIN EN.CITE <EndNote><Cite><Author>Rodgers</Author><Year>2006</Year><RecNum>5411</RecNum><DisplayText>(Rodgers et al. 2006)</DisplayText><record><rec-number>5411</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5411</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rodgers, S. E.</author><author>Perrier, N. D.</author></authors></contributors><auth-address>Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.</auth-address><titles><title>Parathyroid carcinoma</title><secondary-title>Curr Opin Oncol</secondary-title><alt-title>Current opinion in oncology</alt-title></titles><periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></periodical><alt-periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></alt-periodical><pages>16-22</pages><volume>18</volume><number>1</number><keywords><keyword>Chemotherapy, Adjuvant</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/drug therapy/etiology</keyword><keyword>Hyperparathyroidism, Primary/etiology</keyword><keyword>*Parathyroid Neoplasms/complications/genetics/pathology/therapy</keyword><keyword>Radiotherapy, Adjuvant</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1040-8746 (Print)&#xD;1040-8746 (Linking)</isbn><accession-num>16357559</accession-num><urls><related-urls><url>;(41).Contraindications:In untreated hypercalcemic crisis, surgery should be delayed until the metabolic derangement is medically treated. Patients with florid metastatic disease are less likely to derive a large benefit from local surgical resection unless the amount of tumor cytoreduction is enough to decrease the hypercalcemic effects of hyperparathyroidism ADDIN EN.CITE <EndNote><Cite><Author>Rodgers</Author><Year>2006</Year><RecNum>5411</RecNum><DisplayText>(Rodgers et al. 2006)</DisplayText><record><rec-number>5411</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5411</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rodgers, S. E.</author><author>Perrier, N. D.</author></authors></contributors><auth-address>Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.</auth-address><titles><title>Parathyroid carcinoma</title><secondary-title>Curr Opin Oncol</secondary-title><alt-title>Current opinion in oncology</alt-title></titles><periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></periodical><alt-periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></alt-periodical><pages>16-22</pages><volume>18</volume><number>1</number><keywords><keyword>Chemotherapy, Adjuvant</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/drug therapy/etiology</keyword><keyword>Hyperparathyroidism, Primary/etiology</keyword><keyword>*Parathyroid Neoplasms/complications/genetics/pathology/therapy</keyword><keyword>Radiotherapy, Adjuvant</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1040-8746 (Print)&#xD;1040-8746 (Linking)</isbn><accession-num>16357559</accession-num><urls><related-urls><url>;(41).Complications:Poor outcomes are related to incomplete resection, tumor seeding, and cancer persistence or recurrence. Surgical complications include recurrent laryngeal nerve injury, esophageal injury, tracheal injury, neck hematoma, and wound infection. Metabolic complications that can occur after resection include hypocalcemia and hypophosphatemia. Perioperative mortality was estimated to be 1.8% in one series PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).ReoperationStandard procedure:For localized regional recurrent tumors, we recommend cervical and/or mediastinal exploration with wide resection. Finding a recurrent tumor in a reoperative neck is challenging due to the presence of scar tissue and distorted anatomical planes. Locoregional injection of methylene blue dye may enhance resectability by silhouetting the tumor against the background of difficult neck anatomy. If technically feasible, metastatectomy is recommended for localized distant metastasis, which has been shown to help control hypercalcemiaPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).Contraindications:The same contraindications exist as noted above for initial neck exploration. Complications:The types of complications in neck reoperation are the same as aslistes above for initial neck exploration. However, complication rates are 3–5 times higher than for the initial operation PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).Many patients will have multiple reoperations, thus greatly increasing their cumulative surgical complication risks up to 60% and recurrent laryngeal nerve injury rate up to 38% over the course of a patient’s cancer lifespan. There are also organ-specific complications from metastatectomy such as lung resections, bone resection, etc. Metabolic complications also include hypocalcemia and hypophosphatemia PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19).Medical treatment of parathyrotoxicosisParathyrotoxicosis (also referred to as hypercalcemic crisis, parathyroid storm, acute hyperparathyroidism, or parathyroid poisoning) is a medical emergency. It is more commonly due to a functioning parathyroid carcinoma than benign parathyroid lesions. Patients in this acute state can exhibit altered mental status and profound weakness, accompanied by hypercalcemia (916 mg/dL) and azotemia. Although surgical resection is the definitive therapy for treating parathyrotoxicosis, patients should be medically stabilized before surgical intervention takes place.Standard procedure:Aggressive fluid resuscitation with intravenous isotonic sodium chloride fluid infusion is the first line therapy in order to restore intravascular volume and to promote renal diuresis. After restoration of intravascular space as evidenced by adequate urine output, furosemide is given to promote calcium diuresis. All calcium intake and medications such as thiazide diuretics, which can promote renal calcium reabsorption, should be discontinued. Hemodialysis may be required in patients with renal insufficiency or renal failure ADDIN EN.CITE <EndNote><Cite><Author>Ariyan</Author><Year>2004</Year><RecNum>5413</RecNum><DisplayText>(Ariyan et al. 2004)</DisplayText><record><rec-number>5413</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5413</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ariyan, C. E.</author><author>Sosa, J. A.</author></authors></contributors><auth-address>Yale University School of Medicine, Department of Surgery, New Haven, CT, USA.</auth-address><titles><title>Assessment and management of patients with abnormal calcium</title><secondary-title>Crit Care Med</secondary-title><alt-title>Critical care medicine</alt-title></titles><periodical><full-title>Crit Care Med</full-title><abbr-1>Critical care medicine</abbr-1></periodical><alt-periodical><full-title>Crit Care Med</full-title><abbr-1>Critical care medicine</abbr-1></alt-periodical><pages>S146-54</pages><volume>32</volume><number>4 Suppl</number><keywords><keyword>Algorithms</keyword><keyword>Critical Care/*methods</keyword><keyword>Electrocardiography</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/diagnosis/etiology/*therapy</keyword><keyword>Hyperparathyroidism/complications/surgery</keyword><keyword>Hypocalcemia/diagnosis/etiology/*therapy</keyword><keyword>Perioperative Care/*methods</keyword></keywords><dates><year>2004</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0090-3493 (Print)&#xD;0090-3493 (Linking)</isbn><accession-num>15064673</accession-num><urls><related-urls><url>;(42).Calcimimetic agents (such as cinacalcet), and agents that block bone resorption (such as calcitonin and bisphosphonates) can be used adjunctively to help stabilize calcium level. Goal reduction of serum calcium is by 1.5–4 mg/dL in 24 to 48 h ADDIN EN.CITE <EndNote><Cite><Author>Ariyan</Author><Year>2004</Year><RecNum>5413</RecNum><DisplayText>(Ariyan et al. 2004)</DisplayText><record><rec-number>5413</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5413</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ariyan, C. E.</author><author>Sosa, J. A.</author></authors></contributors><auth-address>Yale University School of Medicine, Department of Surgery, New Haven, CT, USA.</auth-address><titles><title>Assessment and management of patients with abnormal calcium</title><secondary-title>Crit Care Med</secondary-title><alt-title>Critical care medicine</alt-title></titles><periodical><full-title>Crit Care Med</full-title><abbr-1>Critical care medicine</abbr-1></periodical><alt-periodical><full-title>Crit Care Med</full-title><abbr-1>Critical care medicine</abbr-1></alt-periodical><pages>S146-54</pages><volume>32</volume><number>4 Suppl</number><keywords><keyword>Algorithms</keyword><keyword>Critical Care/*methods</keyword><keyword>Electrocardiography</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/diagnosis/etiology/*therapy</keyword><keyword>Hyperparathyroidism/complications/surgery</keyword><keyword>Hypocalcemia/diagnosis/etiology/*therapy</keyword><keyword>Perioperative Care/*methods</keyword></keywords><dates><year>2004</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0090-3493 (Print)&#xD;0090-3493 (Linking)</isbn><accession-num>15064673</accession-num><urls><related-urls><url>;(42).Chemotherapy:-No standard chemotherapy regimen is available. Chemotherapy is generally ineffective in the treatment of parathyroid carcinoma. No randomized trials are available to stringently evaluate the efficacy of individual chemotherapeutic agents in parathyroid carcinoma as most efficacy data is derived from case reports ADDIN EN.CITE <EndNote><Cite><Author>Gao</Author><Year>2010</Year><RecNum>5414</RecNum><DisplayText>(Gao et al. 2010)</DisplayText><record><rec-number>5414</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5414</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, W. C.</author><author>Ruan, C. P.</author><author>Zhang, J. C.</author><author>Liu, H. M.</author><author>Xu, X. Y.</author><author>Sun, Y. P.</author><author>Wang, Q.</author></authors></contributors><auth-address>Department of General Surgery, Shanghai Chang Zheng Hospital, Second Military Medical University, 415 Feng Yang Road, 200003 Shanghai, People&apos;s Republic of China.</auth-address><titles><title>Nonfunctional parathyroid carcinoma</title><secondary-title>J Cancer Res Clin Oncol</secondary-title><alt-title>Journal of cancer research and clinical oncology</alt-title></titles><periodical><full-title>J Cancer Res Clin Oncol</full-title><abbr-1>Journal of cancer research and clinical oncology</abbr-1></periodical><alt-periodical><full-title>J Cancer Res Clin Oncol</full-title><abbr-1>Journal of cancer research and clinical oncology</abbr-1></alt-periodical><pages>969-74</pages><volume>136</volume><number>7</number><keywords><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Neoplasms/*diagnosis/*surgery</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1432-1335 (Electronic)&#xD;0171-5216 (Linking)</isbn><accession-num>19967413</accession-num><urls><related-urls><url>;(43).Radiation therapy:-Parathyroid cancer is usually radio resistant; thus, no established radiotherapy protocol exists. However, anecdotal reports from contemporary single institution case series have described a reduction in cancer recurrence in patients who received radiation therapy, dosed between 40 and 70 Gy after initial surgical resection. The small number of cases precludes statistical analysis for generalizable effectiveness. Incorporation of adjuvant radiotherapy for the management of parathyroid carcinoma should be determined on an individual basis ( ADDIN EN.CITE <EndNote><Cite><Author>Chow</Author><Year>1998</Year><RecNum>5415</RecNum><DisplayText>(Chow et al. 1998)</DisplayText><record><rec-number>5415</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5415</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chow, E.</author><author>Tsang, R. W.</author><author>Brierley, J. D.</author><author>Filice, S.</author></authors></contributors><auth-address>Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.</auth-address><titles><title>Parathyroid carcinoma--the Princess Margaret Hospital experience</title><secondary-title>Int J Radiat Oncol Biol Phys</secondary-title><alt-title>International journal of radiation oncology, biology, physics</alt-title></titles><periodical><full-title>Int J Radiat Oncol Biol Phys</full-title><abbr-1>International journal of radiation oncology, biology, physics</abbr-1></periodical><alt-periodical><full-title>Int J Radiat Oncol Biol Phys</full-title><abbr-1>International journal of radiation oncology, biology, physics</abbr-1></alt-periodical><pages>569-72</pages><volume>41</volume><number>3</number><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Combined Modality Therapy</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm, Residual</keyword><keyword>Parathyroid Neoplasms/pathology/*radiotherapy/*surgery</keyword><keyword>Radiotherapy, Adjuvant</keyword><keyword>Retrospective Studies</keyword><keyword>Treatment Failure</keyword></keywords><dates><year>1998</year><pub-dates><date>Jun 1</date></pub-dates></dates><isbn>0360-3016 (Print)&#xD;0360-3016 (Linking)</isbn><accession-num>9635703</accession-num><urls><related-urls><url>).Palliative /Emerging therapy:-Palliative therapy:The primary treatment goal for inoperable metastatic parathyroid carcinoma is controlling PTH-driven hypercalcemia as it is the main cause of morbidity and mortality. Several classes of calcium lowering drugs have been used with transient results lasting for only a few days. These include mitramycin, plicamycin, gallium nitrate, intravenous bisphosphonates, and calcitonin in combination with glucocorticoid ADDIN EN.CITE <EndNote><Cite><Author>Rodgers</Author><Year>2006</Year><RecNum>5411</RecNum><DisplayText>(Rodgers et al. 2006)</DisplayText><record><rec-number>5411</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5411</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rodgers, S. E.</author><author>Perrier, N. D.</author></authors></contributors><auth-address>Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.</auth-address><titles><title>Parathyroid carcinoma</title><secondary-title>Curr Opin Oncol</secondary-title><alt-title>Current opinion in oncology</alt-title></titles><periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></periodical><alt-periodical><full-title>Curr Opin Oncol</full-title><abbr-1>Current opinion in oncology</abbr-1></alt-periodical><pages>16-22</pages><volume>18</volume><number>1</number><keywords><keyword>Chemotherapy, Adjuvant</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/drug therapy/etiology</keyword><keyword>Hyperparathyroidism, Primary/etiology</keyword><keyword>*Parathyroid Neoplasms/complications/genetics/pathology/therapy</keyword><keyword>Radiotherapy, Adjuvant</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1040-8746 (Print)&#xD;1040-8746 (Linking)</isbn><accession-num>16357559</accession-num><urls><related-urls><url>;(41).In one case report, gallium nitrate was effective in lowering serum calcium and PTH levels in parathyroid cancer patients who were refractory to mitramycin. However, with the advent of new drugs such as the calcimimetics, which are more effective at lowering serum calcium and PTH with lesser side effects, the aforementioned agents are gradually falling out of favor PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWx2ZXJiZXJnPC9BdXRob3I+PFllYXI+MjAwNzwvWWVh

cj48UmVjTnVtPjU0MTY8L1JlY051bT48RGlzcGxheVRleHQ+KFNpbHZlcmJlcmcgZXQgYWwuIDIw

MDcpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MTY8L3JlYy1udW1iZXI+PGZv

cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpy

ZnB0dHJ4dzlhdnAiPjU0MTY8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

PlNpbHZlcmJlcmcsIFMuIEouPC9hdXRob3I+PGF1dGhvcj5SdWJpbiwgTS4gUi48L2F1dGhvcj48

YXV0aG9yPkZhaW1hbiwgQy48L2F1dGhvcj48YXV0aG9yPlBlYWNvY2ssIE0uPC9hdXRob3I+PGF1

dGhvcj5TaG9iYWNrLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+U21hbGxyaWRnZSwgUi4gQy48L2F1

dGhvcj48YXV0aG9yPlNjaHdhbmF1ZXIsIEwuIEUuPC9hdXRob3I+PGF1dGhvcj5PbHNvbiwgSy4g

QS48L2F1dGhvcj48YXV0aG9yPktsYXNzZW4sIFAuPC9hdXRob3I+PGF1dGhvcj5CaWxlemlraWFu

LCBKLiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNv

bGxlZ2Ugb2YgUGh5c2ljaWFucyBhbmQgU3VyZ2VvbnMsIENvbHVtYmlhIFVuaXZlcnNpdHksIDYz

MCBXZXN0IDE2OHRoIFN0cmVldCwgTmV3IFlvcmssIE5ldyBZb3JrIDEwMDMyLCBVU0EuIHNqczVA

Y29sdW1iaWEuZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2luYWNhbGNldCBoeWRy

b2NobG9yaWRlIHJlZHVjZXMgdGhlIHNlcnVtIGNhbGNpdW0gY29uY2VudHJhdGlvbiBpbiBpbm9w

ZXJhYmxlIHBhcmF0aHlyb2lkIGNhcmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENs

aW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJu

YWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9m

dWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBh

bmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91

cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MzgwMy04PC9wYWdlcz48dm9sdW1lPjkyPC92b2x1bWU+PG51

bWJlcj4xMDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0vKmJsb29kPC9rZXl3b3JkPjxrZXl3b3Jk

PkNpbmFjYWxjZXQ8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcmNhbGNlbWlhL2Jsb29kLypkcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbSwgUHJpbWFyeS9ibG9vZC8qZHJ1

ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmFwaHRoYWxlbmVzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEhv

cm1vbmUvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zL2Jsb29k

LypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UXVhbGl0eSBvZiBMaWZlPC9rZXl3b3Jk

PjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5

ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4xNzY2NjQ3MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNzY2NjQ3MjwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIxMC9q

Yy4yMDA3LTA1ODU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0Vu

ZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWx2ZXJiZXJnPC9BdXRob3I+PFllYXI+MjAwNzwvWWVh

cj48UmVjTnVtPjU0MTY8L1JlY051bT48RGlzcGxheVRleHQ+KFNpbHZlcmJlcmcgZXQgYWwuIDIw

MDcpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MTY8L3JlYy1udW1iZXI+PGZv

cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpy

ZnB0dHJ4dzlhdnAiPjU0MTY8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

PlNpbHZlcmJlcmcsIFMuIEouPC9hdXRob3I+PGF1dGhvcj5SdWJpbiwgTS4gUi48L2F1dGhvcj48

YXV0aG9yPkZhaW1hbiwgQy48L2F1dGhvcj48YXV0aG9yPlBlYWNvY2ssIE0uPC9hdXRob3I+PGF1

dGhvcj5TaG9iYWNrLCBELiBNLjwvYXV0aG9yPjxhdXRob3I+U21hbGxyaWRnZSwgUi4gQy48L2F1

dGhvcj48YXV0aG9yPlNjaHdhbmF1ZXIsIEwuIEUuPC9hdXRob3I+PGF1dGhvcj5PbHNvbiwgSy4g

QS48L2F1dGhvcj48YXV0aG9yPktsYXNzZW4sIFAuPC9hdXRob3I+PGF1dGhvcj5CaWxlemlraWFu

LCBKLiBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNv

bGxlZ2Ugb2YgUGh5c2ljaWFucyBhbmQgU3VyZ2VvbnMsIENvbHVtYmlhIFVuaXZlcnNpdHksIDYz

MCBXZXN0IDE2OHRoIFN0cmVldCwgTmV3IFlvcmssIE5ldyBZb3JrIDEwMDMyLCBVU0EuIHNqczVA

Y29sdW1iaWEuZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2luYWNhbGNldCBoeWRy

b2NobG9yaWRlIHJlZHVjZXMgdGhlIHNlcnVtIGNhbGNpdW0gY29uY2VudHJhdGlvbiBpbiBpbm9w

ZXJhYmxlIHBhcmF0aHlyb2lkIGNhcmNpbm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENs

aW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJu

YWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwv

dGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9m

dWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBh

bmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91

cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9h

bHQtcGVyaW9kaWNhbD48cGFnZXM+MzgwMy04PC9wYWdlcz48dm9sdW1lPjkyPC92b2x1bWU+PG51

bWJlcj4xMDwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y

ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkNhbGNpdW0vKmJsb29kPC9rZXl3b3JkPjxrZXl3b3Jk

PkNpbmFjYWxjZXQ8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcmNhbGNlbWlhL2Jsb29kLypkcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbSwgUHJpbWFyeS9ibG9vZC8qZHJ1

ZyB0aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmFwaHRoYWxlbmVzLyphZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIEhv

cm1vbmUvYmxvb2Q8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgTmVvcGxhc21zL2Jsb29k

LypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UXVhbGl0eSBvZiBMaWZlPC9rZXl3b3Jk

PjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5

ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3Q8L2RhdGU+PC9wdWItZGF0ZXM+PC9k

YXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNi

bj48YWNjZXNzaW9uLW51bT4xNzY2NjQ3MjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11

cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xNzY2NjQ3MjwvdXJs

PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIxMC9q

Yy4yMDA3LTA1ODU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0Vu

ZE5vdGU+

ADDIN EN.CITE.DATA (45).Emerging therapy:Experimental immunotherapy has been successfully attempted in two inoperable metastatic parathyroid carcinoma cases. This therapeutic approach requires the induction of adaptive immunity with PTH protein fragments. In one case report, a detectable anti-PTH antibody titer, a sustained reduction in PTH and serum calcium, and a marked improvement in hypercalcemia symptoms were achieved after the second, third, and fourth immunizations, respectively. Due to the anecdotal nature of this case report, additional confirmatory work in a larger patient cohort is required to substantiate its efficacy and applicability PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CZXRlYTwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT41NDE3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihCZXRlYSBldCBhbC4gMjAwNCk8L0Rpc3Bs

YXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQxNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2

cCI+NTQxNzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmV0ZWEsIEQu

PC9hdXRob3I+PGF1dGhvcj5CcmFkd2VsbCwgQS4gUi48L2F1dGhvcj48YXV0aG9yPkhhcnZleSwg

VC4gQy48L2F1dGhvcj48YXV0aG9yPk1lYWQsIEcuIFAuPC9hdXRob3I+PGF1dGhvcj5TY2htaWR0

LUdheWssIEguPC9hdXRob3I+PGF1dGhvcj5HaGF5ZSwgQi48L2F1dGhvcj48YXV0aG9yPkRhbHks

IEEuIEYuPC9hdXRob3I+PGF1dGhvcj5CZWNrZXJzLCBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2Nv

bnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNlcnZpY2UgZCZhcG9zO0VuZG9jcmlub2xvZ2llLCBD

ZW50cmUgSG9zcGl0YWxpZXIgVW5pdmVyc2l0YWlyZSBkZSBMaWVnZSwgRG9tYWluZSBVbml2ZXJz

aXRhaXJlIGR1IFNhcnQtVGlsbWFuLCA0MDAwIExpZWdlLCBCZWxnaXVtLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPkhvcm1vbmFsIGFuZCBiaW9jaGVtaWNhbCBub3JtYWxpemF0aW9uIGFu

ZCB0dW1vciBzaHJpbmthZ2UgaW5kdWNlZCBieSBhbnRpLXBhcmF0aHlyb2lkIGhvcm1vbmUgaW1t

dW5vdGhlcmFweSBpbiBhIHBhdGllbnQgd2l0aCBtZXRhc3RhdGljIHBhcmF0aHlyb2lkIGNhcmNp

bm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5v

bG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpv

dXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwv

cGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wg

TWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jp

bm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzQx

My0yMDwvcGFnZXM+PHZvbHVtZT44OTwvdm9sdW1lPjxudW1iZXI+NzwvbnVtYmVyPjxrZXl3b3Jk

cz48a2V5d29yZD5BbmltYWxzPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2R5IEZvcm1hdGlvbjwv

a2V5d29yZD48a2V5d29yZD5DYWxjaXVtL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9t

YS9ibG9vZC9kaWFnbm9zdGljIGltYWdpbmcvKnNlY29uZGFyeS8qdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5DYXR0bGU8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD4qSW1tdW5vdGhlcmFweS9hZHZlcnNlIGVmZmVjdHM8

L2tleXdvcmQ+PGtleXdvcmQ+THVuZyBOZW9wbGFzbXMvYmxvb2QvZGlhZ25vc3RpYyBpbWFnaW5n

LypzZWNvbmRhcnkvKnRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS9ibG9vZC8qaW1tdW5vbG9neTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5

d29yZD5QZXB0aWRlIEZyYWdtZW50cy9pbW11bm9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRvbW9n

cmFwaHksIFgtUmF5IENvbXB1dGVkPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21l

PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50

KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNTI0MDYyNDwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L3B1Ym1lZC8xNTI0MDYyNDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIxMC9qYy4yMDAzLTAzMTkxMTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CZXRlYTwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT41NDE3PC9SZWNOdW0+PERpc3BsYXlUZXh0PihCZXRlYSBldCBhbC4gMjAwNCk8L0Rpc3Bs

YXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTQxNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlz

PjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpkOXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2

cCI+NTQxNzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmV0ZWEsIEQu

PC9hdXRob3I+PGF1dGhvcj5CcmFkd2VsbCwgQS4gUi48L2F1dGhvcj48YXV0aG9yPkhhcnZleSwg

VC4gQy48L2F1dGhvcj48YXV0aG9yPk1lYWQsIEcuIFAuPC9hdXRob3I+PGF1dGhvcj5TY2htaWR0

LUdheWssIEguPC9hdXRob3I+PGF1dGhvcj5HaGF5ZSwgQi48L2F1dGhvcj48YXV0aG9yPkRhbHks

IEEuIEYuPC9hdXRob3I+PGF1dGhvcj5CZWNrZXJzLCBBLjwvYXV0aG9yPjwvYXV0aG9ycz48L2Nv

bnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNlcnZpY2UgZCZhcG9zO0VuZG9jcmlub2xvZ2llLCBD

ZW50cmUgSG9zcGl0YWxpZXIgVW5pdmVyc2l0YWlyZSBkZSBMaWVnZSwgRG9tYWluZSBVbml2ZXJz

aXRhaXJlIGR1IFNhcnQtVGlsbWFuLCA0MDAwIExpZWdlLCBCZWxnaXVtLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPkhvcm1vbmFsIGFuZCBiaW9jaGVtaWNhbCBub3JtYWxpemF0aW9uIGFu

ZCB0dW1vciBzaHJpbmthZ2UgaW5kdWNlZCBieSBhbnRpLXBhcmF0aHlyb2lkIGhvcm1vbmUgaW1t

dW5vdGhlcmFweSBpbiBhIHBhdGllbnQgd2l0aCBtZXRhc3RhdGljIHBhcmF0aHlyb2lkIGNhcmNp

bm9tYTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vj

b25kYXJ5LXRpdGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5v

bG9neSBhbmQgbWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs

LXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpv

dXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwv

cGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wg

TWV0YWI8L2Z1bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jp

bm9sb2d5IGFuZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzQx

My0yMDwvcGFnZXM+PHZvbHVtZT44OTwvdm9sdW1lPjxudW1iZXI+NzwvbnVtYmVyPjxrZXl3b3Jk

cz48a2V5d29yZD5BbmltYWxzPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2R5IEZvcm1hdGlvbjwv

a2V5d29yZD48a2V5d29yZD5DYWxjaXVtL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9t

YS9ibG9vZC9kaWFnbm9zdGljIGltYWdpbmcvKnNlY29uZGFyeS8qdGhlcmFweTwva2V5d29yZD48

a2V5d29yZD5DYXR0bGU8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD4qSW1tdW5vdGhlcmFweS9hZHZlcnNlIGVmZmVjdHM8

L2tleXdvcmQ+PGtleXdvcmQ+THVuZyBOZW9wbGFzbXMvYmxvb2QvZGlhZ25vc3RpYyBpbWFnaW5n

LypzZWNvbmRhcnkvKnRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdv

cmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS9ibG9vZC8qaW1tdW5vbG9neTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKnBhdGhvbG9neTwva2V5d29yZD48a2V5

d29yZD5QZXB0aWRlIEZyYWdtZW50cy9pbW11bm9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlRvbW9n

cmFwaHksIFgtUmF5IENvbXB1dGVkPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21l

PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5KdWw8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50

KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNTI0MDYyNDwv

YWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5s

bS5uaWguZ292L3B1Ym1lZC8xNTI0MDYyNDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIxMC9qYy4yMDAzLTAzMTkxMTwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (46).Ablative therapy is another adjunct for palliation of inoperable metastatic parathyroid cancer. Ethanol ablation by ultrasound guided percutaneous injection of 98% ethanol into parathyroid tumor tissue can directly reduce PTH level and ameliorate intractable hypercalcemia. This therapy appears to have minimal side effects and can be employed serially to achieve desirable therapeutic results. However, ablation should be reserved for palliative cases only because of the potential for tumor seeding from needle tracks and complications associated with ethanol toxicity from large volume injection as well as local nerve and tissue injuries PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb250ZW5lZ3JvPC9BdXRob3I+PFllYXI+MjAwODwvWWVh

cj48UmVjTnVtPjU0MTg8L1JlY051bT48RGlzcGxheVRleHQ+KE1vbnRlbmVncm8gZXQgYWwuIDIw

MDgpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MTg8L3JlYy1udW1iZXI+PGZv

cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpy

ZnB0dHJ4dzlhdnAiPjU0MTg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

Pk1vbnRlbmVncm8sIEYuIEwuPC9hdXRob3I+PGF1dGhvcj5DaGFtbWFzLCBNLiBDLjwvYXV0aG9y

PjxhdXRob3I+SnVsaWFubywgQS4gRy48L2F1dGhvcj48YXV0aG9yPkNlcm5lYSwgQy4gUi48L2F1

dGhvcj48YXV0aG9yPkNvcmRlaXJvLCBBLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydGFtZW50byBkZSBDaXJ1cmdpYSwgSG9zcGl0YWwgZGFz

IENsaW5pY2FzLCBGYWN1bGRhZGUgZGUgTWVkaWNpbmEsIFVuaXZlcnNpZGFkZSBkZSBTYW8gUGF1

bG8sIFNhbyBQYXVsbywgU1AsIEJyYXNpbC4gZmFiaW9tb250ZUB1b2wuY29tLmJyPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RXRoYW5vbCBpbmplY3Rpb24gdW5kZXIgdWx0cmFzb3VuZCBn

dWlkYW5jZSB0byBwYWxsaWF0ZSB1bnJlc2VjdGFibGUgcGFyYXRoeXJvaWQgY2FyY2lub21hPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFycSBCcmFzIEVuZG9jcmlub2wgTWV0YWJvbDwvc2Vjb25k

YXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXJxdWl2b3MgYnJhc2lsZWlyb3MgZGUgZW5kb2NyaW5vbG9n

aWEgZSBtZXRhYm9sb2dpYTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkFycSBCcmFzIEVuZG9jcmlub2wgTWV0YWJvbDwvZnVsbC10aXRsZT48YWJici0xPkFycXVp

dm9zIGJyYXNpbGVpcm9zIGRlIGVuZG9jcmlub2xvZ2lhIGUgbWV0YWJvbG9naWE8L2FiYnItMT48

L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFycSBCcmFzIEVuZG9jcmlu

b2wgTWV0YWJvbDwvZnVsbC10aXRsZT48YWJici0xPkFycXVpdm9zIGJyYXNpbGVpcm9zIGRlIGVu

ZG9jcmlub2xvZ2lhIGUgbWV0YWJvbG9naWE8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdl

cz43MDctMTE8L3BhZ2VzPjx2b2x1bWU+NTI8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5

d29yZHM+PGtleXdvcmQ+RXRoYW5vbC8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkZhdGFsIE91dGNvbWU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5cGVyY2FsY2VtaWEvKmRydWcgdGhlcmFweS9ldGlvbG9neTwva2V5d29y

ZD48a2V5d29yZD5JbmplY3Rpb25zLCBJbnRyYWxlc2lvbmFsPC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWw8L2tleXdvcmQ+PGtleXdvcmQ+UGFsbGlhdGl2ZSBDYXJlLypt

ZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRp

b25zLypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5LCBJbnRl

cnZlbnRpb25hbDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA4PC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTY3Ny05

NDg3IChFbGVjdHJvbmljKSYjeEQ7MDAwNC0yNzMwIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9u

LW51bT4xODYwNDM4NjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0

cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODYwNDM4NjwvdXJsPjwvcmVsYXRlZC11

cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb250ZW5lZ3JvPC9BdXRob3I+PFllYXI+MjAwODwvWWVh

cj48UmVjTnVtPjU0MTg8L1JlY051bT48RGlzcGxheVRleHQ+KE1vbnRlbmVncm8gZXQgYWwuIDIw

MDgpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjU0MTg8L3JlYy1udW1iZXI+PGZv

cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpy

ZnB0dHJ4dzlhdnAiPjU0MTg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91

cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y

Pk1vbnRlbmVncm8sIEYuIEwuPC9hdXRob3I+PGF1dGhvcj5DaGFtbWFzLCBNLiBDLjwvYXV0aG9y

PjxhdXRob3I+SnVsaWFubywgQS4gRy48L2F1dGhvcj48YXV0aG9yPkNlcm5lYSwgQy4gUi48L2F1

dGhvcj48YXV0aG9yPkNvcmRlaXJvLCBBLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydGFtZW50byBkZSBDaXJ1cmdpYSwgSG9zcGl0YWwgZGFz

IENsaW5pY2FzLCBGYWN1bGRhZGUgZGUgTWVkaWNpbmEsIFVuaXZlcnNpZGFkZSBkZSBTYW8gUGF1

bG8sIFNhbyBQYXVsbywgU1AsIEJyYXNpbC4gZmFiaW9tb250ZUB1b2wuY29tLmJyPC9hdXRoLWFk

ZHJlc3M+PHRpdGxlcz48dGl0bGU+RXRoYW5vbCBpbmplY3Rpb24gdW5kZXIgdWx0cmFzb3VuZCBn

dWlkYW5jZSB0byBwYWxsaWF0ZSB1bnJlc2VjdGFibGUgcGFyYXRoeXJvaWQgY2FyY2lub21hPC90

aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkFycSBCcmFzIEVuZG9jcmlub2wgTWV0YWJvbDwvc2Vjb25k

YXJ5LXRpdGxlPjxhbHQtdGl0bGU+QXJxdWl2b3MgYnJhc2lsZWlyb3MgZGUgZW5kb2NyaW5vbG9n

aWEgZSBtZXRhYm9sb2dpYTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkFycSBCcmFzIEVuZG9jcmlub2wgTWV0YWJvbDwvZnVsbC10aXRsZT48YWJici0xPkFycXVp

dm9zIGJyYXNpbGVpcm9zIGRlIGVuZG9jcmlub2xvZ2lhIGUgbWV0YWJvbG9naWE8L2FiYnItMT48

L3BlcmlvZGljYWw+PGFsdC1wZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFycSBCcmFzIEVuZG9jcmlu

b2wgTWV0YWJvbDwvZnVsbC10aXRsZT48YWJici0xPkFycXVpdm9zIGJyYXNpbGVpcm9zIGRlIGVu

ZG9jcmlub2xvZ2lhIGUgbWV0YWJvbG9naWE8L2FiYnItMT48L2FsdC1wZXJpb2RpY2FsPjxwYWdl

cz43MDctMTE8L3BhZ2VzPjx2b2x1bWU+NTI8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5

d29yZHM+PGtleXdvcmQ+RXRoYW5vbC8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3

b3JkPjxrZXl3b3JkPkZhdGFsIE91dGNvbWU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3

b3JkPjxrZXl3b3JkPkh5cGVyY2FsY2VtaWEvKmRydWcgdGhlcmFweS9ldGlvbG9neTwva2V5d29y

ZD48a2V5d29yZD5JbmplY3Rpb25zLCBJbnRyYWxlc2lvbmFsPC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWw8L2tleXdvcmQ+PGtleXdvcmQ+UGFsbGlhdGl2ZSBDYXJlLypt

ZXRob2RzPC9rZXl3b3JkPjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRp

b25zLypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3JhcGh5LCBJbnRl

cnZlbnRpb25hbDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA4PC95ZWFyPjxw

dWItZGF0ZXM+PGRhdGU+SnVuPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTY3Ny05

NDg3IChFbGVjdHJvbmljKSYjeEQ7MDAwNC0yNzMwIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9u

LW51bT4xODYwNDM4NjwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0

cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8xODYwNDM4NjwvdXJsPjwvcmVsYXRlZC11

cmxzPjwvdXJscz48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (47).It is not recommended for use in the central neck region if the recurrent laryngeal nerve is still functioning in that region. Some inoperable distant metastatic lesions, such as intrahepatic and intrapulmonary lesions, are anatomically accessible by interventional radiologists and thus can be ablated transcutaneously with radiofrequency (RFA) or transcatheter arterial embolization (TAE) PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ub2NoaW88L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NTQxOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oVG9jaGlvIGV0IGFsLiAyMDEwKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDE5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Ub2NoaW8s

IE0uPC9hdXRob3I+PGF1dGhvcj5UYWtha2ksIEguPC9hdXRob3I+PGF1dGhvcj5ZYW1ha2Fkbywg

Sy48L2F1dGhvcj48YXV0aG9yPlVyYWtpLCBKLjwvYXV0aG9yPjxhdXRob3I+S2FzaGltYSwgTS48

L2F1dGhvcj48YXV0aG9yPk5ha2F0c3VrYSwgQS48L2F1dGhvcj48YXV0aG9yPlRha2FvLCBNLjwv

YXV0aG9yPjxhdXRob3I+U2hpbWFtb3RvLCBBLjwvYXV0aG9yPjxhdXRob3I+VGFydWthd2EsIFQu

PC9hdXRob3I+PGF1dGhvcj5TaGltcG8sIEguPC9hdXRob3I+PGF1dGhvcj5UYWtlZGEsIEsuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBv

ZiBSYWRpb2xvZ3ksIE1pZSBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgMi0xNzQgRWRv

YmFzaGksIFRzdSwgTWllIDUxNC04NTA3LCBKYXBhbi4gbS10b2NoaW9AY2xpbi5tZWRpYy5taWUt

dS5hYy5qcDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY2FzZSByZXBvcnQgb2YgMjAg

bHVuZyByYWRpb2ZyZXF1ZW5jeSBhYmxhdGlvbiBzZXNzaW9ucyBmb3IgNTAgbHVuZyBtZXRhc3Rh

c2VzIGZyb20gcGFyYXRoeXJvaWQgY2FyY2lub21hIGNhdXNpbmcgaHlwZXJwYXJhdGh5cm9pZGlz

bTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkNhcmRpb3Zhc2N1bGFyIGFuZCBpbnRlcnZlbnRpb25h

bCByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5D

YXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNj

dWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1

bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNjdWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9s

b2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NjU3LTk8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+Q2F0aGV0ZXIg

QWJsYXRpb24vKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkh5cGVyY2FsY2VtaWEvZXRpb2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IeXBl

cnBhcmF0aHlyb2lkaXNtLypldGlvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkx1bmcg

TmVvcGxhc21zLypzZWNvbmRhcnkvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvKmNvbXBsaWNhdGlvbnMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkZWN0b215PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTA4NlggKEVsZWN0cm9uaWMpJiN4RDswMTc0LTE1NTEgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5ODg4NjMxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5ODg4NjMxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDI3MC0wMDktOTczMC00PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ub2NoaW88L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NTQxOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oVG9jaGlvIGV0IGFsLiAyMDEwKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDE5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Ub2NoaW8s

IE0uPC9hdXRob3I+PGF1dGhvcj5UYWtha2ksIEguPC9hdXRob3I+PGF1dGhvcj5ZYW1ha2Fkbywg

Sy48L2F1dGhvcj48YXV0aG9yPlVyYWtpLCBKLjwvYXV0aG9yPjxhdXRob3I+S2FzaGltYSwgTS48

L2F1dGhvcj48YXV0aG9yPk5ha2F0c3VrYSwgQS48L2F1dGhvcj48YXV0aG9yPlRha2FvLCBNLjwv

YXV0aG9yPjxhdXRob3I+U2hpbWFtb3RvLCBBLjwvYXV0aG9yPjxhdXRob3I+VGFydWthd2EsIFQu

PC9hdXRob3I+PGF1dGhvcj5TaGltcG8sIEguPC9hdXRob3I+PGF1dGhvcj5UYWtlZGEsIEsuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBv

ZiBSYWRpb2xvZ3ksIE1pZSBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgMi0xNzQgRWRv

YmFzaGksIFRzdSwgTWllIDUxNC04NTA3LCBKYXBhbi4gbS10b2NoaW9AY2xpbi5tZWRpYy5taWUt

dS5hYy5qcDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY2FzZSByZXBvcnQgb2YgMjAg

bHVuZyByYWRpb2ZyZXF1ZW5jeSBhYmxhdGlvbiBzZXNzaW9ucyBmb3IgNTAgbHVuZyBtZXRhc3Rh

c2VzIGZyb20gcGFyYXRoeXJvaWQgY2FyY2lub21hIGNhdXNpbmcgaHlwZXJwYXJhdGh5cm9pZGlz

bTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkNhcmRpb3Zhc2N1bGFyIGFuZCBpbnRlcnZlbnRpb25h

bCByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5D

YXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNj

dWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1

bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNjdWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9s

b2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NjU3LTk8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+Q2F0aGV0ZXIg

QWJsYXRpb24vKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkh5cGVyY2FsY2VtaWEvZXRpb2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IeXBl

cnBhcmF0aHlyb2lkaXNtLypldGlvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkx1bmcg

TmVvcGxhc21zLypzZWNvbmRhcnkvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvKmNvbXBsaWNhdGlvbnMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkZWN0b215PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTA4NlggKEVsZWN0cm9uaWMpJiN4RDswMTc0LTE1NTEgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5ODg4NjMxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5ODg4NjMxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDI3MC0wMDktOTczMC00PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (48).As described above, management of metastatic parathyroid carcinoma is mostly described in the form of case reports or small case series. Therefore, therapeutic options should be tailored individually PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ub2NoaW88L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NTQxOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oVG9jaGlvIGV0IGFsLiAyMDEwKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDE5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Ub2NoaW8s

IE0uPC9hdXRob3I+PGF1dGhvcj5UYWtha2ksIEguPC9hdXRob3I+PGF1dGhvcj5ZYW1ha2Fkbywg

Sy48L2F1dGhvcj48YXV0aG9yPlVyYWtpLCBKLjwvYXV0aG9yPjxhdXRob3I+S2FzaGltYSwgTS48

L2F1dGhvcj48YXV0aG9yPk5ha2F0c3VrYSwgQS48L2F1dGhvcj48YXV0aG9yPlRha2FvLCBNLjwv

YXV0aG9yPjxhdXRob3I+U2hpbWFtb3RvLCBBLjwvYXV0aG9yPjxhdXRob3I+VGFydWthd2EsIFQu

PC9hdXRob3I+PGF1dGhvcj5TaGltcG8sIEguPC9hdXRob3I+PGF1dGhvcj5UYWtlZGEsIEsuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBv

ZiBSYWRpb2xvZ3ksIE1pZSBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgMi0xNzQgRWRv

YmFzaGksIFRzdSwgTWllIDUxNC04NTA3LCBKYXBhbi4gbS10b2NoaW9AY2xpbi5tZWRpYy5taWUt

dS5hYy5qcDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY2FzZSByZXBvcnQgb2YgMjAg

bHVuZyByYWRpb2ZyZXF1ZW5jeSBhYmxhdGlvbiBzZXNzaW9ucyBmb3IgNTAgbHVuZyBtZXRhc3Rh

c2VzIGZyb20gcGFyYXRoeXJvaWQgY2FyY2lub21hIGNhdXNpbmcgaHlwZXJwYXJhdGh5cm9pZGlz

bTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkNhcmRpb3Zhc2N1bGFyIGFuZCBpbnRlcnZlbnRpb25h

bCByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5D

YXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNj

dWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1

bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNjdWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9s

b2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NjU3LTk8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+Q2F0aGV0ZXIg

QWJsYXRpb24vKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkh5cGVyY2FsY2VtaWEvZXRpb2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IeXBl

cnBhcmF0aHlyb2lkaXNtLypldGlvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkx1bmcg

TmVvcGxhc21zLypzZWNvbmRhcnkvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvKmNvbXBsaWNhdGlvbnMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkZWN0b215PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTA4NlggKEVsZWN0cm9uaWMpJiN4RDswMTc0LTE1NTEgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5ODg4NjMxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5ODg4NjMxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDI3MC0wMDktOTczMC00PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Ub2NoaW88L0F1dGhvcj48WWVhcj4yMDEwPC9ZZWFyPjxS

ZWNOdW0+NTQxOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oVG9jaGlvIGV0IGFsLiAyMDEwKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDE5PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Ub2NoaW8s

IE0uPC9hdXRob3I+PGF1dGhvcj5UYWtha2ksIEguPC9hdXRob3I+PGF1dGhvcj5ZYW1ha2Fkbywg

Sy48L2F1dGhvcj48YXV0aG9yPlVyYWtpLCBKLjwvYXV0aG9yPjxhdXRob3I+S2FzaGltYSwgTS48

L2F1dGhvcj48YXV0aG9yPk5ha2F0c3VrYSwgQS48L2F1dGhvcj48YXV0aG9yPlRha2FvLCBNLjwv

YXV0aG9yPjxhdXRob3I+U2hpbWFtb3RvLCBBLjwvYXV0aG9yPjxhdXRob3I+VGFydWthd2EsIFQu

PC9hdXRob3I+PGF1dGhvcj5TaGltcG8sIEguPC9hdXRob3I+PGF1dGhvcj5UYWtlZGEsIEsuPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RGVwYXJ0bWVudCBv

ZiBSYWRpb2xvZ3ksIE1pZSBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRpY2luZSwgMi0xNzQgRWRv

YmFzaGksIFRzdSwgTWllIDUxNC04NTA3LCBKYXBhbi4gbS10b2NoaW9AY2xpbi5tZWRpYy5taWUt

dS5hYy5qcDwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkEgY2FzZSByZXBvcnQgb2YgMjAg

bHVuZyByYWRpb2ZyZXF1ZW5jeSBhYmxhdGlvbiBzZXNzaW9ucyBmb3IgNTAgbHVuZyBtZXRhc3Rh

c2VzIGZyb20gcGFyYXRoeXJvaWQgY2FyY2lub21hIGNhdXNpbmcgaHlwZXJwYXJhdGh5cm9pZGlz

bTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L3Nl

Y29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkNhcmRpb3Zhc2N1bGFyIGFuZCBpbnRlcnZlbnRpb25h

bCByYWRpb2xvZ3k8L2FsdC10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5D

YXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNj

dWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxh

bHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5DYXJkaW92YXNjIEludGVydmVudCBSYWRpb2w8L2Z1

bGwtdGl0bGU+PGFiYnItMT5DYXJkaW92YXNjdWxhciBhbmQgaW50ZXJ2ZW50aW9uYWwgcmFkaW9s

b2d5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+NjU3LTk8L3BhZ2VzPjx2b2x1bWU+

MzM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+Q2F0aGV0ZXIg

QWJsYXRpb24vKm1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3

b3JkPkh5cGVyY2FsY2VtaWEvZXRpb2xvZ3kvc3VyZ2VyeTwva2V5d29yZD48a2V5d29yZD5IeXBl

cnBhcmF0aHlyb2lkaXNtLypldGlvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkx1bmcg

TmVvcGxhc21zLypzZWNvbmRhcnkvKnN1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBO

ZW9wbGFzbXMvKmNvbXBsaWNhdGlvbnMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3

b3JkPlBhcmF0aHlyb2lkZWN0b215PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIw

MTA8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48

aXNibj4xNDMyLTA4NlggKEVsZWN0cm9uaWMpJiN4RDswMTc0LTE1NTEgKExpbmtpbmcpPC9pc2Ju

PjxhY2Nlc3Npb24tbnVtPjE5ODg4NjMxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVy

bHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzE5ODg4NjMxPC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3Mw

MDI3MC0wMDktOTczMC00PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+

PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (48).Prognosis of Parathyroid Gland carcinomaSurvival analysis of parathyroid carcinoma patients extrapolated from various cancer databases such as SEER, NCDB, and Swedish Cancer Registry, and from longitudinal retrospective studies at single institutions showed an overall survival of 85% and 49–77% at 5 and 10 years follow-up, respectively PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+

PFJlY051bT41Mzg2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxMSwg

TmV5Y2hldiBldCBhbC4gMjAxMSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4

NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpk

OXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTM4Njwva2V5PjwvZm9yZWlnbi1rZXlzPjxy

ZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3Jz

PjxhdXRob3JzPjxhdXRob3I+QWxoZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5QaW5jaG90LCBT

LiBOLjwvYXV0aG9yPjxhdXRob3I+RGF2aXMsIFIuPC9hdXRob3I+PGF1dGhvcj5TaXBwZWwsIFIu

IFMuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1l

bnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIEg0LzcyMiBDU0MgNjAwIEhp

Z2hsYW5kIEF2ZW51ZSwgTWFkaXNvbiwgV0kgNTM3OTIsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5UaGUgbmVjZXNzaXR5IGFuZCByZWxpYWJpbGl0eSBvZiBpbnRyYW9wZXJhdGl2

ZSBwYXJhdGh5cm9pZCBob3Jtb25lIChQVEgpIHRlc3RpbmcgaW4gcGF0aWVudHMgd2l0aCBtaWxk

IGh5cGVycGFyYXRoeXJvaWRpc20gYW5kIFBUSCBsZXZlbHMgaW4gdGhlIG5vcm1hbCByYW5nZTwv

dGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0

LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJp

b2RpY2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxk

IGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5h

bCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjAwNi05PC9wYWdl

cz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj45PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3Jk

PkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qYmxvb2QvZGlh

Z25vc2lzLypzdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TW9uaXRvcmluZywgSW50cmFvcGVyYXRpdmUv

Km1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS8qYmxvb2Q8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXkvYWR2ZXJzZSBlZmZlY3RzLyptZXRob2Rz

PC9rZXl3b3JkPjxrZXl3b3JkPlBvc3RvcGVyYXRpdmUgQ2FyZS9tZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlZmVyZW5jZSBWYWx1ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5

IG9mIFJlc3VsdHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPlJpc2sgQXNzZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXZlcml0eSBv

ZiBJbGxuZXNzIEluZGV4PC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3

b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5T

ZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMp

JiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxNzEzNTczPC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvcHVibWVkLzIxNzEzNTczPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTEtMTE3OS0zPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRo

b3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjUzOTA8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjUzOTA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1

MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5leWNoZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5L

b3VuaWF2c2t5LCBHLjwvYXV0aG9yPjxhdXRob3I+U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5V

ZGFsbCwgRC4gTi48L2F1dGhvcj48YXV0aG9yPlNvbWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9y

PlVtYnJpY2h0LCBDLiBCLjwvYXV0aG9yPjxhdXRob3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2Vy

eSwgVGhlIEpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRp

bW9yZSwgTUQgMjEyMDUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5n

ICZxdW90O3NoYWRvd3MmcXVvdDs6IGRpc2NvdmVyaW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3Rh

bWliaSBzY2FucyB0byBmYWNpbGl0YXRlIG1pbmltYWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVj

dG9teTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0x

PldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQg

am91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8

L3BhZ2VzPjx2b2x1bWU+MzU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5I

eXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5LypkaWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5NaW5pbWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5

d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVjdG9teS8qbWV0aG9kczwva2V5d29yZD48a2V5d29y

ZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxr

ZXl3b3JkPipUZWNobmV0aXVtIFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0

cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMy

LTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjIwODg2MjExPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAt

MDgwMC0xPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5BbGhlZmRoaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+

PFJlY051bT41Mzg2PC9SZWNOdW0+PERpc3BsYXlUZXh0PihBbGhlZmRoaSBldCBhbC4gMjAxMSwg

TmV5Y2hldiBldCBhbC4gMjAxMSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTM4

NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjUwd3hkcHpk

OXZkNXI3ZTl0NWI1OTVkanJmcHR0cnh3OWF2cCI+NTM4Njwva2V5PjwvZm9yZWlnbi1rZXlzPjxy

ZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3Jz

PjxhdXRob3JzPjxhdXRob3I+QWxoZWZkaGksIEEuPC9hdXRob3I+PGF1dGhvcj5QaW5jaG90LCBT

LiBOLjwvYXV0aG9yPjxhdXRob3I+RGF2aXMsIFIuPC9hdXRob3I+PGF1dGhvcj5TaXBwZWwsIFIu

IFMuPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBILjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIERlcGFydG1l

bnQgb2YgU3VyZ2VyeSwgVW5pdmVyc2l0eSBvZiBXaXNjb25zaW4sIEg0LzcyMiBDU0MgNjAwIEhp

Z2hsYW5kIEF2ZW51ZSwgTWFkaXNvbiwgV0kgNTM3OTIsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0

bGVzPjx0aXRsZT5UaGUgbmVjZXNzaXR5IGFuZCByZWxpYWJpbGl0eSBvZiBpbnRyYW9wZXJhdGl2

ZSBwYXJhdGh5cm9pZCBob3Jtb25lIChQVEgpIHRlc3RpbmcgaW4gcGF0aWVudHMgd2l0aCBtaWxk

IGh5cGVycGFyYXRoeXJvaWRpc20gYW5kIFBUSCBsZXZlbHMgaW4gdGhlIG5vcm1hbCByYW5nZTwv

dGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0

LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJp

b2RpY2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxk

IGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5h

bCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MjAwNi05PC9wYWdl

cz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj45PC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3Jk

PkNvaG9ydCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29y

ZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS8qYmxvb2QvZGlh

Z25vc2lzLypzdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+

TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TW9uaXRvcmluZywgSW50cmFvcGVyYXRpdmUv

Km1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgSG9ybW9uZS8qYmxvb2Q8L2tl

eXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXkvYWR2ZXJzZSBlZmZlY3RzLyptZXRob2Rz

PC9rZXl3b3JkPjxrZXl3b3JkPlBvc3RvcGVyYXRpdmUgQ2FyZS9tZXRob2RzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlZmVyZW5jZSBWYWx1ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVwcm9kdWNpYmlsaXR5

IG9mIFJlc3VsdHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3

b3JkPjxrZXl3b3JkPlJpc2sgQXNzZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXZlcml0eSBv

ZiBJbGxuZXNzIEluZGV4PC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3

b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5T

ZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVsZWN0cm9uaWMp

JiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxNzEzNTczPC9h

Y2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxt

Lm5paC5nb3YvcHVibWVkLzIxNzEzNTczPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVj

dHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTEtMTE3OS0zPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRo

b3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjUzOTA8L1JlY051bT48cmVjb3JkPjxyZWMtbnVt

YmVyPjUzOTA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1

MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5leWNoZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5L

b3VuaWF2c2t5LCBHLjwvYXV0aG9yPjxhdXRob3I+U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5V

ZGFsbCwgRC4gTi48L2F1dGhvcj48YXV0aG9yPlNvbWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9y

PlVtYnJpY2h0LCBDLiBCLjwvYXV0aG9yPjxhdXRob3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2Vy

eSwgVGhlIEpvaG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRp

bW9yZSwgTUQgMjEyMDUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5n

ICZxdW90O3NoYWRvd3MmcXVvdDs6IGRpc2NvdmVyaW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3Rh

bWliaSBzY2FucyB0byBmYWNpbGl0YXRlIG1pbmltYWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVj

dG9teTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRs

ZT48YWx0LXRpdGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0x

PldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlv

ZGljYWw+PGZ1bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQg

am91cm5hbCBvZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8

L3BhZ2VzPjx2b2x1bWU+MzU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5I

eXBlcnBhcmF0aHlyb2lkaXNtLCBQcmltYXJ5LypkaWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8

L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5

d29yZD48a2V5d29yZD5NaW5pbWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5

d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZGVjdG9teS8qbWV0aG9kczwva2V5d29yZD48a2V5d29y

ZD5SYWRpb251Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0

aWNhbHM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxr

ZXl3b3JkPipUZWNobmV0aXVtIFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0

cmFzb25vZ3JhcGh5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+

PHB1Yi1kYXRlcz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMy

LTIzMjMgKEVsZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np

b24tbnVtPjIwODg2MjExPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o

dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVk

LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAt

MDgwMC0xPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3Rl

Pn==

ADDIN EN.CITE.DATA (32).Persistent or recurrent disease occurs in more than 50% of parathyroid carcinoma patients, manifested usually by elevated serum PTH and calcium. However, these serum biomarkers remain unaffected in non-functioning parathyroid carcinoma and are thus uninformative in the detection of recurrence in those patients ADDIN EN.CITE <EndNote><Cite><Author>Gao</Author><Year>2010</Year><RecNum>5414</RecNum><DisplayText>(Gao et al. 2010)</DisplayText><record><rec-number>5414</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5414</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, W. C.</author><author>Ruan, C. P.</author><author>Zhang, J. C.</author><author>Liu, H. M.</author><author>Xu, X. Y.</author><author>Sun, Y. P.</author><author>Wang, Q.</author></authors></contributors><auth-address>Department of General Surgery, Shanghai Chang Zheng Hospital, Second Military Medical University, 415 Feng Yang Road, 200003 Shanghai, People&apos;s Republic of China.</auth-address><titles><title>Nonfunctional parathyroid carcinoma</title><secondary-title>J Cancer Res Clin Oncol</secondary-title><alt-title>Journal of cancer research and clinical oncology</alt-title></titles><periodical><full-title>J Cancer Res Clin Oncol</full-title><abbr-1>Journal of cancer research and clinical oncology</abbr-1></periodical><alt-periodical><full-title>J Cancer Res Clin Oncol</full-title><abbr-1>Journal of cancer research and clinical oncology</abbr-1></alt-periodical><pages>969-74</pages><volume>136</volume><number>7</number><keywords><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Neoplasms/*diagnosis/*surgery</keyword></keywords><dates><year>2010</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1432-1335 (Electronic)&#xD;0171-5216 (Linking)</isbn><accession-num>19967413</accession-num><urls><related-urls><url>;(43).Most recurrences are locoregional. Patients with recurrence are likely to require multiple operations and thus have a high rate of surgical complications, especially recurrent laryngeal nerve injuries. Up to 25% of patients with parathyroid carcinoma develop distant metastases during the follow-up period PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48

UmVjTnVtPjUzOTA8L1JlY051bT48RGlzcGxheVRleHQ+KE5leWNoZXYgZXQgYWwuIDIwMTEsIFJh

aGJhcmkgZXQgYWwuIDIwMTEpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzOTA8

L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2

ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm

LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48

YXV0aG9ycz48YXV0aG9yPk5leWNoZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5Lb3VuaWF2c2t5

LCBHLjwvYXV0aG9yPjxhdXRob3I+U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5VZGFsbCwgRC4g

Ti48L2F1dGhvcj48YXV0aG9yPlNvbWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9yPlVtYnJpY2h0

LCBDLiBCLjwvYXV0aG9yPjxhdXRob3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVGhlIEpv

aG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRpbW9yZSwgTUQg

MjEyMDUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5nICZxdW90O3No

YWRvd3MmcXVvdDs6IGRpc2NvdmVyaW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3RhbWliaSBzY2Fu

cyB0byBmYWNpbGl0YXRlIG1pbmltYWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpv

dXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBv

ZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8L3BhZ2VzPjx2

b2x1bWU+MzU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+RmVt

YWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0

aHlyb2lkaXNtLCBQcmltYXJ5LypkaWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5

d29yZD5NaW5pbWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5

d29yZD5QYXJhdGh5cm9pZGVjdG9teS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5SYWRpb251

Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipU

ZWNobmV0aXVtIFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3Jh

cGh5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVs

ZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIw

ODg2MjExPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3

Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVkLXVybHM+PC91

cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAtMDgwMC0xPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5SYWhi

YXJpPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjU0MjI8L1JlY051bT48cmVjb3Jk

PjxyZWMtbnVtYmVyPjU0MjI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0MjI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlJhaGJhcmksIFIuPC9hdXRob3I+PGF1

dGhvcj5Ib2xsb3dheSwgQS4gSy48L2F1dGhvcj48YXV0aG9yPkhlLCBNLjwvYXV0aG9yPjxhdXRo

b3I+S2hhbmFmc2hhciwgRS48L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLiBILjwvYXV0aG9yPjxh

dXRob3I+S2ViZWJldywgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5FbmRvY3JpbmUgT25jb2xvZ3kgU2VjdGlvbiwgU3VyZ2VyeSBCcmFuY2gsIE5hdGlv

bmFsIENhbmNlciBJbnN0aXR1dGUsIEJldGhlc2RhLCBNRCwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPklkZW50aWZpY2F0aW9uIG9mIGRpZmZlcmVudGlhbGx5IGV4cHJlc3NlZCBt

aWNyb1JOQSBpbiBwYXJhdGh5cm9pZCB0dW1vcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5u

IFN1cmcgT25jb2w8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFubmFscyBvZiBzdXJnaWNh

bCBvbmNvbG9neTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFu

biBTdXJnIE9uY29sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHN1cmdpY2FsIG9uY29s

b2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm4g

U3VyZyBPbmNvbDwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiBzdXJnaWNhbCBvbmNvbG9n

eTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjExNTgtNjU8L3BhZ2VzPjx2b2x1bWU+

MTg8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8q

Z2VuZXRpY3MvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5CaW9tYXJrZXJzLCBUdW1vci8q

Z2VuZXRpY3MvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5HZW5lIEV4cHJlc3Npb24gUHJv

ZmlsaW5nPC9rZXl3b3JkPjxrZXl3b3JkPkdlbmUgRXhwcmVzc2lvbiBSZWd1bGF0aW9uLCBOZW9w

bGFzdGljPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBs

YXNpYS8qbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWljcm9STkFzLypn

ZW5ldGljczwva2V5d29yZD48a2V5d29yZD5PbGlnb251Y2xlb3RpZGUgQXJyYXkgU2VxdWVuY2Ug

QW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLyptZXRhYm9saXNt

L3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKmdlbmV0

aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+Uk5BLCBNZXNzZW5nZXIvZ2VuZXRpY3M8

L2tleXdvcmQ+PGtleXdvcmQ+Uk9DIEN1cnZlPC9rZXl3b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJh

bnNjcmlwdGFzZSBQb2x5bWVyYXNlIENoYWluIFJlYWN0aW9uPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xNTM0LTQ2ODEgKEVsZWN0cm9uaWMpJiN4RDsxMDY4LTkyNjUg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxMDg2MDU1PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzIxMDg2MDU1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPjM0NDkzMTc8L2N1

c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyNDUvczEwNDM0LTAxMC0xMzU5LTc8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZXljaGV2PC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48

UmVjTnVtPjUzOTA8L1JlY051bT48RGlzcGxheVRleHQ+KE5leWNoZXYgZXQgYWwuIDIwMTEsIFJh

aGJhcmkgZXQgYWwuIDIwMTEpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjUzOTA8

L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1MHd4ZHB6ZDl2

ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjUzOTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVm

LXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48

YXV0aG9ycz48YXV0aG9yPk5leWNoZXYsIFYuIEsuPC9hdXRob3I+PGF1dGhvcj5Lb3VuaWF2c2t5

LCBHLjwvYXV0aG9yPjxhdXRob3I+U2hpdWUsIFouPC9hdXRob3I+PGF1dGhvcj5VZGFsbCwgRC4g

Ti48L2F1dGhvcj48YXV0aG9yPlNvbWVydmVsbCwgSC48L2F1dGhvcj48YXV0aG9yPlVtYnJpY2h0

LCBDLiBCLjwvYXV0aG9yPjxhdXRob3I+WmVpZ2VyLCBNLiBBLjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgU3VyZ2VyeSwgVGhlIEpv

aG5zIEhvcGtpbnMgVW5pdmVyc2l0eSBTY2hvb2wgb2YgTWVkaWNpbmUsIEJhbHRpbW9yZSwgTUQg

MjEyMDUsIFVTQS48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5DaGFzaW5nICZxdW90O3No

YWRvd3MmcXVvdDs6IGRpc2NvdmVyaW5nIHRoZSBzdWJ0bGV0aWVzIG9mIHNlc3RhbWliaSBzY2Fu

cyB0byBmYWNpbGl0YXRlIG1pbmltYWxseSBpbnZhc2l2ZSBwYXJhdGh5cm9pZGVjdG9teTwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5Xb3JsZCBKIFN1cmc8L3NlY29uZGFyeS10aXRsZT48YWx0LXRp

dGxlPldvcmxkIGpvdXJuYWwgb2Ygc3VyZ2VyeTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp

Y2FsPjxmdWxsLXRpdGxlPldvcmxkIEogU3VyZzwvZnVsbC10aXRsZT48YWJici0xPldvcmxkIGpv

dXJuYWwgb2Ygc3VyZ2VyeTwvYWJici0xPjwvcGVyaW9kaWNhbD48YWx0LXBlcmlvZGljYWw+PGZ1

bGwtdGl0bGU+V29ybGQgSiBTdXJnPC9mdWxsLXRpdGxlPjxhYmJyLTE+V29ybGQgam91cm5hbCBv

ZiBzdXJnZXJ5PC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MTQwLTY8L3BhZ2VzPjx2

b2x1bWU+MzU8L3ZvbHVtZT48bnVtYmVyPjE8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+RmVt

YWxlPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBhcmF0

aHlyb2lkaXNtLCBQcmltYXJ5LypkaWFnbm9zdGljIGltYWdpbmcvKnN1cmdlcnk8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5

d29yZD5NaW5pbWFsbHkgSW52YXNpdmUgU3VyZ2ljYWwgUHJvY2VkdXJlczwva2V5d29yZD48a2V5

d29yZD5QYXJhdGh5cm9pZGVjdG9teS8qbWV0aG9kczwva2V5d29yZD48a2V5d29yZD5SYWRpb251

Y2xpZGUgSW1hZ2luZzwva2V5d29yZD48a2V5d29yZD4qUmFkaW9waGFybWFjZXV0aWNhbHM8L2tl

eXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPipU

ZWNobmV0aXVtIFRjIDk5bSBTZXN0YW1pYmk8L2tleXdvcmQ+PGtleXdvcmQ+VWx0cmFzb25vZ3Jh

cGh5PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5KYW48L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNDMyLTIzMjMgKEVs

ZWN0cm9uaWMpJiN4RDswMzY0LTIzMTMgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIw

ODg2MjExPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3

Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzIwODg2MjExPC91cmw+PC9yZWxhdGVkLXVybHM+PC91

cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDA3L3MwMDI2OC0wMTAtMDgwMC0xPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5SYWhi

YXJpPC9BdXRob3I+PFllYXI+MjAxMTwvWWVhcj48UmVjTnVtPjU0MjI8L1JlY051bT48cmVjb3Jk

PjxyZWMtbnVtYmVyPjU0MjI8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4i

IGRiLWlkPSI1MHd4ZHB6ZDl2ZDVyN2U5dDViNTk1ZGpyZnB0dHJ4dzlhdnAiPjU0MjI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlJhaGJhcmksIFIuPC9hdXRob3I+PGF1

dGhvcj5Ib2xsb3dheSwgQS4gSy48L2F1dGhvcj48YXV0aG9yPkhlLCBNLjwvYXV0aG9yPjxhdXRo

b3I+S2hhbmFmc2hhciwgRS48L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLiBILjwvYXV0aG9yPjxh

dXRob3I+S2ViZWJldywgRS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5FbmRvY3JpbmUgT25jb2xvZ3kgU2VjdGlvbiwgU3VyZ2VyeSBCcmFuY2gsIE5hdGlv

bmFsIENhbmNlciBJbnN0aXR1dGUsIEJldGhlc2RhLCBNRCwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0

aXRsZXM+PHRpdGxlPklkZW50aWZpY2F0aW9uIG9mIGRpZmZlcmVudGlhbGx5IGV4cHJlc3NlZCBt

aWNyb1JOQSBpbiBwYXJhdGh5cm9pZCB0dW1vcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+QW5u

IFN1cmcgT25jb2w8L3NlY29uZGFyeS10aXRsZT48YWx0LXRpdGxlPkFubmFscyBvZiBzdXJnaWNh

bCBvbmNvbG9neTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFu

biBTdXJnIE9uY29sPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uYWxzIG9mIHN1cmdpY2FsIG9uY29s

b2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxhbHQtcGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm4g

U3VyZyBPbmNvbDwvZnVsbC10aXRsZT48YWJici0xPkFubmFscyBvZiBzdXJnaWNhbCBvbmNvbG9n

eTwvYWJici0xPjwvYWx0LXBlcmlvZGljYWw+PHBhZ2VzPjExNTgtNjU8L3BhZ2VzPjx2b2x1bWU+

MTg8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRlbm9tYS8q

Z2VuZXRpY3MvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5CaW9tYXJrZXJzLCBUdW1vci8q

Z2VuZXRpY3MvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5HZW5lIEV4cHJlc3Npb24gUHJv

ZmlsaW5nPC9rZXl3b3JkPjxrZXl3b3JkPkdlbmUgRXhwcmVzc2lvbiBSZWd1bGF0aW9uLCBOZW9w

bGFzdGljPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBlcnBs

YXNpYS8qbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TWljcm9STkFzLypn

ZW5ldGljczwva2V5d29yZD48a2V5d29yZD5PbGlnb251Y2xlb3RpZGUgQXJyYXkgU2VxdWVuY2Ug

QW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWQgR2xhbmRzLyptZXRhYm9saXNt

L3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5QYXJhdGh5cm9pZCBOZW9wbGFzbXMvKmdlbmV0

aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+Uk5BLCBNZXNzZW5nZXIvZ2VuZXRpY3M8

L2tleXdvcmQ+PGtleXdvcmQ+Uk9DIEN1cnZlPC9rZXl3b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJh

bnNjcmlwdGFzZSBQb2x5bWVyYXNlIENoYWluIFJlYWN0aW9uPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTE8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHI8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xNTM0LTQ2ODEgKEVsZWN0cm9uaWMpJiN4RDsxMDY4LTkyNjUg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIxMDg2MDU1PC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzIxMDg2MDU1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPjM0NDkzMTc8L2N1

c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyNDUvczEwNDM0LTAxMC0xMzU5LTc8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (49).The costal margin, the retroperitoneal space is entered. The medial port incision is placed approximately 4 to 5 cm caudal to the inferior margin of the 12th rib. The lateral port is placed directly inferior to the costal margin. A 10-mm port with a "donut" balloon is placed into the middle port site.Mortality due to functional parathyroid carcinoma is usually secondary to intractable hypercalcemia leading to progressive end-organ damage, such as renal failure. The prognosis of parathyroid cancer is somewhat variable. In general, it has a better survival rate than most solid tumors ( ADDIN EN.CITE <EndNote><Cite><Author>Shane</Author><Year>2001</Year><RecNum>5423</RecNum><DisplayText>(Shane 2001)</DisplayText><record><rec-number>5423</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5423</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shane, E.</author></authors></contributors><auth-address>Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.</auth-address><titles><title>Clinical review 122: Parathyroid carcinoma</title><secondary-title>J Clin Endocrinol Metab</secondary-title><alt-title>The Journal of clinical endocrinology and metabolism</alt-title></titles><periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></periodical><alt-periodical><full-title>J Clin Endocrinol Metab</full-title><abbr-1>The Journal of clinical endocrinology and metabolism</abbr-1></alt-periodical><pages>485-93</pages><volume>86</volume><number>2</number><keywords><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hypercalcemia/etiology/therapy</keyword><keyword>Incidence</keyword><keyword>Male</keyword><keyword>Parathyroid Neoplasms/diagnosis/etiology/*physiopathology/therapy</keyword></keywords><dates><year>2001</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0021-972X (Print)&#xD;0021-972X (Linking)</isbn><accession-num>11157996</accession-num><urls><related-urls><url>).There is currently no prognostic staging system. It is estimated that up to 40% of patients with parathyroid carcinoma undergo piecemeal or incomplete tumor resection, mostly attributable to lack of disease recognition either preoperatively or intraoperatively ( ADDIN EN.CITE <EndNote><Cite><Author>Hundahl</Author><Year>1999</Year><RecNum>5424</RecNum><DisplayText>(Hundahl et al. 1999)</DisplayText><record><rec-number>5424</rec-number><foreign-keys><key app="EN" db-id="50wxdpzd9vd5r7e9t5b595djrfpttrxw9avp">5424</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hundahl, S. A.</author><author>Fleming, I. D.</author><author>Fremgen, A. M.</author><author>Menck, H. R.</author></authors></contributors><auth-address>Department of Surgery, The Queen&apos;s Medical Center, Honolulu, Hawaii, USA.</auth-address><titles><title>Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society</title><secondary-title>Cancer</secondary-title><alt-title>Cancer</alt-title></titles><periodical><full-title>Cancer</full-title><abbr-1>Cancer</abbr-1></periodical><alt-periodical><full-title>Cancer</full-title><abbr-1>Cancer</abbr-1></alt-periodical><pages>538-44</pages><volume>86</volume><number>3</number><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Age Distribution</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Parathyroid Neoplasms/epidemiology/ethnology/mortality/pathology/*therapy</keyword><keyword>Parathyroidectomy/statistics &amp; numerical data</keyword><keyword>Sex Distribution</keyword><keyword>United States/epidemiology</keyword></keywords><dates><year>1999</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-543X (Print)&#xD;0008-543X (Linking)</isbn><accession-num>10430265</accession-num><urls><related-urls><url>).However, the empirical selection of a mandatory concurrent thyroidectomy is debatable. A recent retrospective review by Harari et al., showed that mortality and recurrence rates were not affected by the extent of thyroidectomy during the initial operation. This was consistent with other previously published reports of single institutional experiences PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (19). A likely explanation for this observation is that complete removal of tumor is largely driven by accurate intraoperative assessment of the extent of invasiveness by experienced surgeons rather than the amount of tissue structures removed. Currently, there are no established criteria to triage the extent of surgical resection. The most commonly recommended procedure is en bloc resection with whichever nearby structures are involved. The completeness of initial operation has been shown to be an independent prognosticator for disease-free survival (PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJhcmk8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+NTQxMDwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oSGFyYXJpIGV0IGFsLiAyMDExKTwvRGlz

cGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj41NDEwPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTB3eGRwemQ5dmQ1cjdlOXQ1YjU5NWRqcmZwdHRyeHc5

YXZwIj41NDEwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IYXJhcmks

IEEuPC9hdXRob3I+PGF1dGhvcj5XYXJpbmcsIEEuPC9hdXRob3I+PGF1dGhvcj5GZXJuYW5kZXot

UmFudmllciwgRy48L2F1dGhvcj48YXV0aG9yPkh3YW5nLCBKLjwvYXV0aG9yPjxhdXRob3I+U3Vo

LCBJLjwvYXV0aG9yPjxhdXRob3I+TWl0bWFrZXIsIEUuPC9hdXRob3I+PGF1dGhvcj5TaGVuLCBX

LjwvYXV0aG9yPjxhdXRob3I+R29zbmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPkR1aCwgUS4gWS48

L2F1dGhvcj48YXV0aG9yPkNsYXJrLCBPLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9y

cz48YXV0aC1hZGRyZXNzPlNlY3Rpb24gb2YgRW5kb2NyaW5lIFN1cmdlcnksIFVuaXZlcnNpdHkg

b2YgQ2FsaWZvcm5pYSwgTG9zIEFuZ2VsZXMsIENhbGlmb3JuaWEgOTAwOTUsIFVTQS4gYWhhcmFy

aUBtZWRuZXQudWNsYS5lZHU8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5QYXJhdGh5cm9p

ZCBjYXJjaW5vbWE6IGEgNDMteWVhciBvdXRjb21lIGFuZCBzdXJ2aXZhbCBhbmFseXNpczwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRp

dGxlPjxhbHQtdGl0bGU+VGhlIEpvdXJuYWwgb2YgY2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQg

bWV0YWJvbGlzbTwvYWx0LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkog

Q2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjxhYmJyLTE+VGhlIEpvdXJuYWwgb2Yg

Y2xpbmljYWwgZW5kb2NyaW5vbG9neSBhbmQgbWV0YWJvbGlzbTwvYWJici0xPjwvcGVyaW9kaWNh

bD48YWx0LXBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L2Z1

bGwtdGl0bGU+PGFiYnItMT5UaGUgSm91cm5hbCBvZiBjbGluaWNhbCBlbmRvY3Jpbm9sb2d5IGFu

ZCBtZXRhYm9saXNtPC9hYmJyLTE+PC9hbHQtcGVyaW9kaWNhbD48cGFnZXM+MzY3OS04NjwvcGFn

ZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+MTI8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5d29yZD5BZ2VkLCA4

MCBhbmQgb3Zlcjwva2V5d29yZD48a2V5d29yZD5DYXJjaW5vbWEvY29tcGxpY2F0aW9ucy8qbW9y

dGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+SHlwZXJwYXJhdGh5cm9pZGlzbS9l

dGlvbG9neS8qbW9ydGFsaXR5L3BhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TmVvcGxh

c20gUmVjdXJyZW5jZSwgTG9jYWwvKm1vcnRhbGl0eS9wYXRob2xvZ3kvc3VyZ2VyeTwva2V5d29y

ZD48a2V5d29yZD5QYXJhdGh5cm9pZCBHbGFuZHMvKnBhdGhvbG9neS9zdXJnZXJ5PC9rZXl3b3Jk

PjxrZXl3b3JkPlBhcmF0aHlyb2lkIE5lb3BsYXNtcy9jb21wbGljYXRpb25zLyptb3J0YWxpdHkv

cGF0aG9sb2d5L3N1cmdlcnk8L2tleXdvcmQ+PGtleXdvcmQ+UGFyYXRoeXJvaWRlY3RvbXk8L2tl

eXdvcmQ+PGtleXdvcmQ+UmVvcGVyYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9zcGVjdGl2

ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZpdmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlN1cnZpdmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJlYXRtZW50IE91dGNvbWU8

L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxk

YXRlPkRlYzwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE5NDUtNzE5NyAoRWxlY3Ry

b25pYykmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjE5Mzc2

MjY8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi

aS5ubG0ubmloLmdvdi9wdWJtZWQvMjE5Mzc2MjY8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+

PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMTAvamMuMjAxMS0xNTcxPC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA 19). Conclusion: Parathyroid surgery has evolved from conventional open parathyroidectomy, with exploration of all four parathyroid glands, to minimal access open or endoscopic parathyroidectomy. This evolution was made possible by the development of high resolution radiological techniques and the development of the rapid IOPTH assay. Sonography and technetium-99m-sestamibi (99mTc-sestamibi) scintigraphy are the most commonly used imaging techniques for the demonstration of parathyroid lesions.Neck ultrasonography is a non-invasive and relatively inexpensive tool that should be considered in all patients with overt hyperparathyroidism. The recent development and adoption of 99technetium-labelled sestamibi (99mTc-sestamibi) scintigraphy has enhanced our ability to distinguish between single-gland and multigland parathyroid disease. Although not routine, CT scan of the neck and chest may also be indicated in some cases to assess for disseminated disease.Recently, some investigators described a promising method by which a 3rd-generation to 2nd-generation PTH ratio >1 can help predict whether a parathyroid tumor is more likely to be malignant in the preoperative setting (sensitivity: ~75-82%; specificity: ~97-98%).Rapid intraoperative assay is extremely helpful in confirming the complete removal of abnormal “hyperfunctioning” parathyroid tissue (demonstrated by >50% decrease in circulating PTH level 10-15 min after surgical excision), and can help distinguish between single-gland and multi-gland disease.Parathyroidectomy is the treatment of choice for Primary hyperparathyroidism. However, In some patients, with medical comorbidities may preclude surgery, controlling hypercalcemia alone may be the goal.ReferencesStearns M and Cox J (2010): Parathyroid disease: symptoms, differential diagnosis, and management. In: Arora A, Tolley NS, Tuttle RM, eds. A Practical Manual of Thyroid and Parathyroid Disease. Chichester, UK: Wiley- Blackwell; pp: 145-163.Fraser WD (2009): Hyperparathyroidism. Lancet; 374:145–158.Duan K, Gomez Hernandez K, Mete O (2015): Clinicopathological correlates of hyperparathyroidism. J Clin Pathol. In press.Betea D, Potorac I, Beckers A (2015): Parathyroid carcinoma: Challenges in diagnosis and treatment. Ann Endocrinol (Paris); 76:169-77.Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014): Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab.;99:3561-9.Greene AB, Butler RS, Mc Intyre S, et al., (2009): National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg; 209:332–343.Scharpf, J., N. Kyriazidis, D. Kamani and G. Randolph (2016). "Anatomy and embryology of the parathyroid gland." Operative Techniques in Otolaryngology-Head and Neck Surgery 27(3): 117-121.Stewart, W. B. and L. J. Rizzolo (2012). Embryology and Surgical Anatomy of the Thyroid and Parathyroid Glands. Surgery of the Thyroid and Parathyroid Glands. D. Oertli and R. Udelsman. Berlin, Heidelberg, Springer Berlin Heidelberg: 15-23.Akerstrom, G., J. Malmaeus and R. Bergstrom (1984). "Surgical anatomy of human parathyroid glands." Surgery 95(1): 14-21.Kalinin, A. P., A. V. Pavlov, Y. K. Alexandrov, I. V. Kotova, Y. N. Patrunov and S. N. Pamputis (2013). Embryonic Development and Anatomic and Histological Structure of the Parathyroid Glands. The Parathyroid Glands: Imaging and Surgery. Berlin, Heidelberg, Springer Berlin Heidelberg: 1-12.Pavlov, A. V. (2004). "[Adrenergic regulation of the structure and function of the parathyroid glands]." Morfologiia 125(3): 103-108.Limone, P. P., M. Deandrea, E. Gamarra, F. Garino, A. Grassi, G. Magliona, A. Mormile, F. Ragazzoni, M. J. Ramunni and P. Razzore (2016). Etiology and Pathogenesis of Primary Hyperparathyroidism and Hypercalcemias. Primary, Secondary and Tertiary Hyperparathyroidism: Diagnostic and Therapeutic Updates. G. Gasparri, N. Palestini and M. Camandona. Milano, Springer Milan: 41-55.Erickson, L. A. (2014). Atlas of Endocrine Pathology, Springer New York.Michels, T. C. and K. M. Kelly (2013). "Parathyroid disorders." Am Fam Physician 88(4): 249-257.Townsend, C. M., R. D. Beauchamp, B. M. Evers and K. L. Mattox (2012). Sabiston Textbook of Surgery E-Book, Elsevier Health Sciences.Sfeir, J. G. and M. T. Drake (2016). Ectopic Parathyroid Adenoma. Hyperparathyroidism: A Clinical Casebook. A. E. Kearns and R. A. Wermers. Cham, Springer International Publishing: 65-74.Wieneke, J. A. and A. Smith (2008). "Parathyroid Adenoma." Head and Neck Pathology 2(4): 305-308.Kebebew, E. (2008). "Parathyroid carcinoma, a rare but important disorder for endocrinologists, primary care physicians, and endocrine surgeons." Thyroid 18(4): 385-386.Harari, A., A. Waring, G. Fernandez-Ranvier, J. Hwang, I. Suh, E. Mitmaker, W. Shen, J. Gosnell, Q. Y. Duh and O. Clark (2011). "Parathyroid carcinoma: a 43-year outcome and survival analysis." J Clin Endocrinol Metab 96(12): 3679-3686.Karaarslan, S., F. N. Yurum, B. S. Kumbaraci, E. E. Pala, O. N. Sivrikoz, M. Akyildiz and M. H. Bugdayci (2015). "The Role of Parafibromin, Galectin-3, HBME-1, and Ki-67 in the Differential Diagnosis of Parathyroid Tumors." Oman Med J 30(6): 421-427.Taillandier, J., P. Kauffman, F. Raynaud, Y. Ptak and J. Dauplat (1994). "[Preoperative localization of parathyroid adenomas. Role of cervical ultrasonography]." Presse Med 23(3): 116-120.Kairys, J. C., C. Daskalakis and R. J. Weigel (2006). "Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism." World J Surg 30(9): 1658-1663; discussion 1664.Xue, J., Y. Liu, T. Ji, A. Zhao, Y. Liang, H. Deng, Q. Wang, Y. Zhang, L. Yang and A. Yang (2018). "Comparison between technetium-99m methoxyisobutylisonitrilescintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia." Nucl Med Commun 39(12): 1129-1137.Razavi, S., B. Ziebarth, R. Klein and W. Zeng (2018). "Dual time-point quantitative SPECT-CT parathyroid imaging using a single computed tomography: feasibility and operator variability." Nucl Med Commun 39(1): 3-9.Argiro, R., D. Diacinti, B. Sacconi, A. Iannarelli, D. Diacinti, C. Cipriani, D. Pisani, E. Romagnoli, M. Biffoni, C. Di Gioia, J. Pepe, M. Bezzi, C. Letizia, S. Minisola and C. Catalano (2018). "Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans." Eur Radiol.Moralidis, E. (2013). "Radionuclide parathyroid imaging: a concise, updated review." Hell J Nucl Med 16(2): 125-133.Bilezikian, J. P., A. A. Khan, J. T. Potts, Jr. and H. Third International Workshop on the Management of Asymptomatic Primary (2009). "Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop." J Clin Endocrinol Metab 94(2): 335-339.Suliburk, J. W. and N. D. Perrier (2007). "Primary hyperparathyroidism." Oncologist 12(6): 644-653.Alhefdhi, A., D. F. Schneider, R. Sippel and H. Chen (2014). "Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas." J Surg Res 190(1): 198-202.Padmanabhan, H. (2011). "Outpatient management of primary hyperparathyroidism." Am J Med 124(10): 911-914.Chen, H., E. Mack and J. R. Starling (2005). "A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?" Ann Surg 242(3): 375-380; discussion 380-373.Neychev, V. K., G. Kouniavsky, Z. Shiue, D. N. Udall, H. Somervell, C. B. Umbricht and M. A. Zeiger (2011). "Chasing "shadows": discovering the subtleties of sestamibi scans to facilitate minimally invasive parathyroidectomy." World J Surg 35(1): 140-146.Terris, D. J., B. C. Stack, Jr. and C. G. Gourin (2007). "Contemporary parathyroidectomy: exploiting technology." Am J Otolaryngol 28(6): 408-414.Ardito, G., L. Revelli, E. Giustozzi and A. Giordano (2012). "Radio guided parathyroidectomy in forearm graft for recurrent hyperparathyroidism." Br J Radiol 85(1009): e1-3.Henry, J. F., M. Iacobone, E. Mirallie, A. Deveze and S. Pili (2001). "Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism." Surgery 130(6): 999-1004.Abbas, G., S. Dubner and K. S. Heller (2001). "Re-operation for bleeding after thyroidectomy and parathyroidectomy." Head Neck 23(7): 544-546.Westerdahl, J., P. Lindblom, S. Valdemarsson, S. Tibblin and A. Bergenfelz (2000). "Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism." Arch Surg 135(2): 142-147.Caron, N. R., C. Sturgeon and O. H. Clark (2004). "Persistent and recurrent hyperparathyroidism." Curr Treat Options Oncol 5(4): 335-345.Khan A, Grey A, Shoback D (2009): Medical management of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab; 94(2):373-381. Busaidy, N. L., C. Jimenez, M. A. Habra, P. N. Schultz, A. K. El-Naggar, G. L. Clayman, J. A. Asper, E. M. Diaz, Jr., D. B. Evans, R. F. Gagel, A. Garden, A. O. Hoff, J. E. Lee, W. H. Morrison, D. I. Rosenthal, S. I. Sherman, E. M. Sturgis, S. G. Waguespack, R. S. Weber, K. Wirfel and R. Vassilopoulou-Sellin (2004). "Parathyroid carcinoma: a 22-year experience." Head Neck 26(8): 716-726.Rodgers, S. E. and N. D. Perrier (2006). "Parathyroid carcinoma." Curr Opin Oncol 18(1): 16-22.Ariyan, C. E. and J. A. Sosa (2004). "Assessment and management of patients with abnormal calcium." Crit Care Med 32(4 Suppl): S146-154.Gao, W. C., C. P. Ruan, J. C. Zhang, H. M. Liu, X. Y. Xu, Y. P. Sun and Q. Wang (2010). "Nonfunctional parathyroid carcinoma." J Cancer Res Clin Oncol 136(7): 969-974.Chow, E., R. W. Tsang, J. D. Brierley and S. Filice (1998). "Parathyroid carcinoma--the Princess Margaret Hospital experience." Int J Radiat Oncol Biol Phys 41(3): 569-572.Silverberg, S. J., M. R. Rubin, C. Faiman, M. Peacock, D. M. Shoback, R. C. Smallridge, L. E. Schwanauer, K. A. Olson, P. Klassen and J. P. Bilezikian (2007). "Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma." J Clin Endocrinol Metab 92(10): 3803-3808.Betea, D., A. R. Bradwell, T. C. Harvey, G. P. Mead, H. Schmidt-Gayk, B. Ghaye, A. F. Daly and A. Beckers (2004). "Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma." J Clin Endocrinol Metab 89(7): 3413-3420.Montenegro, F. L., M. C. Chammas, A. G. Juliano, C. R. Cernea and A. C. Cordeiro (2008). "Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma." Arq Bras Endocrinol Metabol 52(4): 707-711.Tochio, M., H. Takaki, K. Yamakado, J. Uraki, M. Kashima, A. Nakatsuka, M. Takao, A. Shimamoto, T. Tarukawa, H. Shimpo and K. Takeda (2010). "A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism." Cardiovasc Intervent Radiol 33(3): 657-659.Rahbari, R., A. K. Holloway, M. He, E. Khanafshar, O. H. Clark and E. Kebebew (2011). "Identification of differentially expressed microRNA in parathyroid tumors." Ann Surg Oncol 18(4): 1158-1165.Shane, E. (2001). "Clinical review 122: Parathyroid carcinoma." J Clin Endocrinol Metab 86(2): 485-493.Hundahl, S. A., I. D. Fleming, A. M. Fremgen and H. R. Menck (1999). "Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society." Cancer 86(3): 538-544.8/6/2019 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download